University of Montana

ScholarWorks at University of Montana
Graduate Student Theses, Dissertations, &
Professional Papers

Graduate School

2012

The Role of NADPH Oxidase in Ischemia/Reperfusion-Induced
Alterations to AMPA Receptor Trafficking and NMDA Receptor
Function
Phillip Howard Beske
The University of Montana

Follow this and additional works at: https://scholarworks.umt.edu/etd

Let us know how access to this document benefits you.
Recommended Citation
Beske, Phillip Howard, "The Role of NADPH Oxidase in Ischemia/Reperfusion-Induced Alterations to
AMPA Receptor Trafficking and NMDA Receptor Function" (2012). Graduate Student Theses,
Dissertations, & Professional Papers. 1071.
https://scholarworks.umt.edu/etd/1071

This Dissertation is brought to you for free and open access by the Graduate School at ScholarWorks at University of
Montana. It has been accepted for inclusion in Graduate Student Theses, Dissertations, & Professional Papers by an
authorized administrator of ScholarWorks at University of Montana. For more information, please contact
scholarworks@mso.umt.edu.

THE ROLE OF NADPH OXIDASE IN ISCHEMIA/REPERFUSION-INDUCED
ALTERATIONS TO AMPA RECEPTOR TRAFFICKING AND NMDA RECEPTOR
FUNCTION
By
Phillip Howard Beske
B.A, Luther College, Decorah, IA, USA, 2006
Dissertation Paper
Presented in partial fulfillment of the requirements for the degree of
Doctor of Philosophy
in Neuroscience
The University of Montana
Missoula, MT
January 2012
Approved by:
Stephen Sprang,
Associate Provost for Graduate Education and Dean of The Graduate School
Graduate School
Darrell Jackson, Chair
Department of Biomedical and Pharmaceutical Sciences
Howard Beall
Department of Biomedical and Pharmaceutical Sciences
Jesse Hay
Division of Biological Sciences
David Poulsen
Department of Biomedical and Pharmaceutical Sciences
J.B Alexander (Sandy) Ross, Associate Dean of the Graduate School
Department of Chemistry and Biochemistry

Beske, Phillip, Ph.D, January 2012
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The Role of NADPH Oxidase in Ischemia/Reperfusion-Induced Alterations to
AMPA Receptor Trafficking and NMDA Receptor Function.
Chairperson: Dr. Darrell Jackson
ABSTRACT
Following a stroke, the pathological increase in intracellular calcium arising from the
over-activation of post-synaptic glutamatergic receptors has long been established as a
key contributor to neuronal death. Also contributing to ischemic/reperfusion-induced
neuronal death is oxidative stress, chemically defined as a pathologic state within the cell
arising from the increased generation of reactive oxygen and nitrogen species and/or a
decrease in the ability of the cell to scavenge and detoxify the reactive intermediates.
Strong evidence supports the notion that oxidative stress serves as an important mediator
in leading to alterations in intracellular signaling events, ultimately affecting cellular
function. However, few studies to date have investigated the role of a key reactive
oxygen species generator, NADPH oxidase, in mediating the signaling events leading to
alterations in NMDA and AMPA receptor function following ischemia/reperfusion.
Therefore, the current series of studies examines the role of reactive oxygen species
production from NADPH oxidase following oxygen-glucose deprivation/reperfusion
(OGD/R) and the downstream redox-dependent signaling pathways leading to changes in
NMDA and AMPA receptor function. In-vitro studies using differentiated SH-SY5Y
human neuroblastoma cells were performed to test the hypothesis that NADPH oxidasedependent ROS production mediates the increased tyrosine phosphorylation status of the
NMDA receptor NR2A subunit following OGD/R, ultimately resulting in an
enhancement of NMDA receptor mediated cell death. In-situ studies using acute
organotypical hippocampal slices prepared from adult male rats were performed to
examine the role of the OGD/R-induced increase in NADPH oxidase activity in
accelerating the endocytic machineries involved in the surface removal and selective
degradation of the AMPA receptor GluR2 subunit following OGD/R. These studies
demonstrated that the increased NADPH oxidase-dependent reactive oxygen species
production during reperfusion of OGD treated slices was involved in mediating the
internalization of the GluR2 subunit, not only through increasing the serine 880
phosphorylation of the GluR2 subunit, thereby leading to a decreased anchoring of
GluR2 with membrane scaffolding proteins, but also by enhancing the activity of the
endocytic machinery responsible for the internalization of AMPA receptors. Collectively,
these studies begin to elucidate a role for NADPH oxidase-dependent signaling pathways
in the ischemic/reperfusion-induced pathologic alterations in NMDA and AMPA
receptors known to occur following stroke.
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GENERAL INTRODUCTION
Stroke Classifications and Pathophysiology
Every year in the United States, approximately 795,000 people suffer from a
stroke, making it the leading cause of disability and the third leading cause of death in the
United States after heart disease and cancer (Falluji et al., 2011). In its most basic form,
a stroke is defined as a medical emergency arising from the loss of brain function due to a
disruption in blood delivery to affected areas of the brain. Normal brain function operates
at a high metabolic rate, and since the brain does not store glucose, a nutrient necessary
for energy production, it remains very susceptible to any decreases in the delivery of
glucose through the bloodstream.
However, while most strokes can be generally classified as the deprivation of
oxygen and glucose through inadequate blood delivery to the brain, a stroke can occur in
various forms. About 10 to 15% of stroke patients suffer from hemorrhagic stroke
(Broderick et al., 2007), or a rupture of a blood vessel within the brain, resulting in the
deprivation of both oxygen and glucose to the regions of brain tissue surrounding the
blood vessel rupture.
The most common form of stroke, which constitutes about 80-85% of all strokes,
is termed “ischemic stroke,” occurring when blood flow to an area of the brain is
decreased or completely absent as a result of a vessel occlusion, typically from a
thrombus or embolus (Falluji et al., 2011). A thrombotic stroke results from a blood clot
blocking an blood vessel, which most frequently forms around an atherosclerotic plaque.
Because the blockage of the blood vessel is gradual in nature, the onset of thrombotic
stroke symptoms is frequently at a slower rate (Broderick et al., 2007). The other
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frequent type of ischemic stroke results from an embolus, or a travelling particle of debris
in the bloodstream originating from elsewhere in the body. Most often, the travelling
particle is a blood clot, but can also be other substances including plaque, cancer cells,
air, or clumps of bacteria from an infection of the endocardium. Other types of ischemic
stroke include systemic hypoperfusion, or a general decrease in blood supply often as a
result of circulatory shock or heart attack. Cerebral venous sinus thrombosis, a blood clot
of the dural venous sinuses responsible for draining blood from the brain, can also result
in an ischemic stroke.
Despite the fact that stroke type is fairly easily categorized in various forms,
stroke outcome cannot be classified or diagnosed so simply. The severity of each case of
ischemic stroke varies greatly depending on a variety of factors, including the time of
ischemia, the area of the brain in which blood supply is significantly reduced, the
presence and effectiveness of collateral circulation, and numerous other factors.
While a disturbance in blood flow leading to a complete lack of oxygen (anoxia)
or low levels of oxygen (hypoxia) coupled with no/low glucose delivery levels is in itself
a damaging event (ischemia), the reintroduction of blood supply (reperfusion) after a
period of ischemia further damages the brain tissue. This phenomena is often termed the
“oxygen paradox,” where the reintroduction of blood supply is necessary for survival, but
also results in further damage via inflammation, oxidative stress, and delayed cellular
death. However, while injury from reperfusion does cause further damage, the general
objective of stroke patient care is to restore blood flow as soon as possible without
causing intracerebral hemorrhage (Falluji et al., 2011).
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The brain damage resulting from ischemia/reperfusion is often sub-divided into
two areas, frequently termed the “necrotic core” and the “penumbra.” The necrotic core is
defined as the irreversibly damaged area of the brain immediately surrounding the area of
blood flow blockage (Schaller and Graf, 2004). Cells undergoing necrotic death die
among living neighboring cells without eliciting an inflammatory response via the
activation of microglial cells and do so because of physical, chemical, or osmotic damage
to the plasma membrane. This un-organized cellular death results in a build-up of dead
tissue and cell debris at or near the site of blood vessel occlusion, which after microglial
invasion and subsequent debris removal leads to tissue scarring. In terms of stroke
pathology, these areas of the brain do not have the potential to recover.
In contrast to the necrotic core, the ischemic penumbra is characterized as tissue
that is damaged but still viable in the areas surrounding the necrotic core (Schaller and
Graf, 2004). However, the life expectancy of cells within the penumbra is short, as cells
in the area have enough energy to survive for a short period of time but not enough to
properly maintain function (Hakim, 1998). Also in contrast to the necrotic core, tissue in
the penumbra does not typically die by necrosis, but rather through signals arising within
the cell resulting in programmed cell death (often called “apoptosis”). Therefore, since
tissue within the penumbra is not necessarily fated to die and may have the potential to
recover, the goal of many current stroke therapeutic development involves the design of
compounds with the ability to save as much of the penumbric tissue as possible. As to
date, while there have been and currently are many promising drugs in clinical testing
designed for stroke patient care, an effective and reliable therapeutic used for minimizing
stroke-induced neuronal damage has yet to reach the public.
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Stroke and Excitotoxicity
Calcium cytotoxicity, or more simply put, a pathologically elevated rise in
cytoplasmic calcium concentration, is a central mechanism involved in neuronal death in
many chronic as well as acute neurodegenerative diseases (Alzheimer’s disease,
Parkinson’s disease, Traumatic brain injury, and others). Initial reports of the cytotoxic
nature of high intracellular calcium concentrations date back over 30 years ago and have
long been established as a key event involved in the neurodegeneration observed with
ischemic/reperfusion injury (Szydlowska and Tymianski, 2010). While physiologic
increases in cytoplasmic calcium levels are responsible for many cellular processes such
as cell growth, differentiation, synaptic activity for example, abberent regulation of
neuronal activity leading to the accumulation of high intracellular calcium levels is also
responsible for much of the neuronal death associated with stroke (Arudine et al., 2003).
During ischemia/reperfusion, the abrupt lack of available energy in brain tissue
disrupts the ATP-dependent processes necessary to maintain ionic gradients critical to
normal cellular function and ionic homeostasis. As a consequence of the ion gradient
collapse, excessive levels of neurotransmitter are released into the synapse. Of particular
importance is the excessive release of the neurotransmitter glutamate, the primary
excitatory neurotransmitter in the brain. Additionally, the function of excitatory amino
acid transporters (EAATs) on both neurons and astrocytes is compromised by the lack of
ionic homeostatsis that occurs during ischemia/reperfusion, ultimately impairing the
ability of the transporters to clear glutamate from the synapse, leading to prolonged
elevated glutamate concentrations in the synapse (Camacho and Massieu, 2006). In turn,
excessive levels of glutamate in the synapse over-activate post-synaptic glutamatergic
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targets such as NMDA, AMPA, and kainate receptors, thereby causing the ion channels
to open and allow for the excessive influx of calcium.
In addition to increased calcium influx through post-synaptic receptors,
intracellular stores of calcium are also released from the mitochondria and endoplasmic
reticulum (via the inositol triphosphate receptor (IP3R)) due to the activation of postsynaptic metabotropic glutamate receptors (mGluRs), as well as the activation of other
metabotropic receptors as a consequence of acetylcholine, dopamine, and serotonin
neurotransmitter release (Arudine et al., 2003). Furthermore, enhanced calcium entry into
the neuron following ischemia has also been linked to include other ion channels and
transporters such as the transient receptor potential cation channel, subfamily M, member
2 and 7 (TRPM2/7), Na+/Ca2+ exchangers (NCX), acid-sensing ion channels (ASICs) or
plasma membrane Ca2+ ATPase (PMCA), and L-type voltage-dependent calcium
channels (Szydlowska and Tymianski, 2010).

5

Stroke and Apoptosis
One of the damaging consequences of the pathologic increase in cytosolic
calcium during ischemia/reperfusion arising from the over-activation of NMDA and
calcium-permeable AMPA receptors is the opening of the mitochondrial permeability
transition pore. When mitochondria absorb too much calcium, the organelle opens a pore
to release excess calcium. In addition to calcium exit from the mitochondria, proteins are
also released, particularly cytochrome c, which can initiate programmed cell death
(Stavrovskaya and Kristal, 2006). In conditions of normal physiologic mitochondrial
function, cytochrome c is an essential component of the electron transport chain in the
mitochondria, responsible for transferring electrons between Complexes III (Coenzyme Q
– Cytochrome C reductase) and IV (Cytochrome C oxidase), which is necessary for the
production of ATP. Typically, cytochrome c is associated with the inner membrane of the
mitochondria, but during stress-like cellular conditions, or in response to pro-apoptotic
stimuli, cytochrome c is released into the cytoplasm (Tafani et al., 2002). The release of
cytochrome c is responsible for the activation of cysteine-dependent aspartate-directed
proteases (caspases), which play an essential role in programmed cell death. Termed the
“intrinsic apoptotic pathway”, once cytochrome c is released, it binds with Apoptotic
protease activating factor-1 (Apaf-1), which also binds pro-caspase-9 to form a protein
complex known as the apoptosome (Dejean et al., 2006). Consequently, the apoptosome
cleaves pro-caspase-9 to its active cleaved form of caspase-9, which then cleaves procapase-3 to active caspase-3. Through caspase-3-dependent proteolysis of other caspases,
proteins, and poly(ADP-ribose) polymerase (PARP), caspase-3 activation serves as a
central step responsible for killing the cell from within (Stravrovskaya and Kristal, 2006).
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However, while the release of cytochrome c from the mitochondria is a crucial
event leading to ischemia/reperfusion-induced apoptosis, numerous pathways upstream
of cytochrome c release also affect apoptotic signaling. Oxidative stress, or the
overproduction of reactive oxygen species (ROS) following ischemia/reperfusion,
activates a number of pathways that have been demonstrated to modulate the intrinsic
pathway of apoptosis (Niizuma et al., 2010). Bcl-2 proteins are a family of evolutionarily
related proteins which are important in governing mitochondrial membrane
permeabilization and are typically classified in three sub-groups: anti-apoptotic (Bcl-2,
Bcl-XL, Bcl-w), pro-apoptotic (Bax, Bak, Bad, Bim, Noxa), and p53-upregulated
modulator of apoptosis (PUMA; Niizuma et al., 2010). The pro-apoptotic protein Bax,
which competes with the anti-apoptotic protein Bcl-2 proper, has been shown to be upregulated following ischemia/reperfusion, which further contributes to cytochrome c
release from the mitochondria via promoting the formation of the mitochondrial
apoptosis-induced channel (MAC; Xi et al., 2011) through which cytochrome c can exit.
Another key regulator of apoptosis is p53, which has been shown to transcriptionally upregulate a number of pro-apoptotic proteins after ischemia (Bax, Bid, Noxa, and PUMA),
as well as directly regulate apoptosis in a transcription-independent manner by
translocating to the mitochondria and interacting with the anti-apoptotic Bcl-XL protein,
thereby aiding directly in cytochrome c release (Endo et al., 2006).
Opposing the activity of pro-apoptotic signaling during ischemia is the kinase
Akt, a downstream target of PI3-kinase. Akt is responsible for the phosphorylation and
inactivation of the pro-apoptotic protein Bad following ischemia/reperfusion, ultimately
diminishing the ability of Bad to inhibit the activity of pro-survival Bcl-2 family proteins
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(Kamala et al., 2007). Additionally, Akt is responsible for the phosphorylation of
MDM2, which in turn increases the degradation of p53, thereby diminishing the
contribution of p53 in ischemic-induced apoptotic signaling (Niizuma et al., 2010).
While the “intrinsic” apoptotic pathway is perhaps the best studied in
ischemia/reperfusion, the “extrinsic” or receptor-mediated pathway has also been shown
to contribute to stroke-induced apoptosis. Fas, a death receptor, is also involved in
ischemic apoptosis through the up-regulation of Fas receptor and Fas ligand expression
(Rosenbaum et al., 2000). The Fas receptor forms the death-inducing signaling complex
(DISC) upon ligand binding, which in turn activates procaspase-8, thereby cleaving and
activating the pro-apoptotic protein Bid as well as directly activating caspase-3.
In addition to the intrinsic and extrinsic caspase-dependent apoptotic pathways,
caspase-independent pathways are involved in ischemic/reperfusion mediated
programmed cell death as well (Niizuma et al., 2010). Apoptosis-inducing factor (AIF) is
released from the mitochondria following stroke and translocates to the nucleus,
ultimately leading to large-scale DNA fragmentation and apoptosis via an unidentified
caspase-independent mechanism (Culmsee et al., 2005). In a similar manner,
endonuclease G contributes to caspase-independent apoptosis following
ischemia/reperfusion by translocating from the mitochondria to the nucleus where it is
responsible for DNA fragmentation (Lee et al., 2005). Taken together, the cell undergoes
a complex and multifaceted apoptotic signal involved in the delayed neuronal death seen
within cells of the penumbra following stroke.
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Diagram 1. Schematic representation of the initiation and regulation of neuronal
apoptosis after ischemia. Pathologic mechanisms triggering apoptosis after ischemia
include oxidative stress, energy failure, excitotoxicity (primarily excess glutamate),
axonal injury, trophic factor withdrawal, ER stress, and/or death receptor-ligand binding
(for example TNF, Fas). Regulation of apoptosis occurs through multiple pathways
including kinase-dependent intracellular signaling pathways and Bcl-2 family proteins.
Execution of apoptosis involves the caspase cascade and/or release of apoptogenic factors
from organelles such as mitochondria and lysosomes. Ultimately DNA fragmentation,
cytoskeletal disintegration, and externalization of membrane phosphatidylserine occurs,
signaling macrophages and microglia to engulf cellular debris. Potential therapeutic
targets discussed in this review are highlighted within the dashed yellow lines. AIF,
apoptosis-inducing factor; Apaf-1, apoptotic protease activating factor-1; Bcl, B-cell
lymphoma; CAD, caspase-activated deoxyribonuclease; casp, caspase; cyto c,
cytochrome c; DISC, death-inducing signaling complex; Endo G, endonuclease G; ER,
endoplasmic reticulum; iCAD, inhibitor of CAD; ROS, reactive oxygen species; tBid,
truncated Bid; TNF, tumor necrosis factor; TNFR, TNF receptor; TRAF2, TNF receptor
associated factor. (From Zhang X et al., 2005).
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NADPH Oxidase Structure and Function
Nicotinamide adenine dinucleotide phosphate-oxidase (NADPH oxidase) is a
multi-subunit enzyme responsible for the single electron transfer from NADPH to oxygen
(O2) to form superoxide (O2._) and NADP+ , with flavin adenine dinucleotide (FAD)
serving as a necessary co-factor. NADPH oxidase was first characterized over 40 years
ago as the enzyme responsible for the oxidative burst observed in neutrophils to provide
host defense against bacteria (Infanger et al., 2006). While the role NADPH oxidase was
once thought to be limited only in the modulation of immunological responses, numerous
studies within the past 15 years that have clearly demonstrated that the function of
NADPH oxidase ROS production is much more diverse, involving a large variety of
cellular functions in a wide array of cells and tissues. The NADPH oxidase (Nox) family
has been shown to arise from numerous Nox proteins (Nox1-5 and Duox1/2) in a tissue
specific manner to produce superoxide in not only the immune system, but also the brain,
the vasculature, the kidneys and the digestive tract, ultimately mediating a number of
physiologic processes including the regulation of gene expression, proliferation,
differentiation, migration, apoptosis, and learning and memory (Brown and Griendling,
2009).
Although seven distinct NOX genes have been identified, all share the
commonality of producing superoxide. However, due to subcellular
compartmentalization and expression patterns, specificity is achieved in proper
downstream physiologic targeting from Nox-derived superoxide (Brown and Griendling,
2009). Nox1, the first novel NADPH oxidase subunit to be cloned, is most highly
expressed in the colon (Rokutan et al., 2008), but has also been discovered in endothelial
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cells, the uterus, the placenta (Cui et al., 2006), the prostate, osteoclasts (Lee et al.,
2005), retinal pericytes, neurons, astrocytes, and microglia (Sacre and Krausse, 2009).
Nox1 is activated through association with the membrane subunit p22phox, subsequently
forming a complex with the cytosolic activators p47phox, p67phox, and the small GTPase
Rac. Additionally, Nox1 can associate with the p47phox and p67phox homologues, NoxO1
and NoxA1 (Brown and Griendling, 2009) to produce superoxide.
Nox2, also often called neutrophil NADPH oxidase, was the first discovered Nox
family member. Nox2 is most highly expressed in phagocytes, but has also been
discovered in the central nervous system (CNS; Sacre and Krause, 2009), fibroblasts,
cardiomyocytes, skeletal muscle, hepatocyctes in the liver, and hematopoietic stem cells
(Bedard and Kruase, 2007). Nox2 is formed through the constitutive association with the
membrane subunit p22phox. The cytosolic activator, p47phox, when phosphorylated on 8-9
serine residues by protein kinase C (PKC), results in the exposure of an SH3 binding site
on p47phox. The exposed SH3 binding site consequently interacts with a proline-rich
region of p22phox, thereby allowing for the translocation of p47phox to the membrane (El
Benna et al., 1996). In turn, p67phox binds to the translocated p47phox, which provides a
binding site for activated Rac, thereby forming a functional holoenzyme along with
p40phox (Brown and Griendling, 2009).
Nox3 is most highly expressed in the inner ear, but has also been detected in the
fetal spleen, kidney, lung, and skull (Banfi et al., 2004). Nox3 is activated through
association with p22phox, as well as NoxO1 and p67phox, but many studies done on Nox3
activity have been contradictory, as the exact mechanisms of Nox3 regulation remain
muddled (Cheng et al., 2004; Uneo et al., 2005).
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Nox4 is most highly expressed in the kidney, but is also expressed in smooth
muscle cells, endothelial cells, fibroblasts, keratinocytes, osteoclasts, neurons, and
hepatocytes (Brown and Griendling, 2009). However, unlike the other Nox family
members, Nox4 is unique in that the only requirement for ROS production is the presence
of the membrane subunit p22phox. As a consequence of this constitutive activity, Nox4 is
not dependent on any cellular signals from cytosolic activators, as its activity is governed
solely by the proportional expression of the Nox4 protein (Chen et al., 2008). Nox4 also
differs from other Nox family enzymes because the superoxide produced via Nox4
activity is so rapidly converted to hydrogen peroxide (H2O2) that the superoxide produced
is almost undetectable, thereby making hydrogen peroxide responsible for carrying out
the downstream effects of Nox4 (Serrander et al., 2007).
Nox5 has been demonstrated to be present in lymphatic tissue, the testis,
endothelial cells, the spleen, the uterus, and prostate cancer cells (Brown and Griendling,
2009). Nox5 is also unique in that its activation is regulated by calcium instead of by the
cytosolic activators necessary for Nox1-3 activation (Banfi et al., 2001). Various Nox5
isoforms exist, but most contain an EF-hand motif at the N-terminus, which regulates and
increases Nox5 activity with increasing calcium concentrations (Banfi et al., 2001).
Additionally, PKC mediated phosphorylation of Nox5 increases the sensitivity of Nox5
to calcium, allowing for greater Nox5 activation at lower calcium concentrations
(Jagnandan et al., 2007).
Duox1/Duox2 proteins were originally isolated from the thyroid but are also
expressed in respiratory epithelium (Brown and Griendling, 2009). Duox proteins have a
dual nature because of the presence of an extracellular peroxidase domain along with the
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EF-hand calcium-binding domain seen in Nox5 proteins (De Deken et al., 2000). PKC
phosphorylation of the Duox enzyme also positively modulates Duox1/2 activity, but
uniquely, Duox proteins directly produce hydrogen peroxide via a two electron reduction
of oxygen, rather than via a two step single electron reduction with superoxide as an
intermediate (Dupuy et al., 1989).
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Diagram 2. Nox family members and their regulatory subunits. Although no threedimensional crystallization of Nox proteins has been performed, they are believed to
contain six transmembrane domains based on hydrophobicity analysis (seven for
Duox1/2). Oxidase activity occurs when NADPH binds to Nox on the cytosolic side,
where it transfers electrons to FAD and the heme centers (not shown) and finally to
oxygen on the outer membrane surface, resulting in O2

−

formation. In Nox1-4, the

transmembrane subunit p22phox associates with active and inactive Nox. It is believed to
have between two and four transmembrane segments. Nox1 is believed to primarily
interact with the cytosolic subunits NoxO1, NoxA1, and GTP-Rac on activation;
however, p47phox and p67phox can replace NoxO1 and NoxA1, respectively. Nox2
activation involves association with GTP-Rac, p47phox, p67phox, and p40phox. Nox3
activation is less well defined, but is believed to primarily involve GTP-Rac, p47phox, and
NoxA1 in the inner ear. Nox4 is constitutively active when associating with the cytosolic
p22phox subunit. Nox5 and Duox1/2 activation involves Ca2+ binding to EF-hand domains
in the cytosol. Duox1/2 require the association of DuoxA1/2, respectively, for
localization to the plasma membrane. (From Brown and Griendling, 2009).
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NADPH Oxidase in CNS Physiology
While multiple Nox proteins are often expressed in the same cell or tissue, each of
these enzymes are responsible for regulating a host of different functions in different cell
types. Since all Nox proteins produce the same reactive oxygen species (O2._ or H2O2), it
is clear that the various subcellular localizations and the coupling to external stimuli are
of crucial importance in ultimately determining the response to Nox activation for
downstream signaling (Infanger et al. 2006).
In the CNS, Nox1, Nox2, Nox3, and Nox4 transcripts have been detected (Sorce
and Krause, 2009). In terms of cell specific expression of Nox proteins, Nox1, Nox2, and
Nox4 isoforms are present in neurons, astrocytes, and microglial, while the exact
localization of Nox3 has not yet been fully elucidated (Sorce and Krause, 2009). Spatial
localization studies have indicated that Nox proteins not only have a synaptic
localization, as shown by axonal and dendritic expression on neurons, but are also
localized to the soma (Tejada-Simon et al., 2005).
While data exists for the Nox1 and Nox3-dependent neurologic function
(locomotor activity, movement coordination, blood pressure regulation, and
inflammation), the most documented Nox-dependent CNS physiologic studies revolve
around the Nox2 isoform (Sorce and Kruase, 2009). Nox2 is important in the processes of
long-term potentiation (LTP) and hippocampal dependent memory (Infanger et al.,
2006), which is consistent with histological studies that have demonstrated Nox2 is most
highly expressed in the hippocampus (Serrano et al. 2003; Tejada-Simon et al., 2005). A
controlled intracellular redox environment in hippocampal neurons has as been strongly
implicated in the processes of learning and memory. First, overexpression of superoxide
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dismutase (SOD), the enzyme responsible for converting superoxide to hydrogen
peroxide, has been shown to impair memory function in mice, which can be reversed
with pharmacological inhibition of SOD (Thiels et al., 2000). Also, general ROS
production during neuron-glia signaling in the hippocampus is important in the
translational modifications of neighboring cells that enhance LTP (Atkins and Sweatt,
1999). More direct approaches linking hippocampal function with NADPH oxidase
activity have shown that genetic ablation of proteins in the Nox2 enzyme complex
(gp91phox, p47phox, p67phox, gp22phox) which render Nox2 unable to produce superoxide
lead to impaired cognitive function in mice (Kishida et al., 2006).
At a receptor level, NADPH oxidase activity also has effects on NMDAR
signaling, one of the best-studied post-synaptic receptors involved in hippocampal
learning and memory. NMDAR activity is controlled, in part, by redox potential.
Oxidation of cysteine residues on NR1 and NR2A subunits modify channel conformation
and modulate ligand-binding in an allosteric manner (Lipton et al., 2002). Pharmacologic
Nox inhibition blocks NMDAR dependent LTP, either through oxidant regulation of the
receptor itself (Sorce and Krause, 2009), or the activation of ERK 1/2, which has both
been identified as necessary for LTP (English and Sweatt, 1997) and a downstream target
for NADPH oxidase-derived ROS during LTP (Kishida et al., 2005).
While NADPH oxidase activity is important in the modulation of NMDA receptor
function, NMDA receptors themselves are in turn responsible for regulating Nox enzyme
activity. Stimulation of NMDA receptors produces an intraceullar burst of superoxide
from Nox2, identified mechanistically through calcium entry from NMDAR stimulation
leading to the activation of PKC delta (PKCδ) and subsequent
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phosphorylation/translocation of the cytosolic activators required for Nox2 activity
(Brennan et al., 2009).
NADPH oxidase activity must therefore be carefully regulated, as the underproduction of ROS can impair the processes of learning and memory, and the overproduction of ROS can lead to cellular damage and death. Uncontrolled ROS production
from NADPH oxidase has been linked to a number of neurodegenerative disorders, from
acute injuries such as stroke (Wang et al., 2006) and traumatic brain injury (Dohi et al.,
2010) to chronic disorders such as Alzheimer’s (Bianca et al., 1999) and Parkinson’s
disease (Norris and Giasson, 2005).
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Diagram 3. Normal CNS function depends on a balanced oxidant environment.
Hippocampal processes, such as long-term potentiation and memory, are inhibited in
mice in which basal ROS levels are reduced by scavengers. On the other hand, excessive
production of oxidant radicals is linked to improper neuronal signaling in this and other
brain regions, and in some instances can lead to neuronal cell death. Neurodegenerative
diseases such as Alzheimer’s and Parkinson’s are characterized by increased oxidative
stress, lipid, protein, and DNA oxidation, and neuronal cell death in brain regions
associated with these diseases. More recently NADPH oxidase upregulation and
activation in both neurons and microglia has emerged as an important mechanism of
oxidative stress in CNS. (Adapted from Infanger et al., 2006).
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NADPH Oxidase and Oxidative Stress in Ischemia/Reperfusion
It is well established that ROS, resulting from Nox activity, is a key contributor to
the oxidative stress and subsequent neuronal death associated with stroke. Nox2 knockout
mice, the same which display decreased cognitive abilities, show decreased injury after
global ischemia (Walder et al., 1997). Furthermore, the administration of the NADPH
oxidase inhibitor diphenylene iodonium (DPI) significantly decreased superoxide
production following ischemia (Miller et al., 2006). Additionally, pretreatment and
pharmacologic inhibition of NADPH oxidase prior to the induction of
ischemia/reperfusion with apocynin, a compound demonstrated to inhibit the assembly of
the functional Nox2 holoenyme (Stolk et al., 1994), is neuroprotective in the
hippocampus (Wang et al., 2006).
However, NADPH oxidase activity is not the only source of ROS contributing to
oxidative stress following stroke. During the ischemic phase, when oxygen and glucose
are deprived, little superoxide is produced from NADPH oxidase since the molecular
oxygen necessary for the conversion of oxygen to superoxide through NADPH oxidase
activity is not available. Two other sources of ROS do produce superoxide during the
ischemic phase however in a di-phasic manner, first from the mitochondria (due to
alterations in mitochondrial electron transport function) and second from the cytosolic
enzyme xanthine oxidase (Abramov et al., 2007). It is not until the reperfusion phase in
which oxygen and glucose delivery is restored that NADPH oxidase produces a large
burst of superoxide (Abramov et al., 2007). Additional sources of ROS production
following stroke can result from the action of other oxidase enzymes, such as monoamine
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oxidase, lipooxygenase, and cyclooxygenase, oxidation of unsaturated fatty acids,
metabolism of catecholamines, and quinone formation (Allen and Bayraktutan, 2009).
However, superoxide is not the only reactive species produced during ischemic
injury. Nitric oxide (NO) is also produced at neurotoxic levels in neurons through the
calcium dependent activation of neuronal Nitric oxide synthases (nNOS) following stroke
(Castillo et al., 2000). NOS enzymes catalyze the production of NO from L-arginine and
are thought to function as a retrograde neurotransmitter in normal physiologic function,
but similar to NADPH oxidase, when excessively activated in numerous pathologies, are
known to contribute to cellular death (Allen and Bayraktutan, 2009).
During the extreme state of oxidative stress that occurs during
ischemia/reperfusion, superoxide and NO are not the only known ROS and reactive
nitrogen species (RNS) to be formed within the cellular environment. In normal cellular
physiology, superoxide (O2-) typically undergoes dismutation into hydrogen peroxide
(H2O2) via the activity of the antioxidant family of superoxide dismutases (SODs). The
enzymatic activities of glutathione peroxidase or catalase are then responsible for the
decomposition of hydrogen peroxide to water (H2O) and oxygen (O2). However, in the
presence of transition metals such as iron (Fe2+), hydrogen peroxide (H2O2) can undergo
a Fenton reaction, leading to the formation of the highly reactive hydroxyl radical (.OH)
(Crack and Taylor, 2005). Superoxide can also react with NO to form peroxynitrite
(ONOO-), also a very potent oxidizing agent (Allen and Bayraktutan, 2009).
The effects of increased ROS and RNS levels within the cell have numerous
detrimental results. Lipid peroxidation, a process in which free radicals oxidize lipids in
the cell membrane resulting in cell damage, is one of the major consequences of ROS-

23

mediated injury. Most frequently, polyunsaturated fatty acids are the targets of lipid
peroxidation because of the reactive hydrogens they posses. A ROS species, such as the
.

OH radical, combines with a hydrogen atom to produce water and a fatty acid radical.

Due to the unstable nature of the fatty acid radical, it reacts quickly with molecular
oxygen, thereby creating a peroxyl-fatty acid radical, which reacts with a different fatty
acid, thereby producing a new fatty acid radical and a lipid peroxide. The reaction then
propagates in a chain reaction until it either reacts with another radical to produce a nonradical species (which only occurs when the concentration of radical species is high
enough for there to be a high probability of collision with two radicals) or is caught by an
antioxidant within the cell. One of the harmful products of lipid peroxidation is 4hydroxynonenal (HNE), which is used as a marker for lipid peroxidation and is known to
be toxic in neurons and induce apoptosis (McCracken et al., 2000). Other detrimental
outcomes from increased ROS and RNS levels include protein oxidation/denaturation,
DNA modification leading to fragmentation, phosphatase inactivation and abnormal
kinase signaling, as well as activation of apoptotic pathways through the induction of
mitochondrial cytochrome c release (Allen and Bayraktutan, 2009).
While oxidative stress can be damaging in any cell/tissue/organ, the brain is
particularly susceptible to ROS and RNS-induced damage. Reasons for this include a
high concentration of peroxidisable lipids, low levels of antioxidant protection (especially
catalase), high oxygen and energy consumption, high levels of iron (which can act as a
pro-oxidant under pathologic conditions), and the oxidation reactions of both glutamate
and dopamine which occur at a high rate in neurons (Crack and Taylor, 2005; Saeed et
al., 2007). Furthermore, during ischemia/reperfusion, lactic acid accumulates in neurons
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due to energy depletion, consequently leading to acidosis (Chan, 1996). This acidic
environment within the neuron further promotes a pro-oxidant effect by increasing the H+
concentration, consequently enhancing the conversion of superoxide and hydrogen
peroxide to more reactive species (Allen and Bayraktutan, 2009).
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Glutamatergic Receptors and NMDAR Structure, Function, and Localization
Glutamate, the primary excitatory neurotransmitter within the mammalian CNS,
is responsible for the activation of various receptors that are central to neurotransmission,
synaptic plasticity, and a diverse set of cognitive processes. Synaptic receptor targets for
glutamate can be sub-divided into two groups, ionotropic and metabotropic receptors.
The category of glutamatergic ionotropic receptors, which are all ligand-gated,
nonselective, cation channels, includes the N-methyl D-asparte receptor (NMDAR), the
2-amino-3-(3-hydroxy-5-methylisoazol-4-yl)propionic acid receptor (AMPAR), and the
Kainate receptor (Traynelis et al., 2010). Metabotropic glutamate receptors (mGluRs),
members of the family of G-protein-coupled receptors, also bind glutamate, but fall into
three distinct groups: Type I (mGluR1 and mGluR5) which are Gq coupled and
predominantly located on the post-synapse, Type II (mGluR2 and mGluR3), which are
Gi/Go coupled and are mainly presynaptic, and Type III (mGluR4, mGluR6, mGluR7, and
mGluR8) which are also Gi/Go coupled and located primarily on the presynapse
(Shigemoto et al., 1997). Taken together, the coordinated action of glutamatergic
receptors, along with the input of other receptors, allows for a wide array of functions
based on assorted receptor spatial expression arrangements, temporal activation patterns,
receptor trafficking, protein-protein interactions, phosphorylation events, translation and
transcriptional regulation, and downstream coupled signals necessary for normal synaptic
physiology.
Of all glutamatergic receptors, perhaps the most extensively studied in both
physiology and pathology is the NMDAR. The ionotropic NMDAR arises from seven
different NMDAR subunits: NR1, NR2A-D, and NR3A-B to form a tetrameric complex,
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most typically consisting of two NR1 and two NR2 subunits (Stephenson et al., 2008).
The NMDAR subunits are large in structure, consisting of over 900 amino acid residues,
and assemble as integral membrane proteins that form a central ion pore, with an
extracellular N-terminus and an intracellular C-terminus, which is responsible for
facilitating cytoplasmic protein-protein interactions (Traynelis et al., 2010). The
variability in each NMDAR tetramer arises from the presence of its NR2 subunit, which
differ in their expression profiles, desensitization kinetics, pharmacological properties,
downstream signaling pathways and trafficking mechanisms (Gladding and Raymond,
2011). Additionally, although NR1 expression remains fairly constant throughout
development, NMDAR composition changes with the maturation of neurons in the
hippocampus and cortex. NR2B is highly expressed early in development and declines
into adulthood, while NR2A is absent early and increases in expression with age (CullCandy et al., 2001).
The functional activation of NMDARs is unique among other receptors for a
variety of reasons. First, the activation of NMDARs is dependent on the simultaneous
binding of two agonists: glycine and glutamate. The NR1 subunit provides the glycinebinding site while the NR2 subunit forms the glutamate binding site (Furukawa and
Gouaux, 2003). However, co-binding of the two agonists does not allow for NMDAR
activation, as the presence of a Mg2+ block in the channel pore requires release, which
occurs with postsynaptic depolarization, prior to allowing for calcium influx (Gladding
and Raymond, 2011).
The synaptic localization of NMDARs governs many of its signaling properties.
The same NMDARs residing in a different location will have different signaling
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outcomes (Traynelis et al., 2010). Typically, NMDARs are classified as existing within
three distinct locations: synaptic, perisynaptic, and extrasynaptic (Gladding and
Raymond, 2011). Synaptic NMDARs are those that exist within the postsynaptic density,
a cytoskeletal protein-enriched interconnected network that acts as a scaffold to secure
and anchor NMDARs for the efficient glutamate-induced activation of the receptor
located immediately across the synapse from the presynaptic axon terminal (Newpher
and Ehlers, 2009). This allows for the formation of large macromolecular NMDAR
complexes containing various adaptor and effector proteins involved in downstream
signaling cascades and membrane stability, ultimately effecting NMDAR function and
trafficking (Sheng and Lee, 2000). Perisynaptic NMDARs are classified as located within
200-300 nm of the post-synaptic density, which is typically an area that contains mobile
receptors in transit towards and away from the post-synaptic density (Gladding and
Raymond, 2011). Extrasynaptic NMDARs are localized farther away from the postsynaptic density, residing on the dendritic spine neck, the dendritic shaft, or the soma
(Newpher and Ehlers, 2009). Perisynaptic and extrasynaptic NMDARs are only activated
by high concentrations of glutamate in the synaptic cleft, as low levels of glutamate
release rarely results in glutamate-induced activation of the receptors at extrasynaptic
locales. At low concentrations, glutamate is either first bound by synaptic glutamatergic
receptors or taken out of the synapse by transporter activity before diffusion to the
extrasynapse (Groc et al., 2009).
Initial observations found that calcium entry through synaptic NMDARs leads to
the activation of the transcription factor cyclic-AMP response element binding protein
(CREB), thereby promoting cell survival, while calcium entry from extrasynaptic
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NMDAR activation dominates over synaptic NMDAR activation and inactivates CREB,
thereby diminishing pro-survival signals (Hardingham et al., 2002). Furthermore, it was
also initially proposed that activation of synaptic NR2A subunits mediate pro-survival
while activation of extrasynaptic NR2B subunits elicits cell death (Liu et al., 2007).
However, such generalizations are not always necessarily true. Both NR2A and NR2B
subunits have been reported to mediate either apoptosis or neuroprotection, not only at
synaptic sites, but also at extrasynaptic locations. This suggests that downstream
signaling responses of NMDARs depends more on the surrounding biochemical
environment and the NMDAR associated signaling complexes than simply the subunit
composition and synaptic location (Hardingham and Bading, 2010).
NMDAR localization and function is also regulated through posttranslational
modifications of the intracellular C-terminus domain, particularly through protein-protein
interactions (Gladding and Raymond, 2011). Scaffolding proteins known to be involved
in the anchoring of NMDARs, as well as assembling the formation of a signaling
meshwork, include the membrane associated guanylate kinase (MAGUK) family of
proteins. These include post synaptic density protein-95 (PSD-95), post-synaptic density
protein-93 (PSD-93), synapse associated protein-102 (SAP-102), and synapse associated
protein 97 (SAP-97; Kim and Sheng, 2004). Among the four MAGUK family members,
PSD-95 is the most thoroughly studied in synaptic function. PSD-95 is highly expressed
in the post-synaptic density, and contains three Drosophila disc large tumor suppressor
(DlgA), and zonula occludens-1 protein (zo-1) (PDZ) binding domains, one SRC
homology 3 (SH3) domain, and one guanylate kinase-like (GK) domain (Xu, 2011).
PSD-95 has been demonstrated to be important in NMDAR function through two
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mechanisms, by anchoring NMDARs in the post-synaptic density, and scaffolding
NMDARs to intracellular signaling complexes composed of various kinases,
phosphatases, other scaffolding proteins, and nitric oxide synthase into close proximity of
NMDAR channels (Xu, 2011). One such important scaffolding protein that binds PSD-95
through PDZ domain interactions is Shank, which is believed to function as an actin
scaffold, ultimately serving the purpose as a link between NMDA/PSD-95 complexes and
regulation of the cytoskeleton (Naisbitt et al., 1999). Shank has also been demonstrated
to interact through an EVH1 domain with Homer (Tu et al., 1998), a membrane protein
located on the periphery of the post-synapse that selectively binds mGluRs (Brakeman et
al., 1997). This interaction between NMDAR/PSD-95/Shank and mGluR/Homer
signaling complexes physically bridges the actin cytoskeletal proteins with ionotropic and
metabotropic glutamate receptors. Other proteins included in the large NMDAR/PSDsignaling complex incluce G α-interacting protein (GAIP), G α-interacting protein Cterminus (GPIC) (Yi et al., 2007) and other cytoskeletal proteins such as α-actinin,
spectrin (Dunah et al., 2000), and F-actin (Newpher and Ehlers, 2009), all which play a
role in the surface expression of NMDARs. Taken together, the various assemblies and
interactions of the numerous scaffolded proteins associated with NMDARs govern not
only synaptic anchoring of the receptor, but also downstream signaling complexes and
dendritic cytoskeletal morphology.
In addition to protein-protein interactions, NMDAR phosphorylation events also
mediate synaptic localization and overall receptor function. In particular, tyrosine
phosphorylation has been shown to be a key event in modulating NMDAR expression
and function (Chen and Roche, 2007). Tyrosine phosphorylation of NR2A subunits
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promotes synaptic stability and the potentiation of NMDAR currents (Kalia et al., 2004),
while tyrosine phosphorylation of NR2B subunits can promote extrasynaptic migration of
the receptor (Prybylowski et al., 2005). Kinases that are held in close proximity to
NMDARs via interactions with structural cytoskeletal proteins and scaffolding proteins
such as PSD-95 include the Src Family Kinases (SFK) members Src, Fyn, and Lyn
(Gladding and Raymond, 2011). Phosphatases involved in regulating NMDAR tyrosine
phosphorylation events include Striatal-Enriched tyrosine Phosphatase (STEP;
Braithwaite et al., 2006) and protein tyrosine phosphatase (PTP; Goebel-Goody et al.,
2009). Serine phosphorylation has also been shown to play a role in NMDAR localization
and function, accomplished via the activity of casein kinase II (CK2) (Chung et al.,
2004), cyclic AMP dependent protein kinase A (cAMP-PKA), and protein kinase C
(PKC) (Crump et al., 2001). CK2 mediated NR2B serine phosphorylation and PKC
mediated NR1 serine phosphorylation has been demonstrated to enhance migration from
the synapse (Tingley et al., 1997), while cAMP-PKA mediated serine phosphorylation
has been shown to mediate enhanced synaptic NMDAR expression (Crump et al., 2001).
Additionally, the phosphorylation of the scaffolding proteins themselves by
Ca2+/calmodulin-dependent protein kinase II (CaMKII; Gardoni et al., 2006) and cyclindependent kinase 5 (CdK5) not only affects NMDAR synaptic stability, but also the
binding affinity of SFKs (Kalia et al. 2006).
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Diagram 4. The NMDAR location hypothesis and plasma membrane trafficking.
Synaptic or extrasynaptic-NMDAR localization is linked to activation of cell survival or
apoptotic signaling cascades, respectively. NMDAR stability in the PSD (purple arrows)
is upregulated (right side of PSD in figure) and downregulated (left side of PSD in figure)
by alterations in the surrounding actin cytoskeleton (yellow bars) and NMDAR
interactions with scaffolding, anchoring and effector proteins, calpain cleavage of
NMDARs or associated proteins and posttranslational modifications such as
phosphorylation. STEP dephosphorylates the GluN2B Y1472 residue, allowing the
adaptor protein AP-2 to bind, followed by lateral diffusion to endocytic zones (EZs) at
perisynaptic and extrasynaptic sites (black arrows). Scaffolding proteins (membrane
associated guanylate kinases (MAGUKs)) such as PSD-95 and SAP 102 are associated
with both synaptic and extrasynaptic-NMDARs and may remain associated whilst
receptors laterally diffuse along the plasma membrane (PM). Specific proteins such as
GIPC, alterations in protein phosphorylation and enhanced calpain activity may also
modulate extrasynaptic-NMDAR expression (red arrows). Fyn-mediated phosphorylation
of the NR2B Y1336 residue is likely to promote extrasynaptic-NMDAR calpain
cleavage, but cleaved receptors remain stable at the cell surface. Exocytosis and
endocytosis occurs at extrasynaptic exocytic/endocytic zones and following the latter,
receptors are targeted to either degradation or recycling pathways (green arrows). (From
Gladding and Raymond, 2011).
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In addition to protein-protein interactions and phosphorylation events, NMDAR
localization and function is affected by palmitoylation, ubiqutination, and proteolytic
cleavage (Gladding and Raymond, 2011). Palmitoylation of NMDARs is an important
reversible posttranslational modification that enhances PSD-95 targeting and synaptic
clustering (Christopherson et al. 2003). Additionally, altered palmitoylation of regulatory
proteins such as SFKs affect their membrane targeting, ultimately effecting NMDAR
phosphorylation state and its function and synaptic expression (Smotrys and Liner, 2004).
Monoubiquitination of NMDARs regulates protein trafficking on the plasma membrane,
while polyubiquitination of NMDARs targets the receptor for degradation via the
proteasomal pathway (Glickman and Ciechanover, 2002). Also, the cleavage of the
NMDAR subunits C-terminal region by the Ca2+ activated protease calpain diminishes
PSD-95 scaffolding, thereby promoting extrasynaptic migration while ultimately not
affecting the ion channel function of Ca2+ influx (Guttman et al., 2001).
Taken together, NMDAR expression, function, and localization is a complex yet
tightly regulated process involving differential subunit composition, expression patterns,
synaptic localization, the formation of downstream signaling complexes via interactions
with scaffolding proteins, as well as posttranslational modifications such as
phosphorylation, palmitolyation, and ubiquitination.
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NMDARs in Ischemia/Reperfusion
While calcium influx from NMDARs receptors is critical for normal synaptic
function, the uncontrolled overstimulation of these receptors also plays a central role in a
number of neurodegenerative pathologies (Arudine and Tymianski, 2003). Early
microdialysis studies demonstrated a significant rise in extracellular glutamate
concentrations in response to ischemia in the striatum, hippocampus, cortex, and
thalamus. Interestingly, only the hippocampus was significantly damaged by a mild
global ischemic event (Globus et al., 1990). More specifically, CA1 pyramidal neurons of
the hippocampus are the most vulnerable subpopulation of the brain in response to
ischemic insults (Mitani et al., 1998). NMDAR receptors mediate cellular damage in
response to these elevated glutamate concentrations. Both competitive and noncompetitive NMDAR antagonism reduces neuronal injury following ischemia, albeit at
varying efficacy depending on stroke modalities, drug administration patterns, and
neuroanatomical locations (Lau and Tymianski, 2010). However, while NMDARmediated excitotoxicity has long been established as a primary factor in mediating
neuronal death following ischemia, selective compounds involved in NMDAR
antagonism are not clinically feasible in humans due to their lack of efficacy, harmful
side effects, and relatively short therapeutic window (Gladstone et al., 2002).
Nonetheless, significant research in the past decade has been devoted to further
understanding the mechanisms mediating NMDAR-induced cell death following
ischemia with the hope of leading to novel NMDAR-based therapeutics.
Further complicating full elucidation of NMDA function, particularly in ischemia,
is the fact that NMDARs often modulate opposing functions, particularly neuronal
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survival and death. In recent years however, two hypotheses have been put forward to
unify these contrasting ideas: the location hypothesis and the subtype hypothesis (Lai et
al., 2011). The location hypothesis revolves around ideas of differential function
depending on extrasynaptic or synaptic NMDAR localization. As discussed previously,
preferential activation of synaptic NMDARs following ischemia has been reported to be
involved in pro-survival pathways due to the downstream activation of CREB. In
contrast, selective activation of extrasynaptic NMDARs has been reported to mediate
pro-death effects by diminishing CREB signaling (Hardingham et al., 2002). Contrary to
these findings however, it has also been demonstrated that the synapse-specific protein
PSD-95 is required for NMDAR-mediated excitotoxic neuronal death (Aarts et al., 2002),
and synaptic NMDAR activation is important in ischemic-induced neuronal death (Lai et
al., 2011).
Another hypothesis for differential NMDAR mediated neuronal death following
ischemia is based on differential subtype activation. Because of distinct protein-protein
interactions and differential signaling complexes, NR2B may mediate cellular death
through either direct or indirect protein-protein interactions with pro-death signals
(Martin and Wang, 2010). In support of this theory, selective antagonists for NR2A and
NR2B demonstrated that NR2A subunits mediate pro-survival and NR2B subunits
mediate neuronal death following stroke (Liu et al., 2007). However, such a broad
characterization is not without conflicting reports, as it has also been reported that NR2A
subunits can contribute to neuronal death (von Engelhardt et al., 2007) and that NR2B
subunits can mediate neuronal survival (Martel et al., 2009). Additionally, questions have
risen about the selectivity of the subtype-specific NR2A and NR2B antagonists (Lai et
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al., 2011), as well as the role of heterotrimeric NMDARs containing both NR2A and
NR2B subunits (Traynelis et al., 2010). Taken together, it appears that neither subtypespecific downstream signals nor subtype-specific localization clearly mediate specific
NMDAR functional outputs alone, but rather the combination of the location, subunit
composition, temporal and spatial distributions, protein-protein interactions, and other
posttranslational modifications are responsible for the NMDAR mediated excitotoxicinduced neuronal death during stroke.
One of the better-studied posttranslational modifications of NMDARs known to
affect receptor function following ischemia is receptor phosphorylation. More
specifically, numerous studies have been conducted on the role of tyrosine
phosphorylation of NMDA receptor subunits following ischemia. Functionally, NMDAR
tyrosine phosphorylation results in the potentiation of NMDAR currents (Yu et. al.
1997), thereby facilitating calcium entry and exacerbating calcium cytotoxicity. While
there have been no identified tyrosine phosphorylation sites on NR1 subunits, three
tyrosine phosphorylation sites have been identified on both NR2A subunits (Y1292,
Y1325, and Y1387) and NR2B subunits (Y1252, Y1336, Y1472) (Chen and Roche,
2007). One of the key molecular kinases shown to affect NMDAR tyrosine
phosphorylation and NMDAR function following stroke has been SFKs (particularly Src,
and Fyn), which are up-regulated in activity following ischemia (Jian et al., 2008).
Pharmacologic inhibition of SFKs provides neuroprotection following ischemia by
preventing NR2A tyrosine phosphorylation (Hou et al., 2007). Furthermore, suppression
of PSD-95 expression levels, which have been shown to be important in SFK-mediated
tyrosine phosphorylation of NR2A subunits, also attenuated NR2A tyrosine
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phosphorylation levels and diminished neuronal death following ischemia (Hou et al.,
2003). Additionally, mGluR1 antagonism following ischemia diminishes SFK activation
and prevents NR2A tyrosine phosphorylation, ultimately attenuating infarct size
(Murotomi et al., 2008). The NMDAR NR2B subunit has also been reported to increase
in SFK-mediated tyrosine phosphorylation status following ischemia, leading to both an
enhanced extrasynaptic migration and potentiated calcium current (Jian et al., 2008).
While tyrosine phosphorylation of NMDAR subunits has perhaps been the most
thoroughly studied phosphorylation events following ischemia, serine/threonine
phosphorylation is also involved in NMDAR-induced pathogenesis. Numerous serine
phosphorylation sites exist on NR1 subunits, with S890 and S896 being identified as
targets for PKC phosphorylation, negatively affecting NR1 synaptic clustering (Chen and
Roche, 2007). Phosphorylation of S897 has been identified as a PKA mediated
phosphorylation event, shown to be involved in intracellular NMDAR trafficking (Chen
and Roche, 2007). Ischemia induces PKC gamma (PKCγ) mediated phosphorylation of
NR1 at S890, which when prevented by mGluR5 antagonism, reduced S890
phosphorylation and cell death in the hippocampal CA1 region (Takagi et al., 2010).
NR2A subunits also have multiple serine phosphorylation sites, with PKC-mediated
phosphorylation of NR2A on S1219 and S1312 being involved in the potentiation of
NMDA currents (Grant et al., 2001). Additionally, Cdk5 mediated serine phosphorylation
of S1232 on NR2A subunits increases following ischemia, and when blocked with a
Cdk5 inhibitor, blunts NMDA-evoked currents and attenuated neuronal death in CA1
hippocampal neurons (Li et al., 2001). NMDAR NR2B subunits are also serine
phosphorylated, at PKC sites S1303 and S1323, events involved in the potentiation of
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NR1/NR2B receptor currents (Chen and Roche, 2007). Also, CKII-mediated serine
phosphorylation at S1480 regulates the PDZ binding of NMDARs to PSD-95, ultimately
affecting surface expression (Chen and Roche, 2007). However, the importance of these
sites in ischemic pathology has yet to be investigated.
The dysregulation of NMDAR function, expression, and signaling following
ischemia is a complex process involving many factors, including but not limited to
subunit composition, subunit localization, receptor trafficking, protein-protein
interactions, phosphorylation events, and kinase/phosphatase activity. The breakdown or
dysfunction of any or all of these points of regulation involved in the proper fine-tuning
of NMDAR function contribute to the ischemic-induced NMDAR-mediated neuronal
death observed in stroke pathology.

39

AMPA Receptor Structure and Function
A crucial mechanism in governing synaptic transmission lies in the regulation of
the glutamatergic 2-amino-3-(3-hydroxy-5-methylisoazol-4-yl)propionic acid receptor
(AMPARs). AMPARs arise from four genes (GLUR1-4) that encode four subunits,
which combine in varying stoichiometries to form the primary excitatory ligand-gated ion
channel in the brain (Shepherd and Huganir, 2007). Structurally, AMPARs exist as a
“dimer of dimers,” primarily composed of GluR1 and GluR2 hetero-tetramers (especially
in the forebrain including the hippocampus), with low levels of GluR3 and GluR4,
although subunit expression combinations are varied depending on neuroanatomical
location (Passafaro et al., 2001). Each subunit subtype structurally shares a large
extracellular N-terminal region and a true transmembrane domain, followed by a reentrant loop which does not traverse the membrane but rather dips into it from the
cytosolic side, thereby creating a pore-forming domain (Bennett and Dingledine, 1995).
The re-entrant loop is then followed by a second true transmembrane domain, an
extracellular loop, a third transmembrane domain and a cytosolic C-terminal tail of
varying length (Bennett and Dingledine, 1995). Each subunit contains an extracellular
domain on the first and second true transmembrane domain that form the binding site for
the neurotransmitter glutamate, termed the S1-S2 site (Borges and Dingledine, 1998).
Additionally, each of the four AMPAR subunits occur in two alternatively spliced
versions of the extracellular ligand-binding domain, termed “flip” and “flop”, with
splicing being regulated both developmentally (“flip” splice forms expressed in early
postnatal mammalian life, followed by “flop” isoforms later in development) and
regionally, ultimately effecting kinetic properties of the channel, as the “flop” version
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undergoes desensitization much more rapidly in response to glutamate stimulation than
the “flip” version (Shepherd and Huganir, 2007).
However, while all AMPAR subunits share a large degree of homology, the
presence or absence of a GluR2 subunit contained within the functional AMPAR tetramer
is most important in determining channel properties and ionic permeability as a
consequence of its amino acid makeup. Almost all GluR2 protein contains a positively
charged arginine (R) residue within the channel pore region of the re-entrant membrane
loop substituted from a neutral glutamine (Q) residue, thereby rendering GluR2containing AMPARs impermeable to divalent cation (Ca2+ and Zn2+) conductance, in
addition to making the receptor insensitive to blockade by intracellular polyamines
(Traynelis et al., 2010). The Q/R substitution is a result of hydrolytic RNA editing of a
single adenosine base to inosine though the activity of the adenosine deaminase enzyme
ADAR2 (Bass, 2002). The Q/R editing site is located within subunit interfaces as well,
and is thought to affect receptor assembly in the endoplasmic reticulum (ER) by favoring
heterodimerization with GluR1 over homodimerization with another GluR2 subunit
(Mansour et al., 2001). After ER exit and trafficking to the plasma membrane, the
positive charge of the arginine in the pore region of the GluR2-containing AMPAR
prevents divalent cation entry, exclusively promotes monovalent cation (Na+)
conductance, and repulses intracellular blockade by similarly charged polyamines at
positive voltages (Koike et al., 1997).
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Diagram 5. GluR2 subunit domain structure, schematic subunit structure, and
general structure of AMPAR complex. (A) GluR2 subunit domain structure with cterminus sequence detailed for the GluR2-short splice isoform which is the predominant
form in the brain. Transmembrane domains are depicted in blue, the flip/flop alternatively
spliced region is illustrated in purple, and editing, phosphorylation, and protein
interaction sites are as indicated. (B) Schematic Diagram of an AMPAR Subunit. All
subunits have a similar structure and topology. Three of the four hydrophobic segments
span the membrane, while one dips into the membrane from the cytoplasmic face and
contributes to the channel pore. The alternatively spliced flip/flop region and the cterminal PDZ binding domain are shown, as well as the GluR2-specific Q/R editing.
Schematic of predicted 3D structure of the tetrameric AMPAR complex. (Diagram (A)
was adapted from Isaac et al., 2007). (Diagram (B) from Shepherd and Huganir, 2007).
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However, neuronal inputs in both physiology and pathology modify the
permeability of AMPARs to include conductance of divalent cations via GluR2 surface
removal and expression changes, which is governed by highly complex processes
including endocytosis/exocytosis, phosphorylation events, protein-protein interactions,
and changes to mRNA editing as well as de novo synthesis of GluR2.
The surface removal of AMPARs occurs via the classically studied route of
endocytosis through the action of clathrin-coated pits and dynamin (Shepherd and
Huganir, 2007). The disruption of clathrin-dependent endocytosis through the expression
of a dominant-negative form of dynamin, high concentrations of sucrose, or preventing
the interaction of GluR2 with the clathrin adaptor protein AP-2 all inhibit AMPAR
endocytosis (Carroll et al., 1999; Man et al. 2000; Lee et al., 2003). Specific endocytic
zones separate from the post-synaptic density on the lateral margins of excitatory synapse
are believed to be the site for glutamate receptor internalization (Racz et al., 2004). Once
internalized, AMPARs are trafficked via the activity of Rab GTPases, and are sorted
within early endosomes to recycling endosomes for reinsertion to the surface, or are sent
to late endosome and ultimately to the lysosome for degradation (Ehlers, 2000).
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Rab GTPases and AMPAR Trafficking
The Rab GTPase protein family makes up the largest branch of the Ras GTPase
superfamily, with the existence of over 60 Rab genes in the human genome (Stenmark
and Olkkonen, 2001). Similar to other GTPases involved in regulation, Rab proteins
alternate between two differing conformations: an “inactive” GDP-bound state, and an
“active” GTP-bound state, as the active GTP-bound conformation of Rab proteins
enables them to interact with its downstream effectors (Stenmark and Olkkonen, 2001).
The conformation state of Rab proteins is regulated by guanine nucleotide exchange
factors (GEFs) and GTPase-activating proteins (GAPs; Novick et al., 2006). GEF activity
activates Rab proteins by triggering the binding of GTP, while GAP activity inactivates
the Rab protein by accelerating the hydrolysis of bound GTP to GDP (Novick et al.,
2006).
The state of membrane attachment for Rab proteins is also regulated by
undergoing changes between membrane insertion and extraction (Novick et al. 2006).
This control is achieved through the actions of Rab escort protein (REP) and GDP
dissociation inhibitor (GDI; Stenmark and Olkkonen, 2001). After inactivation through
GAP activity, REP and GDI can extract GDP-bound Rab proteins from the membrane
and recycle the Rab proteins back to the cytosol for further activity after GEF reactivation (Novick et al., 2006). In clathrin-mediated endocytosis, which includes the
endocytosis of AMPARs,
activated Rab5 is responsible for the cytoskeletal motility and homotypic fusion with the
early endosome, and is also required for early endosomal fusion (Levey et al., 2000). In
contrast to Rab5 activity, Rab15 exhibits an inhibitory action to Rab5 by preventing early
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endocytic events (Wandinger-Ness et al., 2000 and 2003). After fusion with the early
endosome, the endocytosed cargo can be shuttled to three different pathways, regulated
by two Rab proteins. Cargo destined towards recycling is directed to Rab4 containing
micro-domains in the early endosome (Sonnichsen et al. 2000). From this domain, the
cargo can travel directly back to the membrane to permit fast recycling. The cargo can
also travel along a slower-recycling pathway, being transported to the perinuclear
recycling endosome (Wandinger-Ness et al, 2003, Zerial et al. 2000). From the recycling
endosome, Rab11 directs the transport back to the membrane. While it remains unclear
weather Rab4 controls recycling along both pathways, it is clear that co-ordination
between Rab5 and Rab4 is responsible for maintaining influx into and efflux out of the
early endosome (Wandinger-Ness et al. 2000). The third pathway involved in transport
from the early endosome does not lead to recycling, but rather degradation. Rab7
mediates the delivery of cargo to the late endosome, from which further Rab7 association
is involved with lysosomal transport (Lefkowitz et al., 2006). From the late endosome,
cargo can be re-directed from the lysosome and transported to the trans Golgi network via
Rab9 (Wandinger-Ness et al., 2003). AMPARs have been demonstrated to co-localize
with Rab5, Rab4, Rab7, and Rab11 throughout the course of endocytic trafficking
towards the lysosome or recycling to the plasma membrane (Ehlers, 2000).
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Diagram 6. Schematic illustration of the Rab-regulated endocytotic and exocytotic
pathways. The biosynthetic pathway transports proteins from the endoplasmic reticulum
(ER) through the Golgi complex to the cell surface. In the trans-Golgi network (TGN),
molecules can enter either constitutive secretory vesicles (CV) or regulated secretory
granules/vesicles (RV). Surface proteins internalized from outside the cell reaches the
early endosomes (EE) first and can be recycled back to the surface, either directly or via a
perinuclear recycling endosome (RE) compartment, or transported to late endosomes
(LE) and lysosomes. The biosynthetic and endocytic circuits (arrows) exchange material
at the level of the Golgi apparatus and the endosomal elements. The localization of
selected mammalian Rab proteins in the membrane compartments participating in these
transport processes is indicated. (Stenmark and Olkkonen, 2001).
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Opposing the activity of surface removal of AMPARs is the exocytosis and
plasma membrane insertion of AMPARs. While the exact localized site of AMPAR
insertion remains controversial, with reports of receptor insertion into the somatic plasma
membrane and lateral diffusion to the synapse (Adesnik et al., 2005) and other reports of
insertion of AMPARs into the dendritic PSD directly via cytoskeleton-associated motors
(Gerges et al., 2006). It is clear however that AMPAR insertion is accomplished through
SNARE-dependent exocytosis (Lu et al., 2001). However, differential trafficking rates
occur depending on subunit composition. Surface insertion of GluR1 has been
demonstrated to occur slowly under basal conditions and rapidly speed up upon increased
neuronal activity and NMDAR activation (Hayashi et al., 2001). GluR2 insertion
however occurs constitutively without the need for increased synaptic activity (Passafaro
et al., 2001). Interestingly, when GluR1/GluR2 heteromers are expressed, the activitydependent trafficking of GluR1 dominates, but when GluR2/GluR3 heteromers are
expressed, the constitutive trafficking pattern of GluR2 dominates (Shepherd and
Huganir, 2007). The differential trafficking mechanisms are dependent on the C-terminal
tail interactions, as the C-terminus of GluR2 has been demonstrated to bind Nethylmaleimide-sensitive fusion protein (NSF; Nishimune et al., 1998), which regulates
exocytosis of GluR2 at synaptic sites, either by its classical role in membrane fusion, or
by dissociating the GluR2-protein-interacting with kinase C alpha 1 (PICK1) complex, an
association known to prevent AMPAR recycling (Hanley et al., 2002).
Synaptic strength is dictated almost entirely on the density of AMPARs that
accumulate at dendritic synapses (Borges and Dingledine, 1998). During LTP, AMPARs
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are rapidly inserted at the plasma membrane to strengthen the connectivity of the
synapse, and conversely, are removed from the membrane and either sent to
recycling/sorting pools or trafficked over towards degradation during LTD (Shepherd and
Huganir, 2007). It is the delicate balance between the processes of AMPAR plasma
membrane insertion or removal, in combination with other receptor inputs (NMDARs,
mGluRs, and others) that compose the most accepted models as the molecular correlate
for the cellular mechanism of learning and memory. Activity of mitogen-activated protein
kinase (MAPK) family is involved in the fine tuning of Rab-regulated AMPAR
trafficking, surface removal, and plasma membrane insertion. Studies have demonstrated
that p38 MAPK activity is responsible for accelerating AMPAR endocytosis and
promoting LTD by enhancing Rab5 activity (Cavalli et al., 2001; Huang et al., 2004;
Zhong et al., 2008). Further studies have linked p38 MAPK activation with a decreased
AMPAR surface expression, while inactivation of p38 MAPK was shown to increase
AMPAR surface clusters under physiological conditions (Zhu et al., 2002; Rumbaugh et
al., 2006). Opposing the activity of p38 MAPK in AMPAR trafficking is extracellular
signal-regulated kinase 1/2 (ERK1/2), which under LTP conditions is responsible for the
exocytosis and surface insertion of AMPARs, thereby strengthening the synapse
(Patterson et al., 2010).
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AMPAR Phosphorylation and Protein-Protein Interactions
Phosphorylation events on AMPAR subunits govern many of the protein-protein
interactions involved in AMPAR stabilization at the synapse. Each phosphorylation event
either promotes an increased or decreased association with various proteins demonstrated
to be involved in receptor anchoring, endocytosis, recycling, and exocytosis.
Dephosphorylation of GluR1 on serine 845, a PKA site, and serine 831, a
CaMKII site is important in AMPAR surface removal. Mutations in these sites prevent
AMPAR internalization induced by NMDAR activation (Lee et al., 2003). However, the
exact mechanisms of how these de-phosphorylation events regulated AMPAR surface
removal have yet to be fully resolved.
Phosphorylation of GluR2 at serine 880 (Ser880) has been shown to be PKCα
dependent (Xia et al., 2000) and is important in the internalization of AMPARs,
ultimately resulting in a decrease in surface GluR2-containing receptors in hippocampal
neurons (Chung et al., 2000). Three proteins, glutamate receptor interacting protein 1
(GRIP1), AMPA receptor binding protein (ABP also known as GRIP2) and PICK1 all
interact with GluR2 at the extreme C-terminal PDZ site (Dong et al., 1997; Srivastava et
al., 1998) where the Ser800 residue resides. Phosphorylation of GluR2 at Ser800 disrupts
the GluR2-GRIP interaction, an interaction that is important in anchoring AMPARs to
the PSD (Matsuda et al., 2000), thereby promoting the binding of PICK1 (Chung et al.,
2000), which decreases surface GluR2 levels via increased endocytosis and delayed
recycling (Terashima et al., 2004; Lu and Ziff 2005; Terashima et al., 2008). However,
other reports have indicated through the use of PICK1 knock-out mice that PICK1 is not
required for NMDA induced GluR2 internalization in hippocampal neurons, but is
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involved in affecting GluR2 membrane expression, as demonstrated by the accelerated
GluR2 recycling that occurs in the same knock-out mice (Lin and Huganir, 2007). The
precise mechanisms though which PICK1 accomplishes decreased GluR2 surface
expression remains unresolved, with reports indicating a role in promoting
internalization, preventing recycling, or a combination of both. However, the notion that
PICK1 is intimately involved in effecting GluR2 surface expression is agreed upon in the
published literature.
The interaction of GluR2 with PICK1 is preceded by activation of PKC alpha
(PKCα), which upon calcium-induced activation, undergoes a comformational change
that exposes a PDZ site for binding with the PDZ domain of PICK1 (Perez et al., 2001).
Phosphorylation of GluR2 Ser880 is dependent on the trafficking of PKC alpha to the
plasma membrane via PICK1, which interacts with a Bin-Amphiphysin-Rvs (BAR)
domain on GRIP1, thereby bringing the complex in close proximity to the c-terminal tail
of GluR2 (Lu and Ziff, 2005). After Ser880 phosphorylation of GluR2, the GluR2-GRIP
interaction is disrupted, the GluR2-PICK1 interaction is favored, and the surface removal
of GluR2 occurs, a process that is thought to be an important mechanism in which
neurons increase their basal excitability through increasing their calcium permeability via
GluR2-lacking AMPARs.
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Diagram 7. Model for the Role of the PICK1-ABP/GRIP Interaction in AMPAR
Trafficking. GluR2 receptors are anchored at synaptic and intracellular membranes by
ABP/GRIP but undergo cycling between these membranes in association with PICK1.
Trafficking of GluR2 receptors from ABP/GRIP anchorage requires the PICK1ABP/GRIP interaction. Activation of PKCα (1) causes PKCα to bind to the PICK1 PDZ
domain, which disrupts the PICK1 PDZ-BAR domain interaction and leads to the
exposure of the PICK1 BAR domain (2). The PICK1-PKCα complex is targeted to the
ABP/GRIP-GluR2 complex through the interaction of the exposed BAR domain with the
Br sequence of ABP/GRIP (3). PICK1 competes with ABP/GRIP for the GluR2
interaction (4). PKCα phosphorylates Ser880 of GluR2. GluR2 phosphorylated at Ser880
cannot bind back to ABP/GRIP (5) but is able to bind to PICK1 (6). The PICK1 BAR
domain directs the PICK1-GluR2 complex to curved membranes (7), where GluR2
receptors bud from the plasma membrane and internalize or bud from an internal
membrane prior to reinsertion into synapses (8). (From Lu and Ziff, 2005).
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Tyrosine phosphorylation of GluR2 is also important in mediating AMPAR
internalization. Tyrosine phosphorylation at residue 876 (Tyr876) disrupts the interaction
of GluR2 with GRIP and ABP, although phosphorylation at Tyr876 did not influence the
interaction with PICK1 (Hayashi and Huganir, 2004). The phosphorylation was
dependent on the activity of SFKs, but not other protein tyrosine kinases such as Fak and
Pyk2, which is consistent with other findings that shown the importance of SFK
regulation in excitatory synaptic transmission (Soderling and Derkach, 2000).
While surface expression levels of AMPARs are an important mechanism
effecting changes in AMPAR function, transcriptional modifications also influence
AMPAR function. Total GluR2 protein levels can also be altered by the action of
repressor element-1 silencing transcription factor (REST), a transcriptional repressor that
diminishes de novo synthesis of GluR2 via the binding with the GluR2 promoter site
(Gorter et al., 1997). GluR2 Q/R mRNA editing, the site important for rendering GluR2containing AMPARs calcium impermeable, can also be inhibited by diminished CREB
signaling, which is responsible for ADAR2 expression, thereby leading to the expression
of calcium permeable AMPARs, thereby strengthening synaptic signaling (Peng et al.,
2006).
Taken together, the mechanisms of AMPAR synaptic delivery and removal is a
process governed by much complexity, with many inputs including subunit composition,
phosphorylation events, protein-protein interactions, and transcriptional alterations,
which are all involved in the mechanism that form the foundation of basal neuronal
function and synaptic plasticity.
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AMPA Receptors in Ischemia/Reperfusion
Initial reports of ischemia-induced glutamate-dependent excitotoxicity suggested
that NMDARs were primarily responsible for mediating the majority of calcium overload
observed following stroke. However, more recently, it has been shown that the overactivation of calcium-permeable AMPARs, when expressed, result in similar levels of
intracellular calcium as NMDAR activation (Lu et al., 1997). While the vast majority of
AMPARs in the CNS exhibit low permeability to Ca2+ and Zn2+ due to the presence of the
edited form of the GluR2 subunit, and short-lived changes in the expression of GluR2lacking AMPARs have been reported to be an important mediator of neuronal signaling
in the induction of LTP (Terashima et al., 2008). However, long-lasting switches in
AMPAR subunit composition to GluR2-lacking AMPARs have been implicated in a
number of neurological pathologies. These include drug abuse (Conrad et al., 2007),
epilepsy (Rakhade et al., 2008), Alzheimer’s disease (AD; Shepherd and Hugnair, 2007),
amyotrophic lateral sclerosis (ALS; Kwak and Weiss, 2006), and stroke (Noh et al.,
2005).
Following transient global ischemia induced in hippocampal pyramidal neurons,
an increased number of calcium-permeable AMPAR channels in the CA1 region results,
correlating with an increased vulnerability to neuronal death (Anzai et al., 2003).
Furthermore, increasing GluR2 protein levels (Liu et al., 2004) or pharmacologic
blockade of calcium-permeable AMPARs (Noh et al., 2005) afforded neuroprotection
following ischemia. Additionally, blockade of calcium permeable AMPARs resulted in
decreased Zn2+ accumulation following ischemia (Yin et al., 2002), which also afforded
neuroprotection, and along with other studies involving chelators (Calderone et al.,
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2004), suggest a role for ischemic-induced Zn2+ toxicity through the action of GluR2lacking AMPARs.
Many of the mechanisms involved in physiologic LTD-induced GluR2 surface
occur with ischemia/reperfusion. PKC mediated Ser880 phosphorylation of GluR2 (Liu
et al., 2006) has been implicated following ischemia, resulting in decreased surface
GluR2 levels. Furthermore, ischemia promotes GluR2 dissociation from GRIP1, PICK1
association with ABP (Liu et al., 2006), and GluR2 association with PICK1, a potentially
necessary step involved in GluR2 endocytosis (Dixon et al., 2009). Additionally, peptides
that interfere with PICK1 PDZ domain interactions block the ischemia-induced GluR2
subunit composition switch, ultimately resulting in neuroprotection (Dixon et al., 2009).
To date, no studies have investigated the role of Tyr876 phosphorylation in mediating
GluR2 surface removal following ischemia, although SFKs, which mediates GluR2
Tyr876 phosphorylation (Hayashi and Huganir, 2004), have been well documented to
increase in activity in post-ischemic neurons (Hou et al., 2007; Jian et al., 2008).
Interestingly, GluR1 protein levels are not affected by ischemia, thereby, the selective
degradation of GluR2 ultimately promotes a rise in the number of Ca2+/Zn2+-conducting
AMPARs (Soundarapandian et al., 2005).
In addition to the surface membrane loss of GluR2-containing AMPARs,
translational and transcriptional dysregulation also contributes to the decreased number of
GluR2-containing AMPARs. Following ischemia, particularly in the vulnerable CA1
hippocampal region, GluR2 mRNA is markedly and selectively reduced (PelligriniGiampietro et al., 1997). More specifically, the transcriptional repressor REST mediates
cell death in post-ischemic neurons by suppressing GluR2 protein transcription, and
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genetic knockdown of REST rescues GluR2 levels and provides neuroprotection
(Calderone et al., 2004). Additionally, ADAR2, the nuclear enzyme responsible for
GluR2 pre-mRNA Q/R editing, is selectively reduced following ischemia (Peng et al.,
2006). Furthermore, exogenous ADAR2 gene delivery or expression of a constitutively
active CREB, which induces ADAR2 expression, was also shown to restore GluR2 Q/R
editing and protect neurons from ischemic-induced cellular death (Peng et al., 2006).
Interestingly, direct delivery of the Q/R site edited GluR2 gene rescued ADAR2
degradation (Peng et al., 2006), thereby linking the loss of GluR2 with the selective loss
of ADAR2.
In summary, alterations at multiple levels, including receptor trafficking and
transcriptional/translational regulation all contribute to the ischemic-induced loss of
GluR2-containing Ca2+/Zn2+ impermeable AMPARs, thereby resulting in the surface
expression of AMPARs that are important in mediating excitotoxic ischemic-induced
neuronal death.
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SPECIFIC AIMS
•

•

•

Aim 1: To test the hypothesis that generation of superoxide from NADPH
oxidase following oxygen-glucose deprivation/reperfusion underlies the signaling
mechanism responsible for the increase in NMDAR NR2A subunit tyrosine
phosphorylation.
•

Sub-Aim 1.1 To determine if NADPH oxidase mediates the tyrosine
phosphorylation of NMDAR subunits following oxygen-glucose
deprivation/reperfusion.

•

Sub-Aim 1.2 To determine if NADPH oxidase inhibition dampens the
excitotoxic effect of NMDA stimulation following oxygen-glucose
deprivation/reperfusion.

Aim 2: To test the hypothesis that increased NADPH oxidase activity following
oxygen-glucose deprivation/reperfusion is responsible for the acceleration of
endocytosis of AMPAR subunits.
•

Sub-Aim 2.1 To determine if inhibition of NADPH oxidase prevents the
decrease in surface GluR2-containing AMPARs following exposure to
oxygen-glucose deprivation/reperfusion.

•

Sub-Aim 2.2 To determine if oxygen-glucose deprivation results in an
increased p38 MAPK activity and is mediated by NADPH oxidase activity

•

Sub-Aim 2.3 To determine if NADPH oxidase activity mediates p38
MAPK activation following oxygen-glucose deprivation/reperfusion
results in the formation of the Rab5-GDI complex.

Aim 3: To test the hypothesis that the oxygen-glucose deprivation/reperfusioninduced increase in NADPH oxidase activity is involved in the sustained serine
phosphorylation of the GluR2 AMPAR subunit.
•

Sub-Aim 3.1 To determine if inhibition of NADPH oxidase prevents the
OGD/R-induced increase in Ser880 phosphorylation of the GluR2 subunit.

•

Sub-Aim 3.2 To determine if NADPH oxidase prevents the OGD/Rinduced dissociation of GRIP1 and the increased association with PICK1.
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CHAPTER 1
Inhibition of NADPH Oxidase Prevents the Oxygen-Glucose
Deprivation/Reperfusion Induced Increase in Tyrosine Phosphorylation of the
NMDA Receptor NR2A subunit.
Abstract
Evidence exists that oxidative stress promotes the tyrosine phosphorylation of
NMDA receptor (NMDAR) subunits during reperfusion of post-ischemic brain tissue.
We have now identified the reactive oxygen species (ROS) generator in cultured retinoic
acid differentiated SH-SY5Y neuroblastoma cells that mediates the increase in tyrosine
phosphorylation of the NR2A subunit in response to oxygen-glucose deprivation and
reperfusion (OGD/R). Inhibition of the ROS generator, NADPH oxidase, attenuated the
increased tyrosine phosphorylation of the NR2A subunit, as well as the interaction of
activated Src Family Kinases (SFKs) with PSD-95 induced by OGD/R. In contrast,
inhibition of ROS production from mitochondrial or xanthine oxidase sources failed to
dampen the OGD/R-induced increase in tyrosine phosphorylation of the NR2A subunit.
In addition to attenuating tyrosine phosphorylation of the NR2A subunit, inhibition of
NADPH oxidase also markedly reduced cellular death in SH-SY5Y cells stimulated by
NMDA following OGD. These data suggest that NADPH oxidase has a key role in
facilitating NR2A tyrosine phosphorylation via SFK activation during post-ischemic
reperfusion.
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Materials and Methods
Materials
Ethidium homodimer was bought from Molecular Probes (Eugene, OR, USA).
HALT protease inhibitor cocktail was bought from Pierce (Rockford, IL, USA). All other
chemicals used in the study were purchased from Sigma (St. Louis, MO, USA).
Methods
Cell Culture and differentiation
Human SH-SY5Y neuroblastoma cells were used throughout the study. SH-SY5Y
cells were cultured in Dulbecco’s Modified Eagle’s Medium: Ham’s Nutrient Mixture F12, 1:1 (D-MEM/F-12) purchased from ATCC (Manassas, VA, USA) supplemented with
10% fetal bovine serum (Gibco, Grand Island, NY, USA) and Penicillin (100 µg/mL) /
Streptomycin (100 U/mL). For immunoprecipation and lysate preparation, SH-SY5Y
cells were seeded onto 10 cm dishes at a density of approximately 4 x 106 cells per dish.
Approximately 24 hours later, cells were differentiated by treatment with complete DMEM/F-12 supplemented with 10 µM retinoic acid for 6 days and fresh media containing
retinoic acid was changed every 48 hours (Nitti et al., 2007).
Oxygen-Glucose Deprivation/Reperfusion
Anoxia was achieved by incubating the cultures in a controlled humidified
hypoxic glove box (Coy Laboratories, Grass Lake, MI, USA) for 40 minutes at 37°C.
The gas mixture in the incubator was 0% O2, 5% CO2, and 95% N2. Anoxia was verified
using an oxygen meter with an O2 microelectrode (OM-4; Microelectrodes Inc., Bedford,
MA, USA). Glucose free DMEM without serum was placed in the hypoxic glove box
overnight at 0% O2 at 37°C to de-oxygenate the media. Prior to oxygen-glucose
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deprivation/reperfusion (OGD/R), cells were serum starved for 4 hours. Cells were then
rinsed 3 times with phosphate buffered saline (PBS) prior to placement in the hypoxic
glove box at 37°C. The de-oxygenated glucose and serum free media was then added to
the dishes in the glove box and the cultures were incubated for 40 minutes. Following
OGD, the anoxic glucose free media was removed and cultures were returned to a
normoxic (ambient air O2 levels; 18-21% O2) tissue culture incubator with serum free
media containing glucose (± drug treatment) for the various incubation periods as
described per individual experiments.
Detection of Reactive Oxygen Species Generation
Dihydroethidium (DHE) experiments were modified and adapted from the
method described by Abramov et al. (2007). Briefly, SH-SY5Y cells were plated at 1 x
105 onto nitric acid washed glass coverslips in 35 mm dishes. Approximately 24 hours
after seeding, cells were differentiated as previously described. OGD/R experiments were
performed with 5 µM DHE present in the media throughout the entire experiment and no
pre-loading period was performed. Following treatment, cells were washed 3 times with
cold PBS (4ºC, pH 7.4) and fixed with cold 4% paraformaldehyde/PBS (4ºC, pH 7.4).
Cells were visualized using an Olympus 1X71 inverted microscope equipped with a 60X
oil immersion objective. Images were obtained with Olympus Image Manager. For the
nitrobluetetrazolium (NBT) assay, methods were adapted from Aukrust et al. (1994).
Briefly, 5 x 104 cells were plated onto 12-wells plates and differentiated with retinoic
acid as described above. After 4 hours of serum starvation, media containing 0.1% (w/v)
NBT was added to each well and incubated for 1 hour. After loading, excess NBT was
washed away 3 times with warmed PBS (37ºC, pH 7.4) and the OGD/R treatments were

62

performed along with time-matched normoxic controls. Following treatments, cells were
fixed with absolute methanol (-20ºC) and washed twice with room temperature 70%
methanol. Plates were allowed to air dry before dissolving the formazan deposits by the
addition of 2 M KOH and 100% DMSO to each well. The absorbance was then measured
at 630 nm with a Spectra Max Gemini M2 plate reader (Molecular Devices, Sunnyvale,
CA, USA).
Immunoprecipitation of NR2A and PSD-95
SH-SY5Y cells were plated onto 10 cm tissue culture dishes at a density of 4 x
106 cells per dish as previously described. Approximately 24 hours later, cultures were
differentiated with retinoic acid as previously described. Prior to treatment, the cultures
were serum starved for 4 hours. Immediately following treatment, two 10 cm dishes of
cells were washed twice with cold PBS (4ºC, pH 7.4), and were pooled to ensure
adequate protein yield after harvesting in HEPES lysis buffer (50 mM HEPES, pH 7.5,
0.5% NP-40, 250 mM NaCl, 2 mM EDTA, 10% Glycerol, 1 mM sodium orthovanadate,
1 mM sodium fluoride, 1 µg/mL benzamidine, 2 µl/mL Halt Protease Inhibitor Cocktail
Kit). Cells were briefly sonicated for a 5 second burst at 25% power output with a VirTis
Ultrasonic Cell Disrupter 100 (Gardiner, NY, USA). Cell lysates were spun at 1,000 x g
to remove nuclei and cell debris. Protein concentration was determined using a
bicinchoninic acid assay (BCA), and lysates (500 µg/sample) were then pre-cleared using
Protein-A/G 50/50 mix of agarose beads for 1 hour at 4°C followed by incubation with
primary antibody overnight (affinity-purified rabbit-polyclonal NR2A, Sigma, St. Louis,
MO, USA or an affinity-purified rabbit-monoclonal PSD-95, Cell Signal, Beverley, MA,
USA) at 4°C. The immunocomplex was then incubated for 4 hours with 50 µL Protein-
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A/G beads at 4°C with rotation before being washed 3 times with 500 µL of HEPES lysis
buffer. Samples were eluted from the agarose beads by treatment with Laemmli buffer
and heat (100°C) and then subjected to 7.5% sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE). After transfer to nitrocellulose membranes (Bio-Rad,
Berkeley, CA, USA), blots were blocked for 1 hour at room temperature with 5% BSA in
Tris Buffered Saline, 0.1% Tween 20 (TBS-T) and incubated with an affinity-purifed
phospho-tyrosine (1:2000, Sigma, St. Louis, MO, USA) or phospho-Src Family Kinase
(Tyr416) (1:1000, Cell Signaling Technology, Beverly, MA, USA). Immunoreactive
bands were then visualized and captured with a Fuji imaging system using enhanced
chemiluminescence after adding HRP conjugated secondary antibodies (1:2000) of Goat
anti-Mouse-HRP or Mouse anti-Rabbit-HRP (IgG Light chain specific) both purchased
from Jackson ImmunoResearch (West Grove, PA, USA). Bands were analyzed using
Image-Gauge software.
Immunoblotting
Samples for direct immunoblotting were subjected to 7.5% SDS-PAGE,
transferred to nitrocellulose membranes and blocked with 5% BSA/TBS-T as previously
described. Blots were incubated with primary antibody overnight at 4°C at the
concentration indicated. The affinity purified NR2A rabbit polyclonal antibody (1:2000)
was purchased from Sigma (St. Louis, MO, USA). The affinity purified rabbit-polyclonal
p67phox antibody (1:1000) was purchased from Millipore (Billerica, MA, USA). The
affinity purified rabbit-monoclonal Src Family Kinase (1:1000) antibody was purchased
for Cell Signaling Technology (Beverly, MA, USA). The affinity-purified mousemonoclonal ß-actin (1:5000) antibody was purchased from CalBiochem/EMD
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(Darmstadt, Germany). Goat anti-Mouse-HRP and Goat-anti-Rabbit-HRP secondary
antibodies (1:2000) were purchased from Jackson ImmunoResearch (West Grove, PA,
USA). Immunoreactive bands were visualized and captured with a Fuji imaging system
using enhanced chemiluminescence after adding HRP conjugated secondary antibodies.
Bands were analyzed using Image-Gauge software.
Quantification of cell death
Cell viability was determined using an ethidium homodimer exclusion test as described
by Jackson et al. (2006). Briefly, approximately 5 x 104 cells were plated onto 12 well
plates and 24 hours later cells were differentiated with retinoic acid as previously
indicated. Prior to treatments, cells were serum starved for 4 hours. Following OGD,
cultures were incubated in serum free D-MEM/F-12 containing 5 mM N-methyl-Daspartic acid (NMDA). After 6 hours, cultured media was replaced with 300 µL of warm
PBS (37ºC, pH 7.4) and background fluorescence was determined (Fmin). Cultures were
then provided with 6 µM ethidium homodimer and incubated for 30 minutes at 37°C after
which fluorescence was measured (F). Wells were then incubated with 0.03% saponin for
60 minutes at 37°C at which time a final measurement of fluorescence was taken (Fmax).
Fluorescence data was collected using a Spectra Max Gemini M2 plate reader (Molecular
Devices, Sunnyvale, CA, USA) at excitation/emission wavelengths of 530/620 with a
cutoff of 610 nm. The percentage of dead cells was calculated using the following
formula for each well:
% cell death = [(F-Fmin)/(Fmax-Fmin)] x 100
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Introduction
N-methyl D-aspartate receptor (NMDAR) activation is one of the many important
steps necessary to elicit long-term potentiation (LTP). This is accomplished by NMDARs
not only through calcium entry, but also through the initiation of several downstream
effectors, notably the production of superoxide. NMDAR activation has been shown to
lead to the activation NADPH oxidase, resulting in superoxide production (Brennan et.
al. 2009). The generation of superoxide anions in the central nervous system (CNS) plays
an intriguing dual role, delicately balancing normal function and the potential to cause
cellular damage. Under normal physiologic conditions, superoxide has been shown to be
necessary for LTP in the hippocampus (Klann et al. 1998). Recent studies have
demonstrated that upon activation of NMDARs, a resulting superoxide burst arises from
NADPH oxidase (Brennan et al., 2009, Girouard et al., 2009), which when blocked with
pharmacological inhibition of NADPH oxidase prevents LTP in the hippocampus
(Kishida et al., 2006). Spatial localization of NADPH oxidase subunits revealed
immunohistochemical staining of a membrane bound subunit of NADPH oxidase,
gp91phox, as well as the cytosolic components of NADPH oxidase, p67phox and p47phox, in
the soma and dendrites of mouse hippocampal slices (Tejada-Simon et al., 2005). This
localization is consistent with previous studies that have demonstrated a similar spatial
expression of NMDARs (Spruston et al., 1995). Since superoxide is short lived due to its
highly reactive properties, its generation needs to be in close proximity to its protein
targets to serve as a possible signaling molecule. Given the proximity of NADPH oxidase
to the synapse, the localized production of superoxide can serve as a signaling molecule
to affect NMDAR function.
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However, while ROS may be necessary for the processes of LTP, its uncontrolled overproduction leads the cell into a state of oxidative stress. Abramov et al.
(2007) demonstrated that superoxide anions are generated in a tri-phasic manner in
neurons following 40 minutes oxygen-glucose deprivation/reperfusion (OGD/R). The
three superoxide bursts were identified sequentially originating from mitochondrial,
xanthine oxidase, and NADPH oxidase through pharmacological inhibition as well as
knock out studies, with the tertiary superoxide burst from NADPH oxidase occurring
during reperfusion. Since NADPH oxidase reduces molecular oxygen to superoxide, the
lack of available oxygen during OGD limits the reaction. However, upon re-introduction
of oxygen, a rapid and sustained burst of superoxide from NADPH oxidase occurs.
Furthermore, this superoxide burst is involved in the processes of cellular death, as
pharmacological inhibition of NADPH oxidase during ischemia/reperfusion (I/R) with
the NADPH oxidase inhibitor apocynin is highly neuroprotective (Wang et al., 2006).
NMDARs play a key role in the mechanisms of excitotoxic neuronal death
following I/R. The massive increase in extracellular glutamate known to occur during I/R
injury leads to an over-stimulation of NMDARs, a key factor in neuronal death
accomplished via intercellular calcium overload and increased ROS production. In
addition to excessive glutamate stimulation, NMDARs also undergo phosphorylation
mediated conformational changes following I/R that potentiates the effect of glutamate
NMDAR stimulation. In particular, a rapid and sustained increase in tyrosine
phosphorylation of the NMDAR NR2A subunit has been reported following I/R (Takagi
et al., 1997, Pei et al. 2000, Liu et al., 2001, Jiang et al., 2008, Murotomi et. al., 2008).
Increased tyrosine phosphorylation of the NR2A subunit functionally potentiates
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NMDAR currents by increasing the likelihood of the receptor being in an open
conformation, and decreases the probability of the receptor being in an inactive state (Yu
et. al., 1997).
In recent years, evidence has documented the role of Src Family Kinases (SFKs)
in upregulating the activity of NMDARs (Kalia et. al., 2004) via tyrosine
phosphorylation of residues located on the C-terminus of NR2 subunits (Chen et. al.,
1996). Through inhibition of SFK activity, phosphorylation of NR2 subunits is prevented
and the elicitation of LTP is blocked (Kalia et. al., 2004). While this process is important
for synaptic plasticity, an enhancement of the effect of glutamate during an excitotoxic
event only exacerbates the damage. The SFKs have been implicated in modulating
NMDAR function following I/R (Jian X et al., 2008). Direct inhibition of SFKs with PP2
was shown to provide neuroprotection following ischemic insult (Hou et al., 2007, Jian et
al., 2008). Additionally, the interaction of SFKs with postsynaptic density protein 95
(PSD-95), a scaffolding protein that concentrates NMDARs at the post-synaptic density,
is an important mechanism underlying I/R-induced increases in the tyrosine
phosphorylation of NR2A and NR2B subunits. Suppression of PSD-95 expression
diminishes tyrosine phosphorylation of both subunits following I/R (Hou et. al., 2003).
Furthermore, inhibiting Src interaction with PSD-95 prevents the I/R-induced increase in
tyrosine phosphorylation of the NMDAR NR2A subunit (Hou et. al., 2003). Taken
together, the process of SFKs interacting with PSD-95 facilitates the tyrosine
phosphorylation of NMDAR NR2 subunits, thereby enhancing calcium entry through the
receptor.
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While SFKs become active following I/R (Hou et al., 2007; Jian et al., 2008), the
upstream signals leading to its activation remain largely unresolved. SFKs have been
reported to be redox sensitive in nature (Li et al., 2008, Giannoni et. al., 2010), although
the ROS source responsible for its redox-induced activation during I/R remains unknown.
In this study, we sought to determine whether superoxide production from NADPH
oxidase was involved in the activation of SFKs associated with PSD-95, thereby
mediating the tyrosine phosphorylation of the NMDAR NR2A subunit.
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Results
Increased NADPH oxidase activity following oxygen glucose deprivation in retinoic
acid differentiated SH-SY5Y cells
To examine whether SH-SY5Y cells served as an appropriate cell model to study
the effects of NADPH oxidase activity on NMDAR NR2A subunits following OGD/R,
we examined the expression of NADPH oxidase cytosolic subunit p67phox in retinoic
differentiated and non-retinoic acid differentiated SH-SY5Y cells. Consistent with
previous findings (Nitti et. al., 2007), protein expression of the NADPH oxidase cellular
component p67phox in retinoic acid differentiated SH-SY5Y increased 4-fold as compared
to non-differentiated SH-SY5Y cells (data not shown). Therefore, differentiated SHSY5Y cells were used throughout this study to examine whether NADPH oxidase was
involved in the OGD/R-induced increase in tyrosine phosphorylation of the NR2A
subunit. To determine whether activation of NADPH oxidase activity occurred during
OGD incubation or during the subsequent reperfusion, as previously reported in cortical
neuronal cells (Abramov et al., 2007), we subjected 6-day retinoic acid differentiated SHSY5Y neuroblastoma cells to 40-minutes of OGD followed by reperfusion of cultures for
various incubation times in the presence of dihydroethidium (DHE). There was no
observable increase in superoxide generation in cultures subjected to 40-minutes of OGD
alone (Fig. 1A). Reperfusion of OGD cultures, however, did lead to superoxide
generation that was maximal between 15- and 30-minutes (Fig. 1A and 1B). Treatment of
cultures with the NADPH oxidase inhibitor DPI (100 nM) during reperfusion drastically
decreased DHE fluorescence, suggesting that NADPH oxidase may be responsible for
superoxide production during reperfusion of OGD subjected cultures. Treatment of
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cultures with 1µM phorbol 12-myristate 13-acetate (PMA) for 15 minutes, a known
positive control for NADPH oxidase activity, yielded a strong fluorescent signal. As
anticipated based upon Western blot results showing a low level of p67phox, an increase
in ROS production during reperfusion following 40 minutes of OGD in nondifferentiated SH-SY5Y cells was not observed (data not shown). We also observed an
increase in the reduced product of nitroblue tetrazolium chloride (NBT) in differentiated
SH-SY5Y cultures subjected to OGD/R (Fig. 1B), which was similar to the time course
to ROS production observed with DHE. Treatment of OGD cultures with DPI during
reperfusion blunted NBT reduction (Fig. 1B), suggesting that NADPH oxidase activation
underlies the ROS production during reperfusion of OGD cultures.
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Figure 1. Increased ROS generation during reperfusion of OGD treated cultures of
retinoic acid differentiated SH-SY5Y involves NADPH oxidase activity.
Representative fluorescent images from three independent experiments of reactive
oxygen species production following OGD (A) with vehicle (1:1000 DMSO) or DPI (100
nM) detected using dihydroethidium (DHE). Spectrophotometric quantification of
reactive oxygen species following OGD (B) with vehicle (1:1000 DMSO) or DPI (100
nM) utilizing nitrobluetetrazolium chloride (NBT). Data represent mean ± S.E.M from
three separate experiments that consisted of at least 6 determinents (askteriks * indicates
a p <0.05 from vehicle treated normoxic control; ANOVA with post hoc Bonferroni test).
Phorbol 12-myristate 13-acetate (PMA; 1µM for 15 minutes) was used as a positive
control for NADPH oxidase activity in both the DHE and NBT assays.
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OGD/Reperfusion-induced Increased tyrosine phosphorylation of NMDAR NR2A
subunit
Previous studies have demonstrated that there is a rapid and sustained increase in
tyrosine phosphorylation of the NMDAR NR2A subunit during post-ischemic
reperfusion (Takagi et al., 1997). Therefore, experiments were performed to examine
whether OGD or subsequent reperfusion of OGD subjected cultures would lead to an
increase in tyrosine phosphorylation of the NMDAR NR2A subunit. In non-differentiated
SH-SY5Y cells subjected to OGD/R, there was no observable increase in tyrosine
phosphorylation of the NR2A subunit as compared to time-matched normoxic control
(data not shown). In contrast, we found a significant increase in tyrosine phosphorylation
of the NR2A subunit at 30-minutes of reperfusion in differentiated SH-SY5Y cells
subjected to OGD incubation (Fig. 2A and 2B). This increase in tyrosine phosphorylation
coincided with the time course in which we observed maximal ROS generation (Fig. 1).
Collectively, these results indicate that NMDAR NR2A subunit undergoes an increase in
tyrosine phosphorylation during reperfusion of OGD subjected differentiated SH-SY5Y
cells. This increase in tyrosine phosphorylation of the NR2A subunit coincided with
increased ROS production.
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Figure 2. OGD/R promotes the increase in tyrosine phosphorylation of the NMDAR
NR2A subunit in differentiated SH-SY5Y cells. Immunoprecipitation and
immunoblotting of lysates prepared from differentiated SH-SY5Y cells exposed to
OGD/R reveals a significant increase in tyrosine phosphorylation of the NR2A subunit.
(A) Western blot shown is representative of three independent experiments. (B)
Quantification of the relative densitometry of the phospho-Tyr-NR2A immunoreactive
band. Data represent mean ± S.E.M from three separate experiments. (askteriks *
indicates a p <0.01 from normoxic control; ANOVA with post hoc Bonferroni test).
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Inhibition of NADPH oxidase attenuates OGD/Reperfusion-induced increase in NR2A
tyrosine phosphorylation
To examine whether mitochondrial, xanthine oxidase, or NADPH oxidase is the
ROS generator that mediates the oxidative stress signaling cascade responsible for the
increase in tyrosine phosphorylation of the NR2A subunit in differentiated SH-SY5Y
cells, cultures were treated during reperfusion with 0.5 µM of the mitochondrial
depolarization uncoupler carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone
(FCCP), the xanthine oxidase inhibitor oxypurinol (1 µM), or the NADPH oxidase
inhibitor DPI (100 nM). Treatment of cultures with FCCP or oxypurinol failed to prevent
increase in tyrosine phosphorylation of the NR2A subunit during 30-minutes of
reperfusion of OGD treated SH-SY5Y cultures (Fig. 3B). However, inhibition of
NADPH oxidase activity with DPI prevented the increase in tyrosine phosphorylation of
the NR2A subunit at 30 minutes of reperfusion following OGD. There were no changes
in total protein levels of NR2A in cultures treated with DPI, oxypurinol, or FCCP. These
results indicate that NADPH oxidase underlies the oxidative stress-signaling cascade
responsible for the OGD/R-induced increase in NR2A tyrosine phosphorylation.
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Figure 3. Inhibition of NADPH Oxidase activity blocks the OGD/R-induced increase
in tyrosine phosphorylation of the NMDAR NR2A. Inhibition of superoxide
generation from xanthine oxidase with oxypurinol (1 µM) and mitochondria with FCCP
(0.5 µM) failed to prevent the OGD/R-induced increase in tyrosine phosphorylation of
the NMDAR NR2A subunit. However, inhibition of NADPH Oxidase with DPI (100
nM) was found to block the increase in tyrosine phosphorylation of the NR2A subunit.
Representative Western blot (A) of three independent experiments of phospho-TyrNR2A with vehicle (1:1000 DMSO), DPI, oxypurinol, and FCCP. (B) Quantification of
the density of the phospho-Tyr-NR2A band. Data represent mean ± S.E.M from three
separate experiments. (askteriks * indicates a p <0.05 from normoxic control; ANOVA
with post hoc Bonferroni test).
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OGD/Reperfusion-induced association between Src-family kinase and PSD-95 is
prevented with inhibition of NADPH oxidase activity
SFKs have been shown to mediate increases in tyrosine phosphorylation of
NMDAR subunits after transient cerebral ischemia (Takagi et al., 1997; Pei et al., 2000;
Liu et al., 2001; Hou et al., 2007; Jiang et al., 2008). To determine whether SFKs were
involved in mediating OGD/R-induced increase in tyrosine phosphorylation of the NR2A
subunit in differentiated SH-SY5Y cells, cultures were treated with the potent SFK
inhibitor PP2. Administration of PP2 (1 µM) immediately following OGD blunted the
increase in tyrosine phosphorylation of the NR2A subunit (Fig. 4B). In a previous study,
it was reported that suppression of PSD-95 expression reduced the increase in tyrosine
phosphorylation of the NR2A subunit after transient brain ischemia in the hippocampus
(Hou et. al. 2003). Therefore, to determine whether activation of NADPH oxidase
facilitated the interaction of activated SFKs associating with the scaffolding postsynaptic
density protein 95 (PSD-95), we performed an immunoprecipitation of PSD-95 combined
with immunoblotting for activated SFKs. We found that the active form of SFKs
(phospho-Tyr416) associated with PSD-95 during reperfusion of OGD cultures (Fig. 5A),
as early as 5 minutes of reperfusion and sustained for at least 30 minutes of reperfusion.
Inhibition of NADPH oxidase significantly reduced the association of activated SFKs
with PSD-95 during reperfusion of OGD cultures (Fig. 5C). These results indicate that
the OGD/R-induced activation of NADPH oxidase facilitates the interaction of activated
SFKs with PSD-95 thereby facilitating the tyrosine phosphorylation of the NR2A
subunit.

77

Figure 4. The OGD/R-induced increase in tyrosine phosphorylation of the NMDAR
NR2A subunit is attenuated by treatment with the Src Inhibitor PP2. Inhibition of
Src Family Kinase activity with the selective inhibitor PP2 rescued the increase in
tyrosine phosphorylation of the NMDAR NR2A subunit. (A) Representative Western
blot from 3 independent experiments illustrates the dampened tyrosine phosphorylation
of NR2A with direct inhibition of Src Family Kinases during reperfusion following OGD
with PP2 (1 µM). (B) Quantification of the density of the phospho-Tyr-NR2A band. Data
represent mean ± S.E.M from three separate experiments. (askteriks * indicates a p <0.05
from normoxic control; ANOVA with post hoc Bonferroni test).

78

Figure 5. OGD/R promotes the interaction between activated Src Family Kinases
and PSD-95, which is reduced with NADPH oxidase inhibition differentiated SHSY5Y cells. (A) Immunoprecipitation of PSD-95 and immunoblotting with phosphoSFK(Tyr416) shows the increase in the active form (phospho-Tyr416) of SFKs bound to
PSD-95 with treatment of OGD/R compared to normoxic controls (Norm). Western blot
is representative of three independent experiments. (B) Quantification of the density of
the phospho-SFK(Tyr416) band after PSD-95 immunoprecipitation. (C) Representative
western blot from Immunopreciptation of PSD-95 from three independent experiments
illustrates the dampening of activated SFKs bound to PSD-95 with DPI (100nM) or PP2
(1 µM) treatment during reperfusion following 40 minutes of OGD. (D) Quantification of
the density of the phospho-SFK(Tyr416) band after PSD-95 immunoprecipitation. For
both (B) and (D), data represent mean ± S.E.M from three separate experiments.
(askteriks * indicates a p <0.05 from normoxic control; ** indicates a p <0.001; ANOVA
with post hoc Bonferroni test).
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Inhibition of NADPH oxidase following OGD/R dampens the exacerbated effect of
NMDA induced cellular death.
One of the functional consequences of NMDAR NR2A tyrosine phosphorylation
is a potentiation of NMDAR currents (Yu et. al. 1997). Through an increased
permeability to calcium, the effect of glutamate stimulation of NMDARs is amplified,
thereby exacerbating calcium overload and subsequent cellular death. Previous studies
have demonstrated a marked decrease in cellular viability of SH-SY5Y cells when
exposed to NMDA stimulation (0.25-5 mM, Corasanitl et al., 2007). To determine if the
OGD/R-induced activation of NADPH oxidase contributed to NMDAR mediated cellular
death, we used an ethidium homodimer exclusion assay as a marker for cellular viability.
We found that following 40 minutes of OGD, treatment of differentiated SH-SY5Y cells
with NMDA (5 mM) elicited an increased susceptibility to cellular death after 6 hours as
compared to normoxic NMDA stimulated controls (Fig. 6). However, inhibiting NADPH
oxidase during the 6 hours of NMDA treatment with DPI (100 nM) following the 40
minutes of OGD, significantly reduced susceptibility to NMDA mediated cellular death.
These results indicate that the NMDAR mediated cell death in post-ischemic
differentiated SH-SY5Y cells involves NADPH oxidase.
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Figure 6. Inhibition of NADPH Oxidase activity decreases NMDA-mediated cell
death following exposure to OGD. Differentiated SH-SY5Y cells exhibit an increased
susceptibility to cell death after 6 hours of NMDA (5 mM) stimulation following 40
minutes of OGD as assessed by the ethidium homodimer exclusion assay. This enhanced
NMDA-induced cell death is diminished with NADPH oxidase inhibition using DPI (100
nM). Data represent mean ± S.E.M from three independent experiments consisting of 1012 determinents (askteriks * indicates a p <0.05 from normoxic control; ANOVA with
post hoc Bonferroni test).
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Discussion
There are several lines of evidence that indicate that oxidative stress signaling
cascades strongly contribute to synaptic glutamatergic excitotoxicity following postischemic neuronal injury. While numerous studies have identified changes in NMDAR
subunit function following ischemia (Liu et al., 2001, Jiang et al., 2008), as well as the
downstream signaling cascades leading to cellular death (Arundine and Tymianski 2003,
Forder and Tymianski 2008), upstream mechanisms leading to these changes remain
largely unresolved. Therefore, experiments were conducted to identify the source of ROS
generation involved in the oxidative stress-signaling cascade responsible for the increase
in tyrosine phosphorylation of the NMDAR NR2A subunit. Additionally, we performed
experiments to establish the mechanism in which the OGD/R-induced activation of
NADPH oxidase leads to this increase in tyrosine phosphorylation of the NR2A subunit,
as well as to demonstrate a functional consequence of NADPH oxidase activity on
enhanced NMDAR-induced cellular death following OGD/R.
Superoxide, which can serve as a signaling molecule to alter NMDAR function,
can be produced during ischemia/reperfusion from numerous sources. Abramov et al.
(2007) demonstrated that in cortical neuronal cultures, both during OGD and the
subsequent reperfusion, superoxide is generated in a tri-phasic manner from distinct
sources. The primary and secondary burst arise from the mitochondria and the enzyme
xanthine oxidase during the OGD phase. During the reperfusion following OGD, a
tertiary burst of superoxide was observed which was shown to be a result of NADPH
oxidase activity. Further studies have also reported that NADPH oxidase activity results
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in the production of superoxide in vivo in the hippocampus of adult mice subjected to
ischemia/reperfusion (Suh et al., 2008).
We therefore sought to determine the temporal pattern of ROS production
following exposure to OGD/R in retinoic acid differentiated SH-SY5Y cells utilizing
DHE fluorescence as well as NBT reduction. ROS production, while observed to be
minimal during 40 minutes of OGD, was maximally increased by 15 minutes of
reperfusion and was drastically blunted when NADPH oxidase was inhibited with DPI,
both in the DHE and NBT assays (Fig. 1A and 1B). In contrast, ROS generation during
reperfusion following OGD was minimal in non-differentiated SH-SY5Y cells (data not
shown), which may be due to the decrease in NADPH oxidase subunit protein expression
levels seen reported by Nitti et al. (2007), and confirmed by our study. While superoxide
production from NADPH oxidase has been shown to contribute to neuronal death (Wang
et al., 2006, Suh et al., 2008) following stroke, its basal activity under physiologic
conditions is thought to be critical in the processes of LTP as demonstrated by an
inhibition of LTP in knock-out studies of mice lacking a functional NADPH oxidase
holoenzyme (Kishada et al., 2006). Therefore, under pathologic conditions such as
ischemia/reperfusion, we sought to determine if superoxide produced from NADPH
oxidase played a role in mediating the increased tyrosine phosphorylation of the NMDAR
NR2A subunit following OGD/R.
Modifications on the C-terminal regions of NMDAR subunits in the brain via
phosphorylation are thought to play a key role in neuronal development, synaptic
plasticity, and a variety of pathologic conditions (Lau and Huganir, 1995). While
increases in both serine and threonine phosphorylation does occur on NR1 and NR2
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subunits, potentiation of NMDA currents seems to be accomplished via direct tyrosine
phosphorylation of NR2 subunits by protein tyrosine kinases (Chen et al., 1996).
Tyrosine phosphorylation of the NR2A increases the probability that the receptor will
enter a long-lived open conformation, as well as decrease the likelihood of the receptor
entering a long-lasting closed state (Yu et al., 1997). This increase in tyrosine
phosphorylation ultimately affects the amount of calcium that is able to enter through the
receptor, resulting in an increased effect of glutamate upon NMDAR stimulation. While
this is an important phenomenon for synaptic plasticity under physiologic conditions, the
increased entry of calcium through NMDAR during pathologic insults only exacerbates
neuronal death via calcium overload. We found that a significant increase in tyrosine
phosphorylation of the NMDAR NR2A subunit occurred during reperfusion of OGD
subjected in retinoic acid differentiated SH-SY5Y cells. As indicated previously, ROS
generation by NADPH oxidase occurs during post-ischemic reperfusion (Abramov et. al.
2007). While numerous reports have established that ischemic insult results in an increase
of NMDAR tyrosine phosphorylation (Takagi et al., 1997; Pei et al. 2000), oxidative
stress signaling pathways leading to the increases in phosphorylation status still remained
largely unresolved. We found that inhibition of NADPH oxidase activity with DPI
significantly attenuated the OGD/R-induced increase in NR2A tyrosine phosphorylation.
Inhibition of mitochondrial ROS production with FCCP or xanthine oxidase ROS
production with oxypurinol had no significant effect on reducing NR2A tyrosine
phosphorylation, suggesting that the key superoxide source for signaling for changes in
NMDAR NR2A tyrosine phosphorylation is NADPH oxidase. These findings are
consistent with previous studies by Murotomi et al. (2008 and 2010), as inhibition of
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NADPH oxidase with mGluR1 antagonism reduced the increase in tyrosine
phosphorylation of the NR2A subunit following I/R, ultimately decreasing infarct size in
vivo. However, these studies did not report underlying mechanisms between NADPH
oxidase activation and an increase in NMDAR NR2 subunit phosphorylation status.
SFKs, originally discovered as a proto-ocongene yet later found to be highly
expressed in fully differentiated mature neurons (Cotton and Brugge, 1983), are
important in mediating NMDAR tyrosine phosphorylation (Yu et al., 1997; Liu et al.,
2001). SFKs have also been shown to be activated and form interactions with NMDARs
during ischemia (Jian et al., 2008). We demonstrated that OGD/R-induced tyrosine
phosphorylation of the NR2A subunit involves the activity of SFKs. This SFK mediated
tyrosine phosphorylation of the NR2A subunit appears to also involve interaction with
PSD-95. This is consistent with the findings of Hou et al. (2003) that reported I/Rinduced increase in NR2 subunit phosphorylation requires activated Src to bind to PSD95 prior to phosphorylating NR2 subunits. We have extended this finding by
demonstrating that inhibition of NADPH oxidase leads to a diminished SFK interaction
with PSD-95. Additionally, the OGD/R-induced increase in tyrosine phosphorylation of
the NMDAR NR2A subunit is diminished by inhibiting NADPH oxidase activity.
Therefore, this result suggests that OGD/R-induced increase in NR2A tyrosine
phosphorylation involves the NADPH oxidase mediated SFK interaction with PSD-95.
SFKs have been shown to play a role in mediating cellular death during stroke, as
treatment with the inhibitor PP2 has been demonstrated to be neuroprotective (Hou et al.,
2007, Jian et al., 2008). In retinoic acid differentiated SH-SY5Y cells, we demonstrated
that treatment with PP2 significantly reduced the OGD/R-induced tyrosine
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phosphorylation of the NR2A subunit, further indicating the importance of SFKs in
mediating the tyrosine phosphorylation of NMDARs. A possible explanation of SFK
activation during OGD/R lies in the redox sensitive nature of SFK activity (Li et al.,
2008), which would explain the large increase in SFK activation observed when in a state
of oxidative stress such as stroke.
Lastly, we sought to determine if inhibition of NADPH oxidase could protect
against the exacerbated excitotoxic effect of NMDA stimulation following OGD/R.
Wang and others (2006) had previously showed the neuroprotective effect of NADPH
oxidase inhibition in vivo following I/R. However, the mechanism providing this
neuroprotection was not fully investigated. Physiologic LTP studies have demonstrated
that pharmacologic inhibition of NADPH oxidase diminishes the ability of receptor
signaling to potentiate synaptic currents (Kishida et. al. 2006). While necessary for LTP
under physiologic conditions, the dampening of excitatory receptor signaling could be
beneficial in pathologic conditions leading to calcium overload via excitotoxcicity as
during I/R. Through inhibition of NADPH oxidase activity with DPI, enchanced cell
death after NMDA stimulation following OGD/R was significantly rescued. A plausible
mechanism for such protection could be explained by the prevention of the increase in
tyrosine phosphorylation of the NMDAR NR2A subunit with NADPH oxidase inhibition,
thereby diminishing the enhanced excitotoxic effect of NMDAR stimulation.
In summary, we have demonstrated that NADPH oxidase is activated and is a
major source of ROS generation during reperfusion following OGD in retinoic acid
differentiated SH-SY5Y cells. This ROS burst from NADPH oxidase is important in
mediating the activation of SFKs and its interaction with PSD-95, which consequently
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are responsible for the observed increase in the tyrosine phosphorylation of the NMDAR
NR2A subunit. Collectively, this data indicates an upstream mechanism leading to
changes in the phosphorylation of NMDAR NR2A subunit, thereby ultimately affecting
the potentiated properties of the receptor in post-ischemic tissue.
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ISCHEMIA/REPERUSION

Diagram 8. Proposed model for CHAPTER 1. NADPH oxidase signaling following
OGD/R leads to the activation of SFKs, which tyrosine phosphorylate NR2A and NR2B
subunits, leading to an enhanced calcium entry via potentiation of NMDAR channels (1)
and possible extrasynaptic migration (2).
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CHAPTER 2
Oxygen-Glucose Deprivation/Reperfusion-Induced Degradation of the GluR2
AMPA Receptor Subunit Involves NADPH Oxidase and p38 MAPK.
Abstract
Following a stroke, the pathological increase in intracellular calcium arising from
the over-activation of post-synaptic glutamatergic receptors has long been established as
a key contributor to neuronal death. More recently, calcium and zinc permeable 2-amino3-(3-hydroxy-5-methylisoazol-4-yl)propionic acid receptors (AMPARs) have been
shown to contribute to neuronal death following ischemic-reperfusion injury via an
unusual subunit composition change to GluR2-lacking AMPARs that renders the receptor
permeable to divalent cations. In this study, we investigated the effect of superoxide
production from NADPH oxidase in contributing to an oxidative stress-signaling cascade
involved in the accelerated endocytosis and degradation, resulting in the AMPAR subunit
switch in post-ischemic tissue. Inhibition of NADPH oxidase with apocynin attenuated
the oxygen-glucose deprivation/reperfusion-induced (OGD/R) degradation of the
AMPAR GluR2 subunit, as well as damped the OGD/R-induced increase in p38 MAPK
activation, thereby affecting early endocytic machineries by decreasing the GDI:Rab5
complex formation. Direct inhibition of p38 MAPK with SB202190 also rescued GluR2
degradation following OGD/R through preventing the surface removal of GluR2 by
decreasing the Rab5-GDI interaction. Furthermore, inhibition of clathrin-mediated
endocytosis prevented the surface removal of GluR2 and subsequent degradation.
Collectively, these data suggest that NADPH oxidase has an important role in mediating
GluR2 degradation in hippocampal slices following exposure to OGD/R.
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Materials and Methods
Preparation of acute rat hippocampal slices
Adult male (6-8 week) Sprague-Dawley rats (Charles River Labs, Wilmington,
MA, USA) were anesthetized with isoflurane and rapidly decapitated. The entire brain
was then removed and placed in an ice-cold cutting solution (75mm Sucrose, 80mm
NaCl, 2.5 mM KCl, 1.25 mM NaH2PO4, 24 mM NaHCO3, 25 mM Glucose, 4mM
MgCl2, 1mM L-Ascorbic Acid, 3mM Na Pyruvate, 0.5 mM CaCl2, pH 7.4). Both
hippocampi were then quickly dissected away from the brain and coronal 400 micron
thick slices were made using a tissue chopper. Slices were then subsequently equilibrated
in oxygenated (95% O2, 5% CO2) artificial cerebrospinal fluid (aCSF; 124 mM NaCl, 2.5
mM KCl, 1.25 mM KH2PO4, 26 mM NaHCO3, 10 mM Glucose, 1.5 mM MgCl2, 2.5
mM CaCl2, pH 7.4) for 90 minutes prior to treatment with OGD/R, with fresh aCSF
being replaced every 15-30 minutes during the equilibration phase. Pre-treatment with 30
µM apocynin (Sigma, St. Louis, MO, USA) or 1:1000 vehicle (DMSO) occurred during
the final 30 minutes of the equilibration process and was present throughout the duration
of the experiment, either during time matched normoxia treated controls or OGD and
subsequent reperfusion. Treatment with 10 µM of the selective p38 MAPK inhibitor
SB202190 (Sigma, St. Louis, MO, USA) occurred immediately following OGD and was
left in for the duration of reperfusion or time matched normoxia treated controls.
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Oxygen-Glucose Deprivation/Reperfusion of hippocampal slices
Following equilibration in oxygenated aCSF, slices to be subjected to OGD/R
were rinsed with aCSF without glucose (aCSF with 10 mM Mannitol substituted for 10
mM Glucose, pH 7.4), to remove glucose from the slices, and incubated for 40 minutes in
a hypoxic glove box (Coy Laboratories, Grass Lake, MI, USA) containing a gas mixture
of 0% O2, 95% N2, 5% CO2 with aCSF minus glucose. The aCSF minus glucose media
used for OGD was placed in 0% O2 overnight to ensure complete anoxia. Following
OGD, slices were removed from the hypoxic glove box and transferred back to
oxygenated aCSF containing glucose for the time periods indicated. Normoxic controls
were left in aCSF containing glucose throughout the entire experiment and were time
matched to the last of the OGD/R time points.

Detection of ROS using nitro-bluetetrazolium chloride
Slices were incubated in oxygenated aCSF with nitro-bluetetrazolium chloride
(NBT; 0.5 mg/mL; Sigma, St. Louis, MO, USA) for 10 minutes prior to OGD/R. Excess
NBT was then rinsed away with aCSF minus glucose and OGD/R treatment proceded as
previously described. At the indicated time point, the reaction was stopped with 0.25 M
HCl. Slices were visualized via phase contrast microscopy (Olympus SZX16, 4X air
objective), then lysed via sonication in DMSO containing a protease inhibitor cocktail.
The lysate was then aliquoted into a 96 well plate and absorbance was read at 550 nM on
a spectrophotometric microplate reader (VersaMax plate reader, Molecular Devices,
Sunnyvale, CA, USA).
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Propidium Iodide Staining
Following dissection and equilibration, hippocampal slices were treated with
either 40 minutes of OGD alone, OGD plus reperfusion time points, or time matched
normoxia. Slices were incubated with propidium iodide (4 mg/mL, Sigma) in aCSF for
the final 30 minutes of treatment. Slices were then rinsed 3 times in PBS to remove
excess propidium iodide and visualized in triplicates for each time point using a
fluorescent dissecting microscope (Olympus). Staurosporine (10 µM, 30 minutes) was
used a positive control for cell death.

Lysate Preparation
Slices were removed from aCSF at the indicated time point and rinsed with ice
cold PBS. For total protein level detection, slices were places in tubes containing lysis
buffer (250 mM Sucrose, 20 mM HEPES, 2 mM EDTA, 5 mM MgCl2, 1 mM
dithiothreitol, 1 mM AEBSF, 1% protease and phosphatase inhibitor cocktail (Thermo,
Rockland, IL, USA), 1% Triton X-100, 0.01% saponin, pH 7.4) and lysed immediately
via sonication for a 3 separate 5 second bursts at 25% power output with a VirTis
Ultrasonic Cell Disrupter 100 (Gardiner, NY, USA). Samples were then spun at 1,000 x g
to remove nuclei and cellular debris and a BCA assay was performed to determine
protein content. Samples were then denatured in Laemmli buffer and heat (100°C) for 10
minutes and resolved via sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE). For cellular and membrane fractionations, slices were placed in lysis
buffer without Triton X-100 or saponin, lysed via sonication, and then spun at 1,000 x g
for 10 minutes to remove the nuclei and cellular debris. The supernatant was then
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collected and spun in a swinging bucket rotor at 100,000 x g for 30 minutes. The
resulting supernatant yielded a clean cytosolic fraction. The membrane fraction pellet
was then extracted on ice using lysis buffer containing Triton X-100 and saponin,
disrupted via sonication, and spun at 1,000 x g to remove any insoluable proteins. Protein
levels were determined using a bicinchoninic acid assay (BCA; Thermo), and samples
were heated with Laemmli buffer as previously described and resolved via SDS-PAGE.
Samples were then transferred to a nitrocellulose membrane (Bio-Rad, Berkeley, CA,
USA) for subsequent detection via immunoblotting.

Immunoblotting
Blots were blocked for 1 hour at room temp with either 5% BSA (for phosphoantibody detection) or 5% non-fat dry milk in Tris Buffered Saline, 0.1% Tween 20, pH
7.5 (TBS-T). After blocking, blots were incubated with primary antibody overnight at
4°C at the concentration indicated. The affinity purified GluR1 rabbit-polyclonal
antibody (1:1000) was purchased from AbCam (Cambridge, MA, USA). The affinity
purified rabbit-monoclonal GluR2 antibody (1:2000) was purchased from Epitomics
(Burlingame, CA, USA). The affinity purified rabbit-polyclonal p38 MAP Kinase
(1:1000) antibody and the affinity purified rabbit-monoclonal phospho-p38 MAP Kinase
(Thr180/Tyr182) (1:500) were purchased from Cell Signaling Technology (Beverly, MA,
USA). Goat anti-Mouse-HRP and Goat-anti-Rabbit-HRP secondary antibodies (1:2000)
were purchased from Jackson ImmunoResearch (West Grove, PA, USA). The affinity
purified mouse monoclonal Rab5 (1:250) antibody and the affinity purified goat
polyclonal p67phox (1:250), gp91phox (1:250), and phosphoglycerate kinase 1 (PGK;
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1:250) antibodies were purchased from Santa Cruz Biotechnologies (Santa Cruz, CA,
USA). The donkey anti-Goat-HRP secondary antibody was also purchased from Santa
Cruz. Immunoreactive bands were visualized and captured with a Fuji imaging system
using enhanced chemiluminescence after adding HRP conjugated secondary antibodies.
Bands were analyzed using Fuji Image-Gauge software. Blots were stripped and reprobed up to 4 times using Restore Plus Western Blotting Stripping Buffer (Thermo).

Immunoprecipitation
To visualize the Rab5-GDI protein complex, rat hippocampal slices were lysed in
a buffer containing 50 mM Tris-HCl, 100 mM NaCl, 5 mM EGTA, 5 mM EDTA, 1 mM
phenylmethylsulfonyl fluoride, 0.5% Triton X-100, and 1% protease and phosphatase
inhibitor cocktail. Protein concentration was then determined using a BCA assay, and
lysates (500 µg/sample in 500 µl) were then pre-cleared using Protein-A/G 50/50 mix of
agarose beads for 1 hour at 4°C followed by incubation with a Rab5 antibody overnight
at 4°C. The immunocomplex was then incubated for 4 hours with 50 µL Protein-A/G
beads at 4°C with rotation before being washed 3 times with lysis buffer. Samples were
eluted from the agarose beads by treatment with Laemmli buffer and heat (100°C) for 10
minutes and then subjected to SDS-PAGE. After transfer to nitrocellulose membranes,
blots were blocked as previously described and incubated overnight at 4°C with a mouse
affinity-purifed Rab-GDI anti-body (1:1000; Synaptic Systems, Goettingen, Germany).
Immunoreactive bands were analyzed using Fuji Image-Gauge software.
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Immunostaining of hippocampal slices
Slices were treated to either normoxia or OGD/R as previously described, washed
with PBS, and fixed using 4% paraformaldehyde. Slices were then cryoprotected (30%
sucrose/PBS) overnight before resectioning on a sliding Microtome to produce 60 micron
thick slices. The slices were then permeablized (0.4% Triton X-100), blocked (20%
BSA/PBS), and then stained with primary antibodies for Rab5 (1:200) or Rab-GDI
(1:200). Slices were then rinsed three times with PBS and treated with pre-immune serum
for 30 minutes at room temperature prior to being stained with fluorescent secondary
antibodies. The slices were then rinsed three times with PBS prior to being stained with a
NeuroTrace fluorsecent Nissl stain (Invitrogen, Carlsbad, CA, USA) for 20 minutes at
room temperature. Slices were then rinsed three times with PBS and mounted on to slides
for visualization via fluorescent confocal microscopy (Olympus FV1000, 40X oil
objective).

Biotinylation of hippocampal slices
Acute adult rat hippocampal slices were prepared and treated to OGD/R or time
matched normoxia as previously described, washed with ice cold Buffer A (25 mM
HEPES, 119 mM NaCl, 5 mM KCL, 2 mM CaCl2, 2 mM MgCl2, 30 mM glucose, pH
7.4), and incubated at 4°C in Buffer A containing 0.5 mg/ml of sulfo-NHS-SS-biotin
(Thermo) for 30 minutes with gentle agitation. After biotin labeling, slices were washed
three times in ice cold Buffer A. For cleaved controls, slices were treated to two 15
minute incubations in Glutathione Buffer (75 mM glutathione, 75 mM NaCl, 10 mM
EDTA, 1 % bovine serum albumin, pH 7.4) and rinsed 3 times in ice cold Buffer A.
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Slices were then lysed via sonication with 3 separate 5 second bursts at 25% power
output in Buffer A containing 1% protease and phosphatase inhibitor cocktail, and then
spun at 1,000 x g to remove the nuclei and cellular debris. The supernatant was then
collected and spun in a swinging bucket rotor at 100,000 x g. The biotin labeled
membrane fraction was then solubilized on ice for 10 minutes using Solubilization Buffer
(10 mM Tris, 150 mM Nacl, 1% protease and phosphatase inhibitor cocktail, 1 % Triton
X-100, pH 8). The biotin labeled membrane pellet was then collected and sonicated with
2 separate 5 second bursts at 25% power output and a BCA assay was performed to
determine protein content. Biotin labeled membrane proteins (500µg sample/500µl of
Solubilization buffer) were then incubated overnight with gentle agitation at 4°C with 60
µl 50% streptavidin sepharose beads (GE Healthcare, Little Chalfont, UK). The
streptavidin sepharose beads were then washed twice with High Salt Buffer
(Solubilization Buffer containing 0.6 M NaCl, pH 8.0), followed by two washes with
Solubilization Buffer. The streptavidin sepharose bead complex was then denatured with
Laemmli and heat (80°C) for 10 minutes, subjected to SDS-PAGE, and transfered to
nitrocellulose membranes for subsequent immunoblotting with GluR1 and GluR2
antibodies as previously described. Immunoreactive bands were analyzed using Fuji
Image-Gauge software. For experiments using high sucrose concentrations to prevent
clathrin-mediated endocytosis, 0.45 M sucrose was added to aCSF with/without glucose
solutions. Slices were incubated in oxygenated aCSF with glucose containing 0.45 M
sucrose for 30 minutes prior to OGD treatment in pre-anoxiated aCSF without glucose
containing 0.45 M sucrose. Subsequent reperfusion of slices occurred in oxygenated
aCSF with glucose containing 0.45 M sucrose or time matched normoxia.
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Introduction
Annually in the United States, approximately 795,000 individuals suffer from a
stroke, thereby making it the third leading cause of death and the leading cause of
disability in the United States (Falluji et al., 2011). Despite an enormous amount of
research effort by both the scientific and pharmaceutical communities, efficacious
therapeutic interventions for stroke patients has yet to reach the clinic. One of the well
studied phenomena known to occur following stroke is the cytotoxic accumulation of
intracellular calcium, resulting from the excessive release of the excitatory
neurotransmitter glutamate, a process known as “excitotoxicity” (Szydlowska and
Tymianski, 2010). While physiologic increases in calcium are a key event in regulating
many cellular processes including synaptic plasticity, the over-activation of post-synaptic
receptors in turn leads to the accumulation of high intracellular calcium, an event known
to be responsible for much of the neuronal death associated with stroke (Arudine and
Tymianski, 2003).
Excitatory synaptic transmission is therefore a tightly regulated process, mediated
by both the total number and the temporal activation of the 2-amino-3-(3-hydroxy-5methylisoazol-4-yl)propionic acid receptor (AMPAR). The co-ordination of N-methyl Daspartate receptor (NMDAR) and AMPAR localization and activity govern the basic
tenants of synaptic plasticity, with the extent of intracellular calcium concentration
dictating the differential activation of downstream signaling cascades (Kullman and
Lamsa, 2007). In its most basic form, AMPARs are inserted into the post-synaptic
membrane during long term potentiation (LTP), or strengthening of the synapse, and
removed from the surface during long term depression (LTD), or weakening of the

97

synapse (Shepherd and Huganir, 2007). It is therefore this delicate balance between
AMPAR trafficking, be it synaptic AMPAR delivery or synaptic AMPAR removal, in
combination with numerous other receptor inputs, which composes the molecular basis
for the cellular mechanisms of learning and memory.
However, the complexity of the process of AMPAR trafficking also involves
numerous other inputs, including subunit composition, phosphorylation events, and
protein-protein interactions. Specifically focusing on subunit composition, the presence
or absence of the GluR2 subunit, one of four genes (GLUR1-4) which combine in various
stochiometeries as a “dimer of dimers” to form the functional AMPAR tetramer, governs
much of AMPAR channel properties and ionic permeability as a result of its amino acid
makeup (Shepherd and Huganir, 2007). Hydrolytic RNA editing of the GluR2 transcript
via the activity of the adenosine deaminase enzyme ADAR2 (Bass, 2002) substitutes a
neutrally charged glutamine (Q) for a positively charged arginine (R) in the region which
structurally composes the AMPAR channel pore, thereby making AMPARs that contain
GluR2 (Q607R) impermeable to divalent cations (Ca2+ and Zn2+), while AMPARs
lacking GluR2 are able to conduct Ca2+ and Zn2+ (Traynelis et al, 2010). In the
hippocampus, the majority of AMPARs are composed of GluR1 and GluR2 (Q607R)
hetero-tetramers, with lower levels of GluR3 and GluR4, although subunit expression
patterns are both activity dependent (Clem et al., 2010) and are vastly varied depending
on neuroanatomical location (Passafaro et al., 2001).
Surface removal of GluR2 containing AMPARs is a process thought to be
important in increasing the basal excitability of neurons by increasing Ca2+ permeability
via GluR2-lacking AMPARs (Lu and Ziff, 2005). While this short-lived change in
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promoting GluR2-lacking AMPAR subunit composition has been reported to be
important in the induction of LTP (Terahsima et al., 2008), long-lasting changes in the
switch of AMPAR subunit composition to Ca2+ and Zn2+ permeable AMPARs have been
demonstrated to contribute to neuronal death in a number of Central Nervous System
(CNS) pathologies, including Alzheimer’s disease (Liu et al., 2010), Parkinson’s disease,
Huntington’s disease (Jayakar and Dikshit, 2004), and stroke (Noh et al., 2005).
While initial reports of stroke-induced glutamate-dependent excitotoxicity
demonstrated that excess activity of NMDARs was primarily responsible for mediating
calcium cytotoxicity and subsequent neuronal death (Ford et al, 1989; Mcintosh et al.,
1989), more recently it has been documented that calcium permeable AMPARs also
contribute to neuronal death following stroke (Yin et al., 2002,; Anzai et al., 2003; Liu et
al., 2004; Noh et al., 2005).
In this study, we show that the superoxide producing enzyme nicotinamide
adenine dinucleotide phosphate oxidase (NADPH oxidase) is involved in mediating the
removal of AMPARs from the surface of acute adult rat hippocampal slices subjected to
oxygen-glucose deprivation/reperfusion (OGD/R) by enhancing the endocytic
machineries responsible for AMPAR internalization. More specifically, we found that the
OGD/R-induced activation of NADPH oxidase contributes to the activation of p38
mitogen-activated protein kinase (p38 MAPK), a kinase that has been demonstrated to be
involved in AMPAR surface removal (Cavalli et al., 2001; Huang et al., 2005; Zhong et
al. 2008). Furthermore, we show that total GluR2 protein levels are significantly reduced
following OGD/R while total GluR1 protein levels are not affected. Inhibition of
NADPH oxidase during OGD/R diminished p38 MAPK activation, reduced the activity
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of early endocytic machineries, decreased AMPAR surface removal, and rescued total
and surface GluR2 protein levels. These results provide direct evidence of a NADPH
oxidase-mediated oxidative stress-signaling cascade responsible for the AMPAR
dysfunction observed following ischemia/reperfusion.
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Results
NADPH oxidase contributes to oxidative stress in the adult rat hippocampus following
exposure to OGD/R
To assess the contribution of NADPH oxidase in promoting the oxidative stress
observed following OGD/R, a NBT test was performed in acute adult rat hippocampal
slices treated to OGD/R or time matched normoxia in the presence or absence of the
NADPH oxidase inhibitor apocynin (30 µM). NBT is reduced by superoxide or oxidant
metabolites to form formazan, an insoluble dye which can be observed via colorimetry
and quantified (Altman, 1977). Treatment of hippocampal slices to OGD/R increased
formazan formation, illustrating a large increase in the oxidative environment,
particularly during the reperfusion phase in slices subjected to OGD (Fig. 7A and 7B). It
had previously been demonstrated that OGD/R results in a tri-phasic production of
reactive oxygen species (ROS), sequentially identified as resulting from the
mitochondria, xanthine oxidase, and a large tertiary burst resulting from NADPH oxidase
during reperfusion (Abramov et al., 2007). Consistent with these results, we found that
pharmacologic inhibition of NADPH oxidase with apocynin significantly reduced
formazan deposits following OGD/R, suggesting that NADPH oxidase significantly
contributes to oxidative stress in the rat hippocampus during reperfusion following OGD
exposure.
NADPH oxidase is composed of both catalytic and regulatory subunits that
assemble at the plasma membrane to form a functional holoenzyme. NOX2, one of 7
NADPH oxidase family members to be identified (NOX 1-5, DUOX 1/2; Brown and
Griendling, 2009), is most the highly expressed isoform in neurons of the CNS and
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requires the membrane bound gp91phox catalytic subunit and translocation/assembly of the
cytosolic activators p47phox and p67phox in order for superoxide-producing activity to
occur (Bedard and Krause, 2007). Consistent with the NBT assay results, we found a
significant and long lasting association of the cytosolic activator p67phox with the
membrane fraction following OGD/R treatment (Fig. 7C and 7D), with maximal
membrane interaction at 30 minutes of reperfusion following OGD. Apocynin has been
demonstrated to block Nox2 assembly (Stolk et al., 1994), and consistent with these
findings, we found that apocynin prevented the OGD/R-induced association of p67phox
with the membrane fraction at the 40/30 OGD/R time point (Fig. 7E and 7F). However,
inhibition of NADPH oxidase activity with apocynin not only reduced oxidative stress,
but also increased cellular viability in acute rat hippocampal slices treated to OGD/R as
assessed by propidium iodide staining (Fig. 8) results that are in agreement with the
findings Wang et al. (2006) in the gerbil hippocampus. Taken together, these results
(Figs. 7 and 8) strongly support the view that NADPH oxidase is a major contributor to
the oxidative stress environment observed following ischemia/reperfusion, in turn
contributing to cellular death.
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Figure 7. NADPH oxidase activity contributes to oxidative stress during reperfusion
of OGD-treated hippocampal slices. Adult rat hippocampal slices were loaded with
NBT and subjected to either time-matched normoxia, OGD alone, or OGD with various
reperfusion time points. Phase contrast images (A) were collected on a dissecting scope.
Reduced NBT was quantified (B) by cellular lysis in DMSO with the absorbance of the
resultant supernatant being collected at 550 nM. Apocynin treatment (30 µM)
dramatically decreased the amount of reduced NBT as compared to untreated slices,
suggesting NADPH oxidase is a major contributor to the oxidative burst observed during
reperfusion following exposure to OGD. Phorbol 12-myristate 13-acetate (PMA; 10 µM,
10 minutes) was used as a positive control for NADPH oxidase activity. Data are
presented as the % mean of untreated controls ± S.D and is representative of three
independent experiments with at least 5 individual hippocampal slices per group.
(askteriks * indicates a p of at least <0.05; ANOVA with post hoc Bonferroni test).
Lysates were prepared and resolved via centrifugation and detergent extraction in Figure
1C to yield cytosolic (C) and membrane (M) fractions, which illustrates the translocation
of the cytosolic 67phox to the plasma membrane. The cytosolic phosphoglycerate kinase
(PGK) and the membrane bound component of NADPH oxidase, gp91phox, were used as
markers for cytosolic and membrane fractions. Data are expressed in (D and F) as relative
mean densitometry of membrane bound p67phox as of ratio of gp91phox ± S.D (askteriks *
indicates a p of at least <0.05 from normoxic controls; ANOVA with post hoc Bonferroni
test).
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Figure 8. NADPH oxidase inhibition with apocynin is neuroprotective in adult rat
hippocampal slices exposed to OGD/R. Adult rat hippocampal slices were subjected to
time matched normoxia, OGD alone, or OGD with various reperfusion time points in the
presence or absence of the NADPH oxidase inhibitor apocynin (30 µM). Cellular
viability was assessed using propidium iodide staining (4 µg/mL, 30 minutes).
Staurosporine (10 µM, 30 minutes) was used as a positive control for cell death. Images
are representative of two independent experiments that were done in triplicate for each
group.
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OGD/R induces AMPAR surface removal and the selective degradation of GluR2,
which is attenuated with NADPH oxidase inhibition
Numerous studies have demonstrated that ischemia/reperfusion results in a
functional change in the subunit composition of AMPARs, from those containing GluR2
to those lacking the GluR2 subunit (Pellegrini-Giampietro et al., 1992; PellegriniGiampietro et al. 1997; Optiz et al., 2000; Liu et al., 2004), an event known to contribute
to AMPAR-mediated cell death (Anzai et al., 2003; Noh et al., 2005; Soundarapandian et
al., 2005). To examine this phenomena in our model of acute adult rat hippocampal
slices, time course experiments were performed to examine total protein levels of GluR1
and GluR2. While total protein levels of GluR1 were not significantly altered from
normoxia treated controls, total GluR2 protein levels were significantly reduced after 40
minutes of OGD followed by 30 minutes of reperfusion (Fig. 9A and 9B). However,
through the use of biotin surface protein labeling experiments, both GluR1 and GluR2
subunits are removed from the cell surface following exposure to OGD/R (Fig. 9C and
9D), while only GluR2 is degraded. These results indicate a differential trafficking event
leading to the selective degradation of GluR2, thereby promoting AMPARs that are
GluR2-lacking and consequently Ca2+/Zn2+-permeable following OGD/R.
However, inhibition of NADPH oxidase activity with apocynin during OGD/R
significantly rescued the OGD/R-induced degradation of total/membrane bound GluR2
(Fig. 10 A-D). Furthermore, treatment of slices with apocynin during OGD/R also
decreased the surface removal of GluR2, as well as GluR1 (Fig. 10E and 10F),
suggesting an OGD/R-induced NADPH oxidase-dependent signaling cascade is involved
in increased endocytic trafficking and subsequent selective GluR2 degradation.
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Figure 9. GluR2 is selectively degraded in the rat hippocampus following oxygenglucose deprivation/reperfusion. Total lysates were prepared from hippocampal slices
exposed to time-matched normoxia, OGD alone, or OGD/R time points. Representative
Western blot (A) of four independent experiments illustrates the selective decrease in
GluR2 protein levels. However, a representative Western blot (C) of three independent
experiments reveals that after biotinylation of surface proteins, both GluR1 and GluR2
are decreased. Data are expressed in (B) and (D) as relative mean densitometry of
normoxic controls (corrected to β-actin in the case of (B)) ± S.D (askteriks * indicates a p
of at least <0.05 from normoxic (N) control; ANOVA with post hoc Bonferroni test).
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Figure 10. Total/Membrane and surface bound GluR2 is degraded in the rat
hippocampus following oxygen-glucose deprivation/reperfusion and is attenuated
with inhibition of NADPH Oxidase activity. Lysates were prepared from rat
hippocampal slices exposed to OGD/R with vehicle (1:000 DMSO) or 30 µm of the
NADPH Oxidase inhibitor apocynin (Apo). Samples were prepared as either total lysates
(A), resolved (Fig 3C) via centrifugation and detergent extraction to yield cytosolic (C)
and membrane (M) fractions or surface biotin labeled proteins isolated with streptavidin
beads (E) from 4 independent experiments. Glutathione cleavage (75 mM) following
biotin labeling is also illustrated as an additional control. Data is expressed in (B), (D)
and (F) as % mean densitometry of Normoxic vehicle treated control (corrected to β-actin
in the case of (B)) ± S.D. (askteriks * indicates a p <0.05; ANOVA with post hoc
Bonferroni test).

109

OGD/R promotes the activation of p38 MAPK and the formation of the Rab5:GDI
complex, which is diminished with NADPH oxidase inhibition
Increasing lines of evidence indicate an important role for p38 MAPK in
promoting the endocytosis of AMPARs in neurons during LTD (Huang et al., 2005;
Shepherd and Huganir, 2007; Zhong et al., 2008). Early endocytic membrane trafficking
is primarily regulated through the action of the small GTPase Rab5 (Stenmark and
Olkkonen, 2001), which is governed in part by the activity of guanyl nucleotide
dissociation inhibitors (GDI) (Novick et al., 2006). GDI extracts inactive GDP-bound
Rab5 from membranes to form the cytosolic GDI:Rab5 complex, which is subsequently
delivered to the appropriate membrane target for further activity (Novick and Zerial,
1997). Serine phosphorylation of GDI, mediated by p38 MAPK, enhances its ability to
extract Rab5 and form the GDI:Rab5 complex, thereby increasing endocytic trafficking
(Cavalli et al., 2001).
Oxidative stress is well documented to induce the activation of p38 MAPK
(Robinson and Cobb, 1997, Ogura and Kitamura 1998, Blair et al., 1999), including
oxidative stress generated by ischemia (Lu et al., 2011). Therefore, experiments were
performed to examine if the oxidative stress observed in adult rat hippocampal slices
exposed to OGD/R resulted in the activation of p38 MAPK. Consistent with the NBT
data illustrating the oxidative environment within the hippocampal slices, our data
revealed a significant increase in the amount of activated p38 MAPK (phosphoThr180/Tyr182) after 40 minutes of OGD and 15 minutes of reperfusion (Fig. 11A and
11B). Additionally, by diminishing oxidative stress during OGD/R through the inhibition
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of NADPH oxidase activity with apocynin, the activated levels of p38 MAPK were
significantly reduced at all OGD/R time points (Fig. 11C and 11D).
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Figure 11. Increased p38 MAPK activity in adult rat hippocampal slices following
exposure to oxygen-glucose deprivation/reperfusion is blunted with NADPH oxidase
inhibition. (A) Representative Western blot from 3 independent experiments of
hippocampal slices illustrates the time course of p38 MAPK activation (phosphoThr180/Tyr182) during reperfusion following 40 minutes of OGD. (C) Representative
Western blot of the OGD/R-induced increase in p38 MAPK activation illustrating the
decrease in phospho-p38 MAPK levels with apocynin (30 µM) treatment compared to
vehicle (1:1000 DMSO). Quantification (B) and (D) of the density of the phosphop38MAPK immunoreactive band expressed as a ratio of the phosphorylated form of p38
MAPK to total p38 MAPK protein levels. Data represent % densitometry mean (of
normoxic control) ± S.D from three separate experiments. (askteriks * in (B) indicates a p
<0.01 from normoxic controls or between groups shown in (D); ANOVA with post hoc
Bonferroni test).
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Next, the formation of the GDI:Rab5 complex, an association enhanced by p38
mediated phosphorylation of GDI, was examined following OGD/R. Consistent with the
time-course of p38 MAPK activation following OGD/R, immunohistochemical staining
(Fig. 12A) and immunoprecipitation assays (Fig. 12B and 12C) revealed that Rab5 and
GDI form a complex during reperfusion following 40 minutes of OGD. However,
inhibition of NADPH oxidase during OGD/R, which was demonstrated to attenuate p38
MAPK activation (Fig. 11C and 11D), significantly reduced the OGD/R-induced increase
in the GDI:Rab5 complex formation (Fig. 13A and 13B). Additionally, direct inhibition
of p38 MAPK with the selective inhibitor SB202190 (10 µM) during reperfusion of
OGD-treated slices also prevented the formation of the GDI:Rab5 complex (Fig. 13A and
13B), further illustrating the importance of p38 MAPK activity in promoting the
GDI:Rab5 complex, a result in agreement with the findings of others (Cavalli et al., 2001,
Huang et al., 2005).
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Figure 12. OGD/R promotes the formation of the Rab5-GDI complex. Hippocampal
slices subjected to time matched normoxia, OGD alone, or OGD with reperfusion time
points were immunostained (A) for Rab5 (Texas Red) and GDI (FITC), which reveals colocalization during reperfusion following exposure to OGD. Images were collected via
confocal microscopy (40X) and are representative of three independent experiments done
in triplicates. (B) Immunoprecipitation of Rab5 from total lysates prepared from adult
male rat hippocampal slices treated to OGD/R show an increase in the formation of the
Rab5:GDI complex. Also illustrated in (B) is the GDI immunoreactive band resulting
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from the supernatant following immunoprecipitation of Rab5, in addition to total levels
of both Rab5 and GDI. Quantification (C) of the density of the Rab5-GDI
immunocomplex band are expressed as a % densitometry mean of normoxic controls ±
S.D from three separate experiments. (asterisk * in (C) indicates a p <0.05 from normoxic
controls or between groups shown; ANOVA with post hoc Bonferroni test).
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Figure 13. Inhibition of NADPH oxidase and p38 MAPK prevents the OGD/Rinduced formation of the Rab5-GDI complex. Immunoprecipitated lysates (A)
prepared from hippocampal slices subjected to time matched normoxia or OGD/R with
either vehicle (1:1000 DMSO), 30 µM apocynin, or 10 µM of the selective p38 MAPK
inhibitor SB202190 attenuates the formation of the Rab5-GDI complex. Quantification
(B) of the density of the Rab5-GDI immunocomplex band are expressed as a %
densitometry mean of normoxic controls ± S.D from three separate experiments.
(askteriks * in (B) indicates a p <0.01 from normoxic controls or between groups shown;
ANOVA with post hoc Bonferroni test). Also illustrated in (A) is the GDI
immunoreactive band resulting from the supernatant following immunoprecipitation of
Rab5, in addition to total levels of both Rab5 and GDI.
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Direct inhibition of p38 MAPK or clathrin-dependent endocytosis rescues the OGD/Rinduced AMPAR surface removal and selective degradation of GluR2
As previously mentioned, p38 MAPK activation has been reported to mediate
AMPAR surface removal (Zhong et al., 2008; Xiong et al., 2006; Huang et al., 2005).
Experiments were performed on OGD/R-treated adult rat hippocampal slices in the
presence or absence of the selective p38 MAPK inhibitor SB202190 (10 µM) to examine
the effect on GluR1 and GluR2 protein levels and surface expression. The addition of the
selective p38 MAPK inhibitor SB202190 (10 µM) did not have any significant effect on
the membrane translocation of p67phox (data not shown), indicating that SB202190 does
not affect the OGD/R-induced increase in NADPH oxidase activity. However, inhibition
of p38 MAPK prevented the OGD/R-induced decrease in total/membrane GluR2 protein
levels (Fig. 14A-14D). In addition to rescuing the loss of GluR2 protein following
OGD/R, treatment of SB202190 during reperfusion of OGD-treated slices also prevented
the surface membrane removal of GluR1 and GluR2 (Fig. 14E and 14F), as assessed by
biotin labeling of surface proteins and subsequent streptavidin bead pulldown. These
observations demonstrate that p38 MAPK activity is involved in the rapid loss of surface
AMPARs in rat hippocampal slices following exposure to OGD/R, presumably through
the p38 MAPK-mediated stimulation of endocytic machineries. Through p38 MAPK
mediated phosphorylation of GDI (Cavalli et al., 2001), the activity of GDI in extracting
GDP-bound Rab5 in increased, consequently forming the cytosolic GDI-Rab5 complex
and allowing Rab5 to once again become GTP-bound for further Rab5 mediated
endocytosis.
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To further confirm the importance of endocytosis in the processes of the OGD/Rinduced degradation of GluR2, slices were treated with hypertonic sucrose (0.45 M) to
prevent clathrin coated pit formation (Heuser and Anderson, 1989). Studies have
demonstrated that the formation of the clathrin coat is a necessary step for AMPAR
internalization (Carroll et al., 1999). In agreement with previous findings, we found that
hypertonic sucrose treatment prevented the surface removal of GluR2 as assessed by
surface biotin labeling (Fig. 15C and 15D) of sucrose hypertonic OGD/R-treated slices,
ultimately rescuing the selective degradation of GluR2 (Fig. 15A and 15B). These
experiments further illustrate the importance of early endocytic trafficking in the OGD/Rinduced loss of Glur2.
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Figure 14. Inhibition of p38 MAPK rescues GluR2 degradation following exposure
to OGD/R. Lysates were prepared from hippocampal slices exposed to OGD/R with
either vehicle (1:000 DMSO) or 10 µM of the p38 MAPK inhibitor SB202190.
Representative western blots of total lysates (A), fractionated lysates (C) (cytosolic = C
and membrane = M) or surface biotin labeled proteins isolated with streptavidin beads
(E) from 4 independent experiments. Glutathione cleavage (75 mM) following biotin
labeling is also illustrated as an additional control. Data is expressed in (B), (D) and (F)
as % mean densitometry of Normoxic vehicle treated control (corrected to β-actin in the
case of (B)) ± S.D. (askterik * indicates a p <0.05; ANOVA with post hoc Bonferroni
test).
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Figure 15. Inhibition of clathrin-dependent endocytosis rescues GluR2 degradation
following exposure to OGD/R. Lysates were prepared from hippocampal slices exposed
to OGD/R with or without hypertonic sucrose (0.45 M) added to aCSF. Representative
western blots of total lysates (A) or surface biotin labeled proteins isolated with
streptavidin beads (C) from 4 independent experiments. Glutathione cleavage (75 mM)
following biotin labeling is also illustrated as an additional control. Data is expressed in
(B) and (C) as % mean densitometry of Normoxic vehicle treated control (corrected to βactin in the case of (B)) ± S.D. (askterik * indicates a p <0.05; ANOVA with post hoc
Bonferroni test).
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Discussion
Following ischemia/reperfusion, the loss of surface GluR2-containing Ca2+/Zn2+impermeable AMPARs correlates with areas of the brain most susceptible to delayed
neuronal death (Liu et al., 2004). This switch from Ca2+/Zn2+-impermeable to Ca2+/Zn2+permeable AMPARs occurs through the surface removal and degradation of the GluR2
subunit (Dixon et al., 2009), the insertion of GluR2-lacking AMPARs to the plasma
membrane (Liu et al., 2006), in addition to transcriptional and translational
downregulation of GluR2 transcript (Pelligrini-Giampietro et al., 1997) and the RNA
editing proteins involved in rendering GluR2 (Q607R) impermeable to divalent cation
conductance (Peng et al., 2006).
In this study, we found that the OGD/R-induced activation of NADPH oxidase
resulted in an increase in the endocytic machineries responsible for the internalization of
AMPAR subunits. The data in this study indicate that ROS arising from NADPH oxidase
activity during the reperfusion of OGD treated acute rat hippocampal slices are involved
in the activation of p38 MAPK, which enhances Rab5/GDI complex formation and
presumably accelerates Rab5 early endocytic trafficking by increasing the activity of GDI
in extracting Rab5 from endosomal membranes, ultimately facilitating further endocytic
traffic. Furthermore, the results from this study indicate a differential trafficking of the
two AMPAR subunits GluR1 and GluR2, as OGD/R promoted the selective degradation
of GluR2 while GluR1 protein levels remained largely unaffected, despite equal levels of
GluR1 surface removal as GluR2. Inhibition of NADPH oxidase during OGD/R
dampened p38 MAPK activation, decreased Rab5-GDI complex formation, and
maintained significantly more GluR1 and GluR2 at the plasma membrane when
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compared to vehicle treated controls. Direct inhibition of p38 MAPK activity with the
selective inhibitor SB202190 also maintained surface levels of GluR1 and GluR2,
presumably through the inability of p38 MAPK to enhance endocytosis. Additionally,
both p38 MAPK and NADPH oxidase inhibition during OGD/R also prevented the
selective decrease in total GluR2 protein levels, thereby potentially rescuing the divalent
cation impermeability of AMPARs in the hippocampus.
The activation of p38 MAPK has been established by previous studies to be both
redox sensitive (Robinson and Cobb, 1997; Ogura and Kitamura 1998; Blair et al., 1999)
and activated by ischemia/reperfusion (Ozawa et al., 1999; Sugino et al. 2000; Liu et al.,
2009; Lu et al., 2011). While p38 MAPK activation has been clearly demonstrated to
occur following ischemia/reperfusion, the exact upstream mechanisms that potentially
modulate p38 MAPK activity are not yet fully resolved. One study has identified Nitric
oxide (NO) as the upstream signal of p38 MAPK activation following hypoxia/reoxygenation (Chen et al., 2009), while others have indicated a role for NADPH oxidasederived ROS (Jian et al., 2011). Consistent with the findings of others (Abramov et al.,
2007), we found that NADPH oxidase was the main contributor to the oxidative stress
environment observed during the reperfusion of OGD subjected hippocampal slices. The
data presented in this study strongly suggests that ROS derived from NADPH oxidase
activity is an important mediator of p38 MAPK activity, but the contribution of nitric
oxide synthase and other sources of ROS cannot be discounted.
Additionally, the data presented does not fully elucidate the mechanisms of how
NADPH oxidase-derived ROS results in a sustained OGD/R-induced p38 MAPK
activation. The activity of p38 MAPK pathways is tightly regulated and opposed by a
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family of dual-specificity MAPK phosphatases (Camps et al. 2000; Farooq and Zhou,
2004), which have been shown to become inactivated by ROS at low micromolar
concentrations (Denu and Tanner, 1998; Seth and Rudolph, 2006). Furthermore, studies
have shown that ROS-mediated inactivation of dual-specificity MAPK phosphatase
activity potentially mediates enhanced MAPK activity under oxidative stress conditions
(Hou et al., 2008). The inactivation of phosphatases involved in turning off p38 MAPK
by ROS originating from the OGD/R-induced increase in NADPH oxidase activity must
also therefore be considered as a potential target mechanism involved in the sustained
p38 MAPK activation following OGD/R.
Various p38 MAPK inhibitors have been obviously demonstrated to afford
neuroprotection following ischemia (Mackay and Mochly-Rosen, 1999; Barone et al.,
2001; Legos et al., 2001), primarily attributed towards shutting off pro-apoptotic signals
and minimizing inflammation. Interestingly however, p38 MAPK inhibitors have also
been demonstrated to provide neuronal protection in models of excitotoxic injury,
specifically those demonstrated to be independent of affecting NMDAR
electrophysiological currents or having any affect on NMDA agonist induced cell death
(Legos et al., 2002), suggesting alternative pathways outside of the classic NMDAR
excitotoxic induced caspase activation.
One such NMDA-independent alternative neuroprotective mechanism for p38
MAPK inhibition could be through the maintenance of surface levels of GluR2containing AMPARs. Recent studies have demonstrated that the internalization of
AMPARs is dependent on the p38 MAPK/Rab5-mediated endocytosis in a
clathrin/dynamin-dependent manner (Cavalli et al., 2001; Huang et al., 2005; Zhong et
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al., 2008). Rab5 serves as a key mediator of early endocytic trafficking events including
early endosomal fusion (Gorvel et al., 1991), internalization (Bucci et al. 1992), and
clathrin-coated vesicle formation (McLauchlan et al., 1999). GDI, when activated by p38
MAPK, extracts inactive GDP-bound Rab5 from endosomal membranes to form the
cytosolic GDI-Rab5 complex (Cavalli et al., 2001), eventually leading to Rab5 delivery
to the plasma membrane where upon re-activation it can mediate endocytosis by
triggering the formation of clathrin-coated pits, internalization, and subsequent sorting of
receptors and other membrane protein into early endosome (McLauchlan et al., 1999).
Given this important role of p38 MAPK/Rab5 in regulating endocytosis, the data
from this study suggests that the large and sustained increase in activation of p38 MAPK
is in part responsible for the accelerated surface removal of both the GluR1 and GluR2
AMPAR subunits following exposure to OGD/R. Our data supports that this is
accomplished through the increase in the p38 MAPK-dependent GDI-Rab5 complex
formation. Consistent with this notion, through inhibition of NADPH oxidase activity
during OGD/R, our data show the OGD/R-induced p38 MAPK-mediated GDI-Rab5
complex formation is diminished. Similar inhibition of GDI-Rab5 complex formation
during OGD/R is also seen with direct p38 MAPK inhibition using the selective p38
MAPK inhibitor SB202190. In line with these findings, through dampening the activity
of the endocytic machinery involved in AMPAR surface removal following OGD/R with
inhibition of NADPH oxidase or p38 MAPK, the data presented in this study showed that
GluR1 and GluR2 surface protein levels were significantly increased compared to vehicle
treated controls. Experiments performed with hypertonic sucrose to inhibit clathrinmediated endocytosis also illustrate the importance of early endocytic steps in the surface
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removal and differential trafficking towards GluR2 degradation. Further studies need be
done to fully understand the selective trafficking of GluR2 subunits towards degradative
pathways, while GluR1 subunits protein levels remain intact. Additionally, the impact of
OGD/R on endocytic recycling pathways needs to be studied, as dysregulation of the
pathways involved in AMPAR re-insertion after surface removal may also serve as a
critical event in the sustained loss of GluR2-containing AMPARs. Importantly however,
the data indicates that through the attenuation of the OGD/R-induced acceleration of
endocytic trafficking, the selective GluR2 trafficking towards degradation is prevented.
Collectively, this study provides compelling evidence for a NADPH oxidasedependent oxidative stress signaling cascade involved in the OGD/R-induced surface
removal of AMPAR subunits, ultimately leading to the subsequent selective degradation
of GluR2.
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CHAPTER 3
NADPH Oxidase Activity is involved in the Oxygen-Glucose
Deprivation/Reperfusion-induced Serine880 phosphorylation of the AMPA
Receptor GluR2 Subunit.
Abstract
Following ischemia/reperfusion, an interesting subunit composition switch occurs
in which GluR2-subunit containing Ca2+/Zn2+- impermeable AMPA receptors change to
GluR2-lacking Ca2+/Zn2+-permeable AMPA receptors, an event known to exacerbate
delayed cellular death following stroke. In the present study, we investigated the early
phosphorylation events leading to GluR2 surface removal in rat hippocampal slices
following treatment with oxygen-glucose deprivation/reperfusion (OGD/R). We found
that OGD/R results in a sustained phosphorylation of the GluR2 C-terminal serine residue
880 (Ser880), leading to the dissociation of GluR2 from the scaffolding proteins
glutamate receptor interacting protein-1 (GRIP1) and AMPA receptor binding protein
(ABP), thus favoring the association of GluR2 with protein interacting with C kinase-1
(PICK1), a protein known to be involved in diminishing surface expression of GluR2.
Additionally, we found that inhibition of NADPH oxidase prevented the OGD/R-induced
increase in Ser880 phosphorylation of GluR2, ultimately attenuating the loss of
GRIP1/ABP-GluR2 interaction and diminishing the GluR2/PICK1 complex formation.
Furthermore, inhibition of NADPH oxidase dampened the increase in activity of protein
kinase C α (PCKα) following OGD/R and its subsequent association with PICK1, a
necessary step prior to phosphorylation of Ser880 of GluR2. While the exact mechanisms
of NADPH oxidase mediated GluR2 Ser880 phosphorylation have yet to be elucidated,
outside of either directly or indirectly enhancing PKCα activity, this study provides some
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of the first evidence in which NADPH oxidase dependent signaling may be involved in
the surface signal of GluR2 subunit removal and subsequent degradation.
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Materials and Methods
Preparation of acute rat hippocampal slices
Adult male (6-8 week) Sprague-Dawley rats (Charles River Labs, Wilmington,
MA, USA) were anesthetized with isoflurane and rapidly decapitated. The entire brain
was then removed and placed in an ice-cold cutting solution (75mM Sucrose, 80mM
NaCl, 2.5 mM KCl, 1.25 mM NaH2PO4, 24 mM NaHCO3, 25 mM Glucose, 4 mM
MgCl2, 1mM L-Ascorbic Acid, 3 mM Na Pyruvate, 0.5 mM CaCl2, pH 7.4). Both
hippocampi were then quickly dissected away from the brain and coronal 400 micron
thick slices were made using a vibratome tissue chopper (McIlwain, Schwalbach,
Germany). Slices were then subsequently equilibrated in oxygenated (95% O2, 5% CO2)
artificial cerebrospinal fluid (aCSF; 124 mM NaCl, 2.5 mM KCl, 1.25 mM KH2PO4, 26
mM NaHCO3, 10 mM Glucose, 1.5 mM MgCl2, 2.5 mM CaCl2, pH 7.4) for 90 minutes
prior to treatment with OGD/R. Fresh aCSF was switched out every 30 minutes during
equilibration. Pre-treatment with 30 µM apocynin (Sigma, St. Louis, MO, USA) or
1:1000 vehicle (DMSO) occurred during the final 30 minutes of the equilibration process
and was present throughout the duration of the experiment, either during time matched
normoxia treated controls or OGD and subsequent reperfusion.

Oxygen-Glucose Deprivation/Reperfusion of hippocampal slices
Following equilibration in oxygenated aCSF, slices to be treated with OGD/R
were rinsed with aCSF without glucose (aCSF with 10 mM Mannitol substituted for 10
mM Glucose, pH 7.4) to remove glucose from the slices, and incubated for 40 minutes in
a hypoxic glove box (Coy Laboratories, Grass Lake, MI, USA) containing a gas mixture
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of 0% O2, 95% N2, 5% CO2 with aCSF minus glucose. The aCSF minus glucose media
used for OGD was placed in 0% O2 overnight to ensure complete anoxia. Following
OGD, slices were removed from the hypoxic glove box and transferred back to
oxygenated aCSF containing glucose for the time points indicated. Normoxic controls
were left in aCSF containing glucose throughout the entire experiment and were time
matched to the last of the OGD/R time points.

Lysate Preparation
Slices were removed from aCSF at the indicated time point and rinsed with ice
cold PBS (pH 7.4). For total protein level detection, slices were places in tubes
containing lysis buffer (250 mM Sucrose, 20 mM HEPES, 2 mM EDTA, 5 mM MgCl2, 1
mM dithiothreitol, 1 mM AEBSF, 1% protease and phosphatase inhibitor cocktail
(Thermo, Rockland, IL, USA), 1% Triton X-100, 0.01% saponin, pH 7.4) and lysed
immediately via sonication for a 3 separate 5 second bursts at 25% power output with a
VirTis Ultrasonic Cell Disrupter 100 (Gardiner, NY, USA). Samples were then spun at
1,000 x g to remove nuclei and cellular debris and a bicinchoninic acid assay (BCA,
Thermo) assay was performed to determine protein content. Samples were then denatured
in Laemmli buffer and heat (100°C) and resolved via sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE). Samples were then transferred to a
nitrocellulose membrane (Bio-Rad, Berkeley, CA, USA) for subsequent detection via
immunoblotting.
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Immunoblotting
Blots were blocked for 1 hour at room temp with either 5% BSA (for phosphoantibody detection) or 5% non-fat dry milk (for all others) in Tris Buffered Saline, 0.1%
Tween 20, pH 7.5 (TBS-T). After blocking, blots were incubated with primary antibody
overnight at 4°C at the concentration indicated. The affinity purified rabbit-monoclonal
GluR2 antibody (1:2000), Protein Kinase C α (1:2000), and phospho-Protein Kinase C α
(Thr497) (1:2000) were purchased from Epitomics (Burlingame, CA, USA). The affinity
purified goat polyclonal PICK1 antibody was purchase from Santa Cruz Biotechnologies
(Santa Cruz, CA, USA). The affinity purified rabbit polyclonal GRIP1 (1:1000) and ABP
(1:1000) antibodies were purchased from Chemicon (Billerica, MA, USA). Goat antiMouse-HRP and Goat-anti-Rabbit-HRP secondary antibodies (1:2000) were purchased
from Jackson ImmunoResearch (West Grove, PA, USA). The Donkey anti-Goat-HRP
secondary antibody was purchased from Santa Cruz. Immunoreactive bands were
visualized and captured with a Fuji imaging system using enhanced chemiluminescence
after adding HRP conjugated secondary antibodies. Bands were analyzed using Fuji
Image-Gauge software. Blots were stripped and re-probed up to 4 times using Restore
Plus Western Blotting Stripping Buffer (Thermo).

Immunoprecipitation
To visualize the PICK1-PKCα and PICK1-GluR2 protein complex, rat
hippocampal slices were lysed in a buffer containing 50 mM Tris-HCl, 150 mM NaCl, 1
mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 1% NP-40, and 1% protease and
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phosphatase inhibitor cocktail, pH = 7.5. To immunoprecipitate GluR2-GRIP1, GluR2ABP, and GluR2-PICK1, rat hippocampal slices were lysed in “GluR2 complex lysis
Buffer” containing 20 mM HEPES, 2mM EDTA, 2 mM EGTA, 0.1 mM DTT, 100 mM
KCl, 1% Triton X-100 and 1% protease and phosphatase inhibitor cocktail, pH = 7.2.
Protein concentration was then determined using a BCA assay, and lysates (500
µg/sample in 500 µl) were then pre-cleared using Protein-A/G 50/50 mix of agarose
beads for 1 hour at 4°C followed by incubation with either a PICK1 (1:50) or GluR2
(1:200) antibody overnight at 4°C. The immunocomplex was then incubated for 4 hours
with 50 µL Protein-A/G beads at 4°C with rotation before being washed 3 times with
lysis buffer. Samples were then eluted from the agarose beads by treatment with Laemmli
buffer and heat (100°C) and subjected to 7.5% SDS-PAGE. After transfer to
nitrocellulose membranes, blots were blocked as and incubated overnight at 4°C as
previously described. Immunoreactive bands were analyzed using Fuji Image-Gauge
software.
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Introduction
Ischemic/reperfusion injury (stroke) is the leading cause of disability in the
United States and Europe and the second leading cause of death in the world (Feigin,
2005), with effective therapeutics as yet to be discovered. At the cellular level, excessive
stimulation of glutamatergic NMDARs and AMPARs have been demonstrated to play an
important role in mediating excitotoxic ischemic/reperfusion-induced neuronal death
(Arudine and Tymianski, 2003). When under proper physiologic control, AMPARs,
which arise from 4 genes (GLUR1-GLUR4) to form a function receptor tetramer,
mediate the majority of fast excitatory synaptic transmission in the CNS (Borges and
Dingledine, 1998). AMPAR subunit composition varies depending on neuroanatomical
location, but most areas tend to express AMPARs expressing the GluR2 subunit,
especially in the hippocampus (Passafaro et al., 2001). Following ischemia/reperfusion
however, AMPARs undergo a subunit composition switch from GluR2 containing
Ca2+/Zn2+- impermeable AMPA receptors to GluR2-lacking Ca2+/Zn2+-permeable
AMPARs, thus allowing the AMPAR to excessively conduct calcium, an event in
combination with overactive NMDAR stimulation exacerbates cellular death (Kwak et
al., 2006).
Under physiologic conditions, GluR2 endocytosis has been demonstrated to be
mediated by protein kinase C alpha (PKCα) dependent phosphorylation of serine residue
880 (Ser880) (Chung et al., 2000). PKCα, when activated by calcium influx, is trafficked
to the plasma membrane by protein interacting with C kinase 1 (PICK1) (Perez et al.,
2001), where it binds the GluR2 scaffolding protein AMPA receptor binding protein
(ABP) and subsequently phosphorylates GluR2 at Ser880 (Lu and Ziff, 2005).
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Phosphorylation of GluR2 at Ser880 promotes the dissociation of GluR2 with the
scaffolding protein glutamate receptor interacting protein 1 (GRIP1), an interaction that is
important in anchoring AMPARs to the plasma membrane (Matsuda et al., 2000).
Additionally, Ser880 phosphorylation of GluR2 enables the increased binding of the
subunit to PICK1 (Chung et al., 2000), an interaction that has been shown to be important
in decreasing surface GluR2 levels (Terashima et al., 2004; Terashima et al., 2008). As a
result, the population of GluR2 containing AMPARs is reduced, ultimately allowing for
an increase in calcium permeable GluR2-lacking AMPARs, an event important for
synaptic strengthening under physiologic conditions (Seidenman et al., 2003), but
ultimately deleterious if uncontrolled under pathologic conditions such as stroke (Noh et
al., 2005).
Previous studies have demonstrated that ischemia/reperfusion leads to GluR2
dissociation from GRIP1, PICK1 association with ABP (Liu et al., 2006), and GluR2
association with PICK1, a step thought to be important in GluR2 endocytosis.
Additionally, peptides interfering with PICK1 PDZ domain interactions have been shown
to block the ischemia-induced AMPAR subunit composition switch, ultimately resulting
in neuroprotection (Dixon et al., 2009). However, the exact mechanisms beyond PKCα
mediated signaling (Liu et al., 2006) have not been fully described.
In this study, we show that oxygen-glucose deprivation/reperfusion (OGD/R)
exposure of acute adult rat hippocampal slices results in an increase in Ser880
phosphorylation of the GluR2 subunit. Additionally, OGD/R results in an increase in
activated PKCα-PICK1 interaction, a decrease in GluR2-GRIP1/ABP association, and an
increase in GluR2-PICK1 interaction. Interestingly, the reactive oxygen species (ROS)
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generator NADPH oxidase, an enzyme known to contribute to oxidative stress (Abramov
et al., 2007) and cellular death following ischemia (Wang et al., 2006), was found to be
involved in the OGD/R-induced increase in Ser880 GluR2 phosphorylation. Inhibition of
NADPH oxidase with apocynin not only reduced the OGD/R-induced increase in GluR2
Ser880 phosphorylation, but also prevented the decrease in GluR2-GRIP1/ABP
association and attenuated GluR2-PICK1 interaction, ultimately rescuing the selective
decrease in GluR2 protein levels. We therefore suggest that oxidative stress arising from
increased NADPH oxidase activity contributes to GluR2 surface removal, ultimately
increasing neuronal vulnerability to injury following ischemia/reperfusion.
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Results
Oxygen-glucose deprivation/reperfusion results in an increase in activated PKCαPICK association and GluR2 Ser880 phosphorylation
The endocytosis of GluR2 has been demonstrated to be both preceded and
dependent on PKCα mediated Ser880 phosphorylation of the GluR2 subunit (Chung et
al., 2003). We therefore set to determine if exposure of acute adult rat hippocampal slices
to OGD/R resulted in an increase in activated PKCα. In both total lysates and samples
resolved via centrifugation and detergent extraction to yield cytosolic and membrane
fractions, we found an overall increase in phospho-PKCα(Thr497) and a significant
increase in phospho-PKCα(Thr497)-PICK1 association (data not shown), an event known
to be an important step for GluR2 Ser880 phosphorylation (Lu and Ziff, 2005).
Interestingly, OGD alone did not result in a significant PKCα-PICK1 association, but the
reperfusion of OGD-treated slices did, ultimately resulting in a rapid and sustained
phospho-PKCα-PICK1 interaction upon reperfusion. We also performed a time response
experiment to determine a time course of the GluR2 Ser880 phosphorylation status in rat
hippocampal slices treated to OGD/R and found that GluR2 Ser880 phosphorylation
significantly increased during reperfusion while the total level of GluR2 protein
decreased (Fig. 16A and 16B). Collectively, these initial results indicated that OGD/R
promotes the activation of PKCα, which associates with PICK1 to promote the Ser880
phosphorylation of the AMPAR GluR2 subunit.
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Figure 16. OGD/R exposure of adult rat hippocampal slices promotes the Ser880
phosphorylation of GluR2. Representative Western blot (A) from 3 independent
experiments of hippocampal slices illustrates the time course of GluR2 Ser880
phosphorylation. Quantification (B) of GluR2 Ser880 phosphorylation levels expressed
as a ratio of phospho-GluR2(Ser880) to total GluR2 protein levels. Data represent %
densitometry mean (of normoxic control) ± S.D from three separate experiments.
(askteriks * in (B) indicates a p <0.05 from normoxic controls; ANOVA with post hoc
Bonferroni test).
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OGD/R promotes the association of GluR2 with PICK1 in acute adult rat hippocampal
slices
The C-terminal Ser880 phosphorylation of GluR2 has been demonstrated to be
involved in promoting the interaction of GluR2 with the PICK1, an event demonstrated to
reduce surface expression of GluR2 (Terashima et al., 2004, Terashima et al., 2008).
Ischemic-induced PICK1-GluR2 association has also been implicated in restricting
GluR2 from recycling back to the plasma membrane (Dixon et al., 2009), but has not
been demonstrated in our model of stroke using acute adult rat hippocampal slices
exposed to OGD/R. Therefore, experiments were performed to determine if the OGD/Rinduced increase in Ser880 phosphorylation of GluR2 observed in rat hippocampal slices
(Fig. 16A and 16B) functionally lead to an increase in GluR2-PICK1 association.
Temporally consistent with the OGD/R-induced increase in activated PKCα-PICK1 and
the increase in GluR2 Ser880 phosphorylation status, our results indicate a significant
increase in GluR2-PICK1 association during reperfusion of OGD-treated slices (Fig. 17A
and 17B). These results serve as a correlate with the increase in GluR2 Ser880 observed
of GluR2 during the reperfusion of OGD-treated slices, and suggest a prevented
recycling of GluR2 via PICK1-mediated membrane exclusion, data that is consistent with
the findings of the previous study described in “CHAPTER 2” (see Fig. 9C and 9D).
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Figure 17. OGD/R promotes the association of PICK1 with GluR2. Lysates were
prepared from hippocampal slices subjected to time matched normoxia, OGD alone, or
OGD/R and immunoprecipitated with a PICK1 antibody (A). Also shown in (A) is the
GluR2 immunoreactive band resulting from the supernatant following
immunoprecipitation of PICK1, in addition to total levels of both PICK1 and GluR2.
Quantification (B) of the density of the PICK1-GluR2 immunocomplex band are
expressed as a % densitometry mean of normoxic controls ± S.D from three separate
experiments. (askteriks * in (B) indicates a p <0.01 from normoxic controls; ANOVA
with post hoc Bonferroni test).
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Inhibition of NADPH oxidase with apocynin decreases the OGD/R-induced increase in
PKCα activation and subsequent Ser880 phosphorylation of GluR2
Apocynin, an inhibitor of NADPH oxidase activity, has been demonstrated by our
lab and others to decrease ROS (Fig. 7; Genovese et al., 2011), decrease damage to postsynaptic proteins (Murotomi et al., 2011), and provide neuroprotection (Fig. 8; Wang et
al., 2006) during ischemia/reperfusion. Oxidative stress has also been implicated in
affecting ionic homeostasis during ischemia/reperfusion, through the enhancement of
NMDAR currents (Hou et al., 2007; Jian et al., 2008), Phospholipase C mediated
mobilization of intracellular calcium stores (Sato et al., 2009), mitochondrial calcium
release (Clarke et al., 2008; Genovese et al., 2011) and the opening of cation channels
(Hecquet and Malik, 2009) such as the transient receptor potential (melastatin) 2
(TRPM2). Therefore, we sought to determine if the reduction in oxidative stress observed
with the inhibition of NADPH oxidase during OGD/R resulted in an attenuation of
activated PKCα associated with PICK1. Our results illustrate that hippocampal slices pretreated with apocynin (30 µM) prior to OGD/R showed a significant reduction in the
activated form of PKCα associated with PICK1 (Fig. 18A and 18B), indicating that
NADPH oxidase-mediated oxidative stress was involved in the OGD/R-induced increase
in PKCα activity. Additionally, inhibition of NADPH oxidase activity also dampened the
OGD/R-induced increase in GluR2 Ser880 phosphorylation (Fig. 18C and 18D). These
experiments show that the increase in the oxidant environment following OGD/R
resulting from NADPH oxidase activity contributes to the sustained activation of PKCα
associated with PICK1 and the subsequent rise in GluR2 Ser880 phosphorylation.
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Figure 18. The OGD/R-induced increase in activated PKCα associated with PICK1
and rise in Ser880 phosphorylation of Glur2 is blunted with inhibition of NADPH
oxidase. Representative Western blot (A) from 3 independent experiments of
hippocampal slices illustrates the pattern of PKCα (phospho-Thr497)-PICK1 association
of slices exposed to OGD/R in the presence of vehicle (1:1000 DMSO) or apocynin (30
µM) pre-treatment. (C) Representative Western blot of the OGD/R-induced increase in
GluR2 Ser880 phosphorylation. Quantification (B) of the density of the phosphoPKCα(Thr497)-PICK1 immunoreactive band expressed as the relative % mean
densitometry of normoxic controls. Quantification (D) of GluR2 Ser880 phosphorylation
levels expressed as a ratio of phospho-GluR2(Ser880) to total GluR2 protein levels. Data
represent % densitometry mean (of normoxic control) ± S.D from three separate
experiments. (askteriks * in (B) and (D) indicates a p <0.05 from normoxic controls;
ANOVA with post hoc Bonferroni test).
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Inhibition of NADPH oxidase prevents the OGD/R-induced increase in GluR2-PICK1
association and OGD/R-induced loss of GluR2-GRIP1 association
On the C-terminal tail of GluR2, the sequence (IESVKI) serves as the PKCα
mediated phosphorylation site at Ser880 and also as a PDZ binding domain. When GluR2
is in the dephospho-Ser880 state, it preferentially binds the PDZ binding scaffolding
proteins GRIP1 and ABP, which have been demonstrated to be important in retaining
GluR2 at the plasma membrane (Dong et al, 1997; Dong et al., 1999). Upon Ser880
phosphorylation, the affinity for GRIP1 and ABP is reduced and the binding of another
PDZ binding protein, PICK1 is promoted (Chung et al., 2000), potentially facilitating the
surface removal of GluR2. Therefore, experiments were performed to determine if the
decrease in Ser880 GluR2 phosphorylation observed with NADPH oxidase inhibition
during OGD/R resulted in maintenance of GluR2-GRIP1/ABP anchoring, as well as a
decrease in GluR2-PICK1 association. Consistent with the findings from the previous
figure (Fig. 18) of an OGD/R-induced increase in GluR2 Ser880 phosphorylation,
inhibition of NADPH oxidase with apocynin prevented the disruption of GluR2GRIP1/ABP anchoring (Fig. 19A-19D). Additionally, the interaction between GluR2PICK1 was diminished (Fig. 19E and 19F), further confirming the role of NADPH
oxidase in promoting the OGD/R-induced increase in GluR2 Ser880 phosphorylation and
the interaction of GluR2 with its PDZ binding partners GRIP1, ABP, and PICK1.
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Figure 19. Inhibition of NADPH oxidase restores the OGD/R-induced loss of GluR2GRIP1/ABP anchoring and prevents the association of GluR2 with PICK1. Lysates
were prepared from hippocampal slices subjected to time matched normoxia, OGD alone,
or OGD/R in the presence of vehicle (1:1000) or apocynin (30 µM), followed by
immunoprecipitation of GluR2 and subsequent immunoblotting for GRIP1 (A), ABP (C)
and PICK1 (E) complex formation. Quantification (B, D, F) of the density of the GluR2GRIP1, GluR2-ABP, and GluR2-PICK1 immunocomplex band are expressed as a %
densitometry mean of normoxic controls ± S.D from three separate experiments.
(askteriks * indicates a p <0.05; ANOVA with post hoc Bonferroni test).
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Disruption of the OGD/R-induced PICK1-GluR2 association does not effect Ser880
phosphorylation status of GluR2, but does rescue OGD/R-induced GluR2 degradation
PICK1 has been implicated to be involved in decreasing the surface expression of
GluR2-containing AMPARs in both synaptic physiology (Xia et al., 2000; Lu and Ziff,
2005) and CNS pathology such as tramautic brain injury and ischemia (Bell et al., 2009;
Dennis et al., 2011). To more precisely determine the importance of the GluR2-PICK1
interaction in GluR2 trafficking during OGD/R, a direct approach at disrupting the
GluR2-PICK1 interaction was used with the compound FSC231, a small-molecule
inhibitor of the PDZ domain on PICK1 (Thorsen et al., 2010). Due to solubility issues in
vehicle delivery, liposomal packaging was used for our drug delivery method. While
slices treated to OGD/R alone or OGD/R with the empty liposomal vehicle resulted in an
increase in PICK1-GluR2 association, the OGD/R-induced interaction of PICK1 with
GluR2 was diminished when slices were treated with liposomes packaged with FSC231
(100 µM) (Fig. 20A and 20B). Interestingly, while FSC231 did not prevent the OGD/Rinduced increase in Ser880 phosphorylation, it did significantly rescue total levels of
GluR2 protein (Fig. 20C and 20D). These data suggest that the interaction of GluR2 with
PICK1 serves as an important step in the OGD/R-induced selective degradation of GluR2
protein levels, either through an enhanced PICK1-mediated surface removal (Lu and Ziff,
2005; Bell et al. 2009) or a possible ubiquitin-PICK1 directed degradative trafficking
mechanism (Joch et al., 2007).
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Figure 20. Direct inhibition of GluR2 association with PICK1 using the smallmolecule inhibitor FSC231 rescues the OGD/R-induced loss of GluR2 protein levels.
Lysates were prepared from hippocampal slices subjected to time matched normoxia or
OGD/R in the presence of an empty liposomal vehicle or liposomes packaged with
FSC231 (100 µM), followed by immunoprecipitation of PICK1 and subsequent
immunoblotting for GluR2 (A). Also shown in (A) is the GluR2 immunoreactive band
resulting from the supernatant following immunoprecipitation of PICK1. Lysates
prepared from the same samples were also directly subjected to SDS-PAGE and
immunoblotting (B) for determination of total protein levels of GluR2, phosphoGluR2(Ser880) and β-actin as a loading control.
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Discussion
Multiple lines of evidence have shown that the activation of Ca2+/Zn2+-permeable
AMPARs following ischemic injury significantly contributes to neuronal death (Yin et
al., 2002; Anzai et al. 2003; Calderone et al., 2004; Liu et al., 2004; Noh et al. 2005; Liu
et al. 2006). While it has been demonstrated that ischemia results in a decrease in GluR2
protein levels and an increase in AMPAR-mediated Ca2+ currents (Gorter et al., 1997),
the exact mechanistic signals resulting in GluR2-mediated surface removal have yet to be
fully elucidated.
In this study, the data presented indicate that NADPH oxidase activity following
OGD/R promotes the surface removal of GluR2 through increasing PKCα Ser880
phosphorylation of the GluR2 subunit. We found that inhibition of NADPH oxidase
activity with apocynin during OGD/R not only dampened localized activation of PKCα
with PICK1, but also attenuated the OGD/R-induced increase in Ser880 phosphorylation
of GluR2. Furthermore, the decrease in Ser880 phosphorylation observed with NADPH
oxidase inhibition during OGD/R also resulted in a decreased GluR2 interaction with
PICK1, in addition to maintaining association of GluR2 with the membrane anchoring
proteins GRIP1/ABP, ultimately rescuing the OGD/R-induced loss of GluR2 protein
levels. Direct inhibition of the PICK1-GluR2 interaction with the small-molecule
inhibitor FSC231 did not prevent the OGD/R-induced increase in GluR2 Ser880
phosphorylation, but did attenuate the interaction of PICK1 with GluR2 following
exposure to OGD/R. Interestingly, FSC231 treatment during OGD/R also lead to a rescue
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of total GluR2 protein levels, suggesting the interaction of GluR2 with PICK1 serves as
an important step in the ischemic-induced reduction in total GluR2 protein levels.
The PKCα-mediated Ser880 phosphorylation of GluR2 (Xia et al., 2000) has been
shown to be important in the surface removal of GluR2 (Chung et al., 2000). While some
studies have indirectly implicated that increased Ser880 phosphorylation of GluR2 occurs
during ischemia/reperfusion (Liu et al., 2006), no studies to date have directly shown that
an increase in Ser880 occurs with such treatment. We directly found that Ser880
phosphorylation of GluR2 increased significantly during reperfusion of OGD-exposed
slices, but not during OGD without reperfusion. Our data also indicated that the
association of activated PKCα with PICK1, a step necessary prior to Ser880
phosphorylation of GluR2 (Lu and Ziff, 2005), occurred maximally during reperfusion of
OGD treated slices and not during OGD alone, data that is consistent with the time course
established for the increase in Ser880 phosphorylaiton of GluR2.
Phosphorylation of GluR2 at Ser880 has been shown to disrupt the GluR2
association with GRIP1/ABP, proteins that are important in the anchoring of AMPARs to
the cell surface (Matsuda et al., 2000). Dissociation from GRIP1/ABP exposes the PDZ
binding domain on GluR2 where the Ser880 residue resides, and when phosphorylated,
consequently has a high affinity for the PDZ binding domain of PICK1 (Dong et al.,
1997), a protein important in restricting GluR2 from the cell surface (Terashima et. al.
2004; Terashima et. al. 2008). Ischemia has been shown previously to enhance the
interaction of PICK1 with GluR2 and decrease the association of GRIP1/ABP with
GluR2 (Liu et al., 2006). Consistent with these findings, the data presented in this study
illustrates a significant increase in PICK1-GluR2 association as the GRIP1/ABP
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interaction with GluR2 decreases. Interestingly, inhibition of NADPH oxidase with
apocynin maintains GluR2 anchoring to GRIP1/ABP and decreases PICK1-GluR2
association following OGD/R, findings in line with the decrease in GluR2 Ser880
phosphorylation observed with NADPH oxidase inhibition during OGD/R.
Additional studies need be performed to determine the precise manner in which
NADPH oxidase contributes to the OGD/R-induced increase in PKCα activation and
GluR2 Ser880 phosphorylation. The first possibility involves the direct redox-modulation
of PKCα via NADPH oxidase derived ROS. Published reports have demonstrated that
PKC activity is increased with oxidative stress (Ward et al. 1998), which can be
attenuated with anti-oxidant treatment using α-tocopherol (de Diego-Ortero et al., 2009)
or apocynin treatment (Tuttle et al., 2009). However, studies have demonstrated that αtocopherol reduces PKCα activity through non-antioxidant effects (Zingg and Azzi,
2004), potentially confounding the published results of redox-sensitive PKC activity.
However, a reduction in glutathione levels has been reported to result in drastic increases
in PKC activity (Ward et al., 1998). Further research must be completed to fully
understand the relationship between ROS and direct PKC activation.
A second possibility for OGD/R-induced NADPH oxidase-mediated increases in
PKCα activity includes phosphatase inactivation. Protein phosphatase 1 (PP1) and protein
phosphatase 2A (PP2A) have been demonstrated to be important in regulating PKC
activity (Thiels et al., 1996). Studies have shown that H2O2-induced oxidative stress
inactivates both PP1 and PP2A, which is prevented with antioxidant treatment
(O’Loghlen et al, 2003). Additionally, PP1 has been identified as the phosphatase
responsible for the Ser880 dephosphorylation of GluR2 (Hu et al., 2007). OGD/R-
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induced ROS-mediated inactivation of this phosphatase may therefore serve as an
important mediator in not only regulating PKC activity, but also GluR2 Ser880
phosphorylation. Furthermore, studies have demonstrated that the filamentous actin
binding protein neurabin is important in targeting PP1 to the post-synapse for GluR2
Ser880 dephosphorylation (Hu et al., 2007). Additionally, oxidative stress has been
shown to result in the de-polymerization of actin (Tiago et al., 2006), thereby potentially
decreasing the synaptic localization of PP1 necessary for GluR2 Ser880 dephosphorylation. Decreased synaptic localization in addition to increased phosphatase
inactivation could be important steps involved in the sustained activation of PKCα and
phosphorylation of GluR2, events that are attenuated with apocynin by decreasing
NADPH oxidase-mediated oxidative stress during OGD/R.
A third possibility for the mechanism in which OGD/R-induced NADPH oxidase
activity mediates PKCα activation involves enhancing intracellular Ca2+ concentrations.
PKCα activity is positively regulated by increases in Ca2+ (Tiruppathi et al., 2006),
therefore, any enhancement in Ca2+ concentrations will increase PKCα activity. Oxidative
stress and NADPH oxidase activity has been linked to effecting Ca2+ levels through
NMDARs (Hou et al., 2007; Murotomi et al., 2008), phospholipase C-dependent release
of intracellular Ca2+ stores (Sato et al., 2009), mitochondrial Ca2+ release (Clarke et al.,
2008; Genovese et al., 2011) as well as the opening of cation channels (Hecquet and
Malik, 2009). Therefore, inhibition of NADPH oxidase activity during OGD/R could
potentially accomplish the dampening of PKCα activity not only through the maintenance
of PP1 and PP2A phosphatase activity, but also through the attenuation of oxidative

151

stress-enhanced rises in Ca2+ entry and intracellular Ca2+ release necessary for PKCα
activation.
Taken together, this study, in combination with the data presented in “CHAPTER 2”,
demonstrates the effect of OGD/R-induced NADPH oxidase-mediated oxidative stress on
GluR2 membrane scaffolding as well as the effect on the endocytic machineries
responsible for the surface removal of the AMPAR GluR2 subunit. Though these data
provide a novel mechanism for the OGD/R-induced loss of GluR2 surface proteins,
further studies will be necessary to fully characterize the upstream signaling pathways
involved in mediating PKCα activation and the resultant increase in GluR2 Ser880
phosphorylation.
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Diagram 9. Proposed Model for CHAPTER 2 and CHAPTER 3. Following
Ischemia/Reperfusion, NADPH oxidase activity is responsible for the internalization of
GluR1 and GluR2 AMPAR subunits via signaling for an increase in activity in the
endocytic machinery (red arrows) and the Ser880 phosphorylation GluR2, leading to
decreased GluR2 membrane scaffolding (black arrows).
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OVERALL SUMMARY AND CONCLUSIONS
The focus of this research was to examine the role of the superoxide producing
enzyme NADPH oxidase in signaling for altered receptor trafficking and function of
post-synaptic ionotropic NMDA and AMPARs following ischemic/reperfusion-injury.
Superoxide production arising from NADPH oxidase has been implicated in governing
many processes of NMDA and AMPA receptor function (ex: LTP/LTD) under
physiologic conditions, although the precise role of NADPH oxidase in contributing to
these processes under pathologic insults such as ischemia/reperfusion has not been fully
investigated.
The NADPH oxidase enzyme complex is responsible for superoxide production in
wide variety of tissues and cells arising from the assembly of five NADPH oxidase
subunits, two of which that are membrane bound (gp91phox, p22phox) and three of which
are cytosolic activators (p40phox, p47phox, p67phox) which translocate from the cytosol to
the membrane in order to form the functional holoenzyme complex. Superoxide is
produced via the one electron oxidation of NADPH to NADP+ and the subsequent
electron transfer along the NADPH oxidase enzyme subunits necessary for the single
electron reduction of molecular oxygen (O2) to superoxide (O2), a reactive free-radical
due to its unpaired electron. The superoxide produced from NADPH oxidase activity has
been demonstrated to be a critical step important in the processes learning and memory
through a balanced and controlled redox environment. However, the overproduction of
superoxide from NADPH oxidase has also been shown to be involved in contributing to
neuronal death in a number of CNS pathologies, including stroke. Therefore, experiments
were performed to investigate a potential link between the ischemia/reperfusion-induced
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over-activation of NADPH oxidase and possible downstream signaling events leading to
the enhanced activity of NMDA and AMPA receptors known to contribute to excitotoxic
cell death through enhanced calcium entry and resultant calcium cytotoxicity.
In the first study, we sought to determine the involvement of NADPH oxidase
activity in mediating enhanced NMDAR function following oxygen-glucose
deprivation/re-oxygenation (OGD/R). The influx of calcium ions through NMDAR
channels has long been established as a critical mediator of synaptic plasticity.
Additionally, calcium ion influx from NMDA receptors has also long been implicated in
excitotoxic neuronal death following stroke. Studies have demonstrated that superoxide
from NADPH oxidase is an important mediator of NMDA receptor function, specifically
through potentiating NMDA receptor currents via redox signaling. Given the critical role
of NADPH oxidase-dependent enhancement in synaptic plasticity, the role of NADPH
oxidase activity in mediating NMDAR function following stroke is an important process
to investigate.
Using cultured retinoic acid differentiated SH-SY5Y human neuroblastoma cells,
we demonstrated that that OGD/R-treated cultures resulted in an increase in superoxide
production, which was significantly diminished with pharmacologic inhibition of
NADPH oxidase. Furthermore, following re-oxygenation of OGD-treated cultures, an
increased tyrosine phosphorylation of the NR2A NMDA receptor subunit was observed,
an event necessary for the potentiation of NMDAR currents. Additionally, the OGD/Rinduced increase in NR2A tyrosine phosphorylation coincided with the time course of
increased NADPH oxidase activity. In addition to diminishing superoxide production
following oxygen-glucose deprivation/re-oxygenation, we found that pharmacologic
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inhibition of NADPH oxidase also attenuated the OGD/R-induced increase in NR2A
tyrosine phosphorylation. We next examined the activation of Src family kinases (SKFs),
a family of tyrosine kinases previously demonstrated to be important in mediating the
tyrosine phosphorylation of NMDAR subunits and subsequent potentiation of NMDAR
currents. We found that SFKs bound to the NMDA receptor scaffolding protein postsynaptic density protein 95 (PSD-95) increased in activity during re-oxygenation of
OGD-treated cultures minutes prior to NR2A tyrosine phosphorylation. Furthermore, we
found that direct inhibition of SFK activity diminished the OGD/R-induced increase in
NR2A tyrosine phosphorylation, suggesting that SFKs are the tyrosine kinases involved
in mediating NR2A tyrosine phosphorylation. SFKs have been shown to be redox
sensitive in their activation patterns, so we next sought to determine if NADPH oxidasedependent ROS was involved in mediating the activity of SFKs. Indeed, pharmacologic
inhibition of NADPH oxidase during re-oxygenation of OGD-treated cultures diminished
activated SFK scaffolding to PSD-95, implicating an involvement of NADPH oxidase
derived ROS following OGD/R in the increase in tyrosine phosphorylation of the NMDA
receptor NR2A subunit via increasing SFK activity. Lastly, to functionally examine that
inhibition of NADPH oxidase decreased NMDAR signaling, we demonstrated that
inhibition of NADPH oxidase attenuated the agonist-induced NMDAR mediated cellular
death following OGD/R. Taken together, this study is the first to demonstrate a plausible
downstream signaling event and cellular mechanism involved in the neuroprotection
observed by various other labs with NADPH oxidase inhibition during
ischemia/reperfusion.

156

In the second study, we examined whether the OGD/R-induced decrease total
protein levels and surface expression of the AMPAR GluR2 subunit involved NADPH
oxidase activity. AMPARs are another type of ionotropic glutamate receptors known to
be critically important in synaptic plasticity. However, unlike NMDARs, most AMPARs
in the CNS are impermeable to calcium influx upon glutamate stimulation and
subsequent channel opening, especially in the hippocampus. The presence of the edited
GluR2 (Q607R) subunit, one of four (GluR1-4) which combine in varying
stoichiometeries to form a functional AMPA receptor tetramer, is responsible for
governing this impermeability to divalent cations. However, following
ischemic/reperfusion injury, AMPA receptors undergo an unusual subunit composition
change from Ca2+/Zn2+-impermeable GluR2-containing AMPA receptors to Ca2+/Zn2+permeable GluR2-lacking AMPA receptors, an event demonstrated to correlate with
calcium cytotoxicity and subsequent delayed-neuronal death. Given that reactive oxygen
species have been implicated in the endocytosis of numerous receptors, we sought to
determine if NADPH oxidase mediated redox-signaling events were responsible for
AMPAR sequestration and degradation following ischemia/reperfusion.
Using acute rat hippocampal slices prepared from adult (6-8 weeks old) males, we
found that pharmacologic inhibition of NADPH oxidase diminished ROS generation in
hippocampal slices during reperfusion of OGD-exposed slices. Through the use of
surface labeling techniques, we found that OGD/R-treated hippocampal slices resulted in
the internalization of the two most prominent AMPAR subunits, GluR1 and GluR2.
However, when examining total protein levels of both receptor subunits, we found that
only the GluR2 subunit was degraded, while GluR1 protein levels were mostly un-
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affected. Pharmacologic inhibition of NADPH oxidase activity following OGD/R not
only rescued surface levels of both GluR1 and GluR2, but also prevented the selective
decrease in GluR2 protein levels. Previously, the role of p38 mitogen-activated kinase
(p38 MAPK) has been established as a key mediator in signaling for AMPAR surface
removal by enhancing the activity of Rab5, a protein important in early endocytic
trafficking. To investigate the possibility of p38 MAPK signaling, we found that the
activity of p38 MAPK dramatically increased during reperfusion of OGD-treated
hippocampal slices. Additionally, OGD/R resulted in Rab5 complex formation with
guanosine nucleotide dissociation inhibitor (GDI) in a similar time-course as the increase
in p38 MAPK activity. This event has been previously documented to be the mechanism
through which p38 MAPK accomplishes increased surface removal of AMPA receptors.
Given that p38 MAPK is in part regulated via cellular stress-signals such as oxidative
stress, we sought to determine if NADPH oxidase served as an important signal for p38
MAPK activation following OGD/R. Indeed, inhibition of NADPH oxidase derived ROS
during OGD/R not only decreased p38 MAPK activation, but also diminished Rab5-GDI
complex formation, providing evidence that the rescue in surface AMPA receptor levels
observed with NADPH oxidase inhibition during OGD/R is accomplished through
attenuating p38 MAPK-dependent endocytic signals. Furthermore, direct pharmacologic
inhibition of p38 MAPK activity also prevented Rab5-GDI complex formation, rescued
AMPA receptor surface removal, and ultimately prevented the selective degradation of
GluR2 subunit protein levels. Inhibition of clathrin-dependent endocytosis with
hypertonic sucrose treatment also prevented the OGD/R-induced surface removal of
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AMPA receptor subunits in addition to rescuing GluR2 protein loss, further illustrating
the importance of early endocytic events in the OGD/R-induced degradation of GluR2.
In the third study, we sought to expand upon the OGD/R-induced NADPH
oxidase-dependent GluR2 trafficking by examining phosphorylation and protein-protein
interaction events known to be important in GluR2 surface removal. Using the same
acute adult rat hippocampal slice model as previously discussed, we found that serine
phosphorylation of the C-terminal tail of the GluR2 subunit at residue 880 increased
following exposure to OGD/R. In its non-phosphorylated state, GluR2 is held at the
plasma membrane via protein-protein interactions with the scaffolding proteins glutamate
receptor interacting protein 1 (GRIP1) and AMPAR binding protein (ABP). When
phosphorylated at serine residue 880 (Ser880), the affinity of GluR2 with GRIP1 and
ABP is diminished, which enables the binding of GluR2 with protein interacting with C
kinase (PICK1). PICK1 has been demonstrated to be important in decreasing the surface
expression of GluR2. We found that in OGD/R-subjected rat hippocampal slices, GluR2GRIP1 association is decreased, while GluR2-PICK1 association is increased.
Additionally, the interaction of activated protein kinase C alpha (PKCα) with PICK1 has
been shown to mediate delivery of PKCα to the plasma membrane, a step along with
PICK1-ABP binding is necessary for the serine880 phosphorylation of GluR2. In
OGD/R-treated rat hippocampal slices, we found that PKCα is activated and
subsequently associates with PICK1 in a time course consistent with the OGD/R-induced
increase in GluR2 Ser880 phosphorylation. Interestingly, we found that pharmacologic
inhibition of NADPH oxidase during OGD/R attenuated GluR2 Ser880 phosphorylation,
increased GluR2-GRIP1 association, decreased GluR2-PICK1 association, and dampened
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PKCα activation and interaction with PICK1, ultimately preventing the selective
degradation of the GluR2 subunit following OGD/R. Furthermore, we found that the
interaction of GluR2 with PICK1 is a necessary step involved in the OGD/R-induced
GluR2 degradation, as pharmacologic inhibition of the PICK1-GluR2 interaction failed to
prevent GluR2 Ser880 phosphorylation, but succeeded in rescuing total GluR2 protein
levels. This third study, in combination with the second, provides evidence for NADPH
oxidase dependent pathways both at the level of the AMPAR as well as the level of the
endocytic machinery responsible for internalization, with both signals ultimately
contributing to the OGD/R-induced loss of GluR2 protein surface expression.
The research presented also opens up numerous avenues for future research
direction. Other NMDAR subunits, such as the NR2B, also undergo tyrosine
phosphorylation, an event that results in the extra-synaptic targeting of NMDARs. To
date, the role of NADPH oxidase in mediating the OGD/R-induced increase in NR2B
tyrosine phosphorylation has not been investigated. Additionally, other phosphorylation
sites exist on NMDARs, and their role in effecting NMDAR function and synaptic
targeting have not been fully studied, particularly in the context of OGD/R and NADPH
oxidase-mediated signaling events.
Beyond internalization, the OGD/R-induced trafficking of AMPARs subunits has
yet to be fully elucidated. While both GluR1 and GluR2 are internalized, differential
sorting must occur to result in the drastic reduction of GluR2 protein following OGD/R.
Investigation into the cellular signals, protein-protein interactions and endosomal
trafficking patterns of all of the AMPAR subunits would be of great value to further
understand the precise mechanisms involved in the OGD/R-induced degradation of
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GluR2. Additionally, studies aimed at elucidating potential roles for NADPH oxidasederived ROS in mediating AMPAR subunit recycling patterns would provide useful
insight into the decreased surface expression of GluR2 following OGD/R. Experiments
utilizing calcium imagining and/or electrophysiology technique in order to obtain
functional confirmation of the biochemical changes following OGD/R presented in this
dissertation would also be of interest. Lastly, characterization of these findings in an in
vivo model of ischemia/reperfusion could also serve a potential future direction of study
and provide useful knowledge on the role of NADPH oxidase following OGD/R in
mediating cellular signaling events in a living animal model.
In summary, these studies have elucidated an ischemic-induced redox-sensitive
signaling cascade for altered ionotropic glutamatergic receptor function that is dependent
on NADPH oxidase activity. Through inhibition of NADPH oxidase ROS generation, we
speculate that the OGD/R-induced enhancement of calcium entry from NMDAR
potentiation and loss of calcium-impermeable AMPAR expression is prevented,
ultimately increasing cellular viability in post-ischemic tissue. Further studies need be
done to fully understand the intricacies of OGD/R-induced NADPH oxidase signaling,
perhaps ultimately leading to possible NADPH oxidase targeted therapeutic intervention
pharmaceuticals for stroke-patient care.
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